Advanced MRI Markers: Predicting Diabetic Foot Ulcer Healing

Summary: Presented at the American Diabetes Association Scientific Sessions, this prospective observational study from Emory University explores noncontrast MRI perfusion imaging to forecast diabetic foot ulcer (DFU) healing. In 17 patients with chronic plantar forefoot ulcers, the technique measured resting tissue perfusion and microvascular reactivity using a dynamic cuff-occlusion method. Over 12 weeks, 47% of ulcers healed, with non-healers showing elevated resting perfusion but impaired microvascular function—such as delayed time-to-peak hyperemia (171 seconds vs. 101 seconds) and reduced tissue oxygen reserve (-6.5% vs. -3.2%). These findings suggest MRI markers could enhance prognostic accuracy, guiding targeted interventions to prevent amputations in cases where standard vascular assessments fall short, leaving 1 in 6 patients with unresolved wounds after a year.

Key Highlights:

• Noncontrast MRI revealed microvascular deficiencies in non-healers despite adequate macrocirculation, aligning with clinical challenges in DFU management.
• Healing occurred in 47% of chronic ulcers over 12 weeks, emphasizing the need for better predictive tools in limb preservation.
• Key metric: Time-to-peak hyperemia was markedly longer in non-healers (171s vs. 101s), indicating poorer reactive hyperemia for tissue repair.
• Tissue oxygen reserve capacity trended lower in non-healers (-6.5% vs. -3.2%), highlighting MRI’s potential to assess functional perfusion.
• Ongoing research integrates these markers with clinical data for refined models, promising personalized strategies to reduce amputation risks.

Read full article

Keywords:
diabetic foot ulcers,
MRI perfusion imaging,
microvascular reactivity,
DFU healing prediction,
limb preservation

Debridement and ALBC in DFUs: Alleviating Pain and Improving Psychological Status

Summary: This retrospective study of 103 diabetic foot ulcer (DFU) patients examines the impact of debridement combined with antibiotic-loaded bone cement (ALBC) on pain and psychological status. Using Brief Pain Inventory (BPI) and Hospital Anxiety and Depression Scale (HADS), it found significant reductions in pain severity and impact scores (p<0.001), as well as anxiety and depression scores (p<0.001), particularly in patients with baseline symptoms. The treatment promoted wound healing in 69.9% of cases through infection control and granulation tissue formation, highlighting its role in comprehensive DFU management that addresses both physical and mental health.

Key Highlights:

• ALBC reduced pain scores in the pain group (n=61) from baseline, though they remained higher than in the numbness group (n=42), linking higher BMI and Wagner grade III to pain.
• Anxiety scores decreased across groups (n=67 anxiety, n=36 non-anxiety), with fewer moderate/severe cases post-treatment, independent of pain relief.
• Depression scores improved significantly (n=16 depression, n=87 non-depression), correlating with better wound progression and reduced exudate.
• 69.9% of wounds showed healing with induced membrane and granulation tissue, minimizing enlargement and supporting fewer interventions.
• Baseline psychological distress predicted greater improvements after adjusting for confounders like age and ulcer grade, advocating for integrated care.

Read full article

Keywords:
diabetic foot ulcers,
debridement,
antibiotic loaded bone cement,
pain management,
psychological health

UC San Diego Study: Staphylococcus Aureus Delays Wound Healing

Summary: Researchers at UC San Diego have identified how Staphylococcus aureus, a common cause of skin infections, delays wound healing via its quorum sensing system—a bacterial communication method that suppresses host immune responses and tissue repair. Published in a leading medical journal, the study demonstrates that targeting this pathway can restore normal healing processes without antibiotics, offering a novel approach to combat antibiotic resistance while preserving beneficial skin microbiota.

Key Highlights:

• S. aureus quorum sensing coordinates virulence factors that inhibit keratinocyte metabolism and wound closure, even at low bacterial loads.
• Disrupting the accessory gene regulator (agr) system in mouse and human models accelerates healing to levels seen in uninfected wounds.
• This method targets resistant strains like MRSA without killing bacteria, reducing risks of resistance and secondary infections.
• Potential for precision therapies that enhance existing wound care by selectively silencing bacterial signals while supporting skin regeneration.
• Findings highlight the wound microbiome’s role, where harmless staphylococci may aid healing unlike pathogenic S. aureus.

Read full article

Keywords:
Staphylococcus aureus,
quorum sensing,
antibiotic free wound therapy,
MRSA management,
wound healing innovation

Targeting Bacterial Communication: Antibiotic-Free Wound Therapy

Summary: Researchers at UC San Diego have uncovered how Staphylococcus aureus delays wound healing through its quorum-sensing system, which coordinates bacterial virulence and suppresses skin cell metabolism. Published in The Journal of Clinical Investigation, the study demonstrates that interfering with this bacterial communication restores normal healing even in the presence of high bacterial loads, paving the way for antibiotic-free therapies to treat chronic wounds and hospital-acquired infections without promoting resistance.

Key Highlights:

• S. aureus activates its accessory gene regulator (agr) quorum-sensing system during infection, inhibiting keratinocyte lipid enzymes essential for skin repair and dramatically slowing wound closure.
• Disrupting the agr system in mouse and human wound models restored metabolic function in keratinocytes and accelerated healing, comparable to uninfected controls.
• Harmless skin bacteria like Staphylococcus hominis do not impair healing and may even promote beneficial metabolic activity, highlighting the wound microbiome’s role.
• This approach targets MRSA and other resistant strains prevalent in surgical sites, reducing risks of bloodstream infections and pneumonia while preserving healthy bacteria.
• Potential for new therapies that “disarm” bacterial virulence without killing microbes, addressing antibiotic resistance in chronic wound care.

Read full article

Keywords:
quorum sensing,
Staphylococcus aureus,
antibiotic free therapy,
MRSA wounds,
wound healing innovation

Choice of Primary Repair in Animal Bite Wounds: A Novel Management Strategy

Summary: This article introduces a novel management strategy for animal bite wounds, primarily from dogs and cats, which pose significant risks especially to children due to potential infections from oral bacteria. Challenging the standard practice of surgical debridement followed by delayed primary closure, the study evaluates criteria for safe primary repair, demonstrating reduced infection rates, better cosmetic results, and shorter healing times in low-risk cases like facial bites with thorough irrigation and antibiotics.

Key Highlights:

• Animal bites often lead to polymicrobial infections; primary repair is feasible in clean, low-risk wounds after aggressive debridement and prophylactic antibiotics.
• Facial bites in children benefit most from primary closure to prevent scarring and functional impairment.
• Prospective evaluation shows infection rates under 2% with the novel protocol, compared to 5-10% in delayed closure.
• Emphasizes multidisciplinary assessment including wound location, depth, and patient factors for decision-making.
• Calls for updated guidelines to incorporate this strategy, reducing unnecessary delays in healing.

Read full article

Keywords:
animal bite wounds,
primary repair,
delayed closure,
wound infection prevention,
pediatric wound management

Preventing Pressure Injuries in Pediatric EEG Monitoring: The Role of Polyurethane Foam

Summary: This retrospective study evaluates a simple intervention using polyurethane foam to prevent medical device-related pressure injuries (PIs) in children undergoing continuous electroencephalography (CEEG). By placing 5mm-thick foam with silicone dressing on the frontal forehead between electrodes and 4cm-thick foam on the back of the head for immobile patients, the method reduced PI incidence from 6.5% (5/77 patients) in the standard group to 1.5% (1/65 patients) in the intervention group, achieving a 77% prevention rate. This low-cost approach is particularly valuable for infants with fragile skin, minimizing scarring risks without compromising EEG quality.

Key Highlights:

• CEEG electrodes and head wrapping commonly cause PIs in 7.8% of pediatric cases, with higher risks in infants due to immature skin.
• Intervention group showed significantly lower PI rates (1.5% vs. 6.5%), supporting foam’s pressure-redistribution efficacy.
• Method is easy to implement, using inexpensive materials, and suitable for various facilities monitoring seizures or cortical function.
• Risk assessment via Glamorgan scale identified high-risk patients, but foam prevented injuries across ages <18 years.
• Potential to reduce cosmetic scarring and complications, emphasizing proactive wound prevention in device-related care.

Read full article

Keywords:
pressure injuries,
polyurethane foam,
pediatric wound care,
EEG monitoring,
medical device related PIs

The Clinical Effectiveness of Integrated Digital Wound Management Systems

Summary: This rapid review assesses the evidence for clinical and cost-effectiveness of integrated digital wound management (IDWM) systems, which use 3D imaging and apps for accurate wound assessment and monitoring. From 17 studies (2012–2023), IDWM shows high reliability for surface area measurements (especially 3–10cm² wounds), reduces assessment time by up to 79%, improves documentation and patient satisfaction, and enables remote monitoring. However, depth measurement is inaccurate, comparative healing outcomes are limited, and cost-effectiveness remains undetermined due to sparse data.

Key Highlights:

Read full article

Keywords:
integrated digital wound management,
IDWM systems,
wound measurement,
chronic wound care,
digital wound assessment

COVID-19’s Impact on Diabetes Outcomes: Key Insights for Wound Care

Summary: This review synthesizes evidence from 138 studies on the indirect effects of the COVID-19 pandemic on clinical outcomes in diabetic patients, highlighting healthcare disruptions that exacerbated morbidity and mortality. Key findings include consistent rises in diabetes-related deaths and major amputations, with mixed results for foot ulcer presentations and hospitalizations. Vulnerable groups—females, younger adults, and racial/ethnic minorities—faced disproportionate risks, emphasizing the need for targeted interventions to prevent wound complications like delayed ulcer management leading to amputations in future crises.

Key Highlights:

• Diabetes-related mortality increased across all 13 studies, with sharper rises in younger adults (ages 25-44) and racial/ethnic minorities.
• Major amputations rose in 9 of 12 studies, often linked to pandemic delays in foot care and ulcer monitoring.
• Foot ulcer presentations showed mixed trends: 4 studies reported decreases, 4 increases, and 1 no difference, reflecting uneven access to wound care services.
• Hospital and emergency admissions for diabetes varied, with increases noted in pediatric cases and certain adult subgroups amid lockdowns.
• Diabetic ketoacidosis (DKA) outcomes were inconsistent, but 3 systematic reviews indicated overall increases, complicating glycemic control and healing.

Read full article

Keywords:
diabetes complications,
diabetic foot ulcers,
major amputations,
COVID-19 wound care,
healthcare disruptions

Incidence and Predictors of Diabetic Foot Ulcers in Ethiopian Diabetes Patients

Summary: This retrospective cohort study at Debre Berhan Comprehensive Specialized Hospital in Ethiopia (2005–2021) tracked 321 newly diagnosed adult diabetes patients, finding a cumulative diabetic foot ulcer (DFU) incidence of 11.8% (1.01 per 100 person-years). Key predictors included older age (≥70 years, AHR=15.025), rural residence (AHR=2.731), hypertension (AHR=5.609), obesity (AHR=2.936), neuropathy (AHR=4.583), and abnormal HDL levels (AHR=3.713). Using Cox regression and Kaplan-Meier analysis, the study underscores the need for early screening and education to prevent complications like amputations in resource-limited settings.

Key Highlights:

• Cumulative DFU incidence of 11.8%, with higher risks in older patients and those with neuropathy or hypertension.
• Rural residence doubles DFU risk due to limited access to foot care and education.
• Obesity and low HDL levels significantly elevate odds, linking metabolic factors to delayed wound healing.
• Study calls for integrated policies emphasizing screening and self-management to reduce amputation rates.
• Limitations include incomplete data and lack of behavioral factors, highlighting needs for prospective research.

Read full article

Keywords:
diabetic foot ulcers,
DFU predictors,
diabetes complications,
rural wound care,
wound prevention

Enhancing Wound Repair: Artificial Dermal Scaffolds with Recombinant Human Epidermal Growth Factor

Summary: This comparative study investigates the efficacy of artificial dermal (AD) scaffolds compounded with recombinant human epidermal growth factor (Rh-EGF) in promoting wound repair in a rat model. The composite scaffold demonstrates sustained Rh-EGF release, enhances cell proliferation and adhesion in vitro, and accelerates in vivo healing by stimulating epithelial regeneration, collagen production, angiogenesis, and cell proliferation, while showing potential to minimize scar formation through reduced fibrosis markers.

Key Highlights:

• AD/Rh-EGF scaffolds effectively absorb and release Rh-EGF, overcoming limitations like slow vascularization in standard AD materials.
• In vitro assays confirm improved L929 fibroblast proliferation and adhesion with the composite scaffold.
• In vivo, the composite promotes faster wound closure over 21 days compared to AD alone, Rh-EGF alone, or controls.
• Histological analysis reveals enhanced epithelial tissue regeneration, collagen deposition, and angiogenesis, with trends toward lower scar formation.
• Findings support clinical translation for advanced wound dressings in chronic wound management.

Read full article

Keywords:
artificial dermal scaffolds,
Rh-EGF,
wound healing,
angiogenesis,
scar reduction

Negative Pressure Wound Therapy for Complicated Diabetic Foot Wounds

Summary: This retrospective case series assesses negative pressure wound therapy (NPWT) in 30 diabetic patients with complicated foot or lower limb infections over 15 years. Following initial debridement and antibiotics, NPWT at -125 mmHg for 7-12 days promoted granulation and healing in 80% of cases, preventing major amputations despite high-risk features like ischemia and polymicrobial infections (e.g., MRSA, E. coli). Five patients (16.6%) required major amputations, and one died. No associations were found with standard classifications (WIFI, IWGDF, TPI). A literature review supports NPWT as an adjunct for faster healing and reduced amputations in selected DFUs, though guidelines caution its use in active infections. The study highlights NPWT’s potential in real-world settings but calls for larger RCTs to confirm benefits.

Key Highlights:

• NPWT achieved limb preservation in 80% of high-risk diabetic wounds, with 20% fully healing via grafts or sutures.
• Common pathogens like MRSA and E. coli were managed effectively post-debridement, reducing infection persistence.
• Average NPWT duration was 9 days, with hospital stays of 25 days, underscoring its feasibility in clinical practice.
• Challenges include guideline limitations for infected wounds and need for multidisciplinary approaches to optimize outcomes.
• Literature shows NPWT halves amputation risks compared to standard care in some trials, supporting its innovative role.

Read full article

Keywords:
diabetic foot ulcers,
negative pressure wound therapy,
wound healing innovations,
diabetic wound infections,
limb salvage in diabetes

Wound Care Around the World

Summary: This international feature examines wound care practices and challenges across various healthcare systems. Experts discuss access disparities, education, and community-based solutions to improve patient outcomes globally.

Key Highlights:

• Compares international wound care standards and challenges.
• Highlights workforce and education disparities.
• Explores innovations in low-resource settings.
• Encourages collaboration to raise global care quality.

Read full article

Keywords:
global wound care,
education,
health systems,
international practice

Saving Organs, Saving Lives: Transforming Wound Care Through Non-Surgical Treatments

Summary: This blog post showcases the innovative non-surgical approaches at KBK Hospitals in Hyderabad, led by Kakkireni Bharath Kumar, to treat complex wound conditions like cellulitis, gangrene, and diabetic foot ulcers. Aligned with the mission “Save Organ, Save Life,” the hospital prioritizes infection control, tissue preservation, and natural healing to prevent amputations, restore mobility, and enhance patient quality of life through personalized, advanced therapies.

Key Highlights:

• Cellulitis treatment focuses on controlling infections, reducing inflammation, and preventing spread with tailored plans for faster recovery and tissue preservation.
• Gangrene care improves blood circulation, removes dead tissue, and stimulates healing to avoid amputation and restore function without surgery.
• Diabetic foot ulcer programs promote wound closure, minimize infection risks, and support complete recovery using modern technologies and expert monitoring.
• Emphasis on compassionate, holistic care that rebuilds patient confidence and mobility, positioning the hospital as a leader in non-invasive wound management.

Read full article

Keywords:
non surgical wound care,
diabetic foot ulcers,
gangrene treatment,
cellulitis management,
limb preservation

AI-Powered Prediction of Postoperative Wound Infections in Diabetic Patients

Summary: This study develops DiabCompSepsAI, a Random Forest Classifier using NSQIP data to predict postoperative wound infections and sepsis in diabetic patients with high accuracy (94%+). By analyzing factors like surgical duration, wound classification, and comorbidities, the model enables early interventions to mitigate healing complications, reduce hospital stays, and lower costs in this high-risk group.

Key Highlights:

• DiabCompSepsAI achieves 94% accuracy in predicting wound infections and sepsis, outperforming traditional risk assessments.
• Top predictors include prolonged surgery, contaminated wounds, and patient weight, highlighting modifiable factors for better healing.
• A user-friendly Streamlit app supports real-time predictions, integrating into clinical workflows for proactive wound care.
• AUC scores of 0.92–0.95 demonstrate strong discriminative power, aiding in reducing morbidity from diabetic complications.
• Future validation could expand its use to diverse surgical settings, enhancing postoperative management.

Read full article

Keywords:
diabetic wound infection,
postoperative sepsis,
AI wound prediction,
surgical site infections,
diabetic wound healing

America’s Amputation Crisis: The Path Forward to Save Limbs and Lives

Summary: This final installment in a four-part series on America’s preventable amputation crisis emphasizes systemic solutions to combat unnecessary limb loss, especially in patients with peripheral artery disease (PAD) and diabetes. It critiques healthcare incentives favoring amputation over preservation and proposes a comprehensive approach including early PAD screening via the Ankle-Brachial Index (ABI) test, clinician education, supervised exercise therapy (SET), insurance reforms for limb-salvage procedures, and addressing disparities to enhance wound care outcomes and reduce amputation rates.

Key Highlights:

• The Amputation Reduction and Compassion (ARC) Act seeks to mandate PAD screening coverage under Medicare and Medicaid, with state-level advances like Illinois’ 2025 insurance mandate for at-risk groups.
• Supervised exercise therapy (SET) promotes collateral vessel growth to improve circulation, but low completion rates (only 5%) highlight needs for accessible programs like the Global PAD Association’s “My Steps” initiative achieving 75% retention.
• Insurance barriers delay limb-salvage interventions; reforms call for specialist peer reviews and adherence to Society for Vascular Surgery guidelines before approving amputations.
• Addressing disparities in Black communities and the “amputation belt” involves building centers of excellence, telemedicine, and equity audits to cut amputation rates by up to 87% in underserved areas.
• Innovations like deep vein arterialization (DVA) require expedited coverage via Coverage with Evidence Development to support complex wound healing in critical limb-threatening ischemia (CLI).

Read full article

Keywords:
peripheral artery disease,
limb salvage,
supervised exercise therapy,
amputation prevention,
diabetic foot care

Impact of Wound Malodour: VOCs and Health-Related Quality of Life

Summary: This feasibility study examines how malodour from chronic wounds, driven by volatile organic compounds (VOCs) from bacterial colonization and necrosis, affects patients’ health-related quality of life (HRQoL). Analyzing 92 wounds from 66 patients, it identifies key VOCs like dimethyl disulphide and diacetyl, correlates them with pathogens such as Pseudomonas aeruginosa, and highlights a trend toward greater HRQoL impairment in malodorous cases. The findings advocate for innovative, VOC-targeted therapies to reduce social stigma and support wound healing.

Key Highlights:

• Malodour stems from bacterial VOCs (e.g., dimethyl disulphide from prokaryotes) and necrosis, with biofilms linked to higher odour perception.
• Patients with moderate-to-severe odour showed higher HRQoL impairment (Wound-QoL-14 score 2.1 vs. 1.8), correlating with social isolation and delayed care.
• Pathogen-specific biomarkers identified, such as dimethyl trisulphide for P. aeruginosa and indole for E. coli, enabling targeted antimicrobial strategies.
• Current dressings like activated charcoal offer partial relief (48% efficacy); future VOC antagonists could enhance biomaterials for odour control and tissue regeneration.
• Epithializing wounds had lower VOCs and odour, underscoring malodour as a stalled healing marker.

Read full article

Keywords:
wound malodour,
volatile organic compounds,
chronic wounds,
health related quality of life,
wound healing innovation

Remote Assessment and Monitoring With Advanced Wound Therapy to Optimise Clinical Outcomes, Access, and Resources

Summary: This study highlights how remote wound monitoring and advanced wound therapy platforms improve healing and patient access. Digital assessment tools enabled real-time adjustments, optimizing care and reducing healing time.

Key Highlights:

• Utilized digital tools for remote wound tracking.
• Enhanced patient access and treatment accuracy.
• Improved healing speed and reduced complications.
• Supports telehealth integration into chronic wound management.

Read full article

Keywords:
telehealth,
wound monitoring,
advanced wound therapy,
digital health

Factors Influencing Dressing Choice in Wound Care: A Discussion

Summary: This discussion outlines how wound type, exudate level, infection risk, and cost considerations guide dressing selection. It stresses evidence-based choice, patient comfort, and regular reassessment to optimize healing outcomes.

Key Highlights:

• Explains how exudate and infection risk drive dressing selection.
• Highlights cost and patient comfort as clinical factors.
• Encourages evidence-based individualized care.
• Recommends ongoing evaluation during wound healing.

Read full article

Keywords:
dressing choice,
wound assessment,
clinical decision,
wound management

Clinical Evidence and Cost-Effectiveness: Advanced Cellular Tissue Products for Diabetic Foot Ulcers

Summary: This article provides a comprehensive review of the clinical evidence and cost-effectiveness of advanced cellular/tissue products (CTPs) for diabetic foot ulcers (DFUs), focusing on FDA-approved options like Apligraf and Dermagraft. It demonstrates their superiority over standard care in achieving higher healing rates, shorter closure times, and reduced complications such as infections and amputations, while delivering significant long-term cost savings despite initial expenses. The discussion underscores the urgent need for early intervention in DFU management amid rising diabetes prevalence.

Key Highlights:

• CTPs like Apligraf (human skin equivalent) and Dermagraft (dermal skin substitute) promote faster wound closure and lower amputation risks in chronic DFUs unresponsive to standard care.
• Randomized trials show up to twice the healing rates with CTPs, supported by real-world data and meta-analyses confirming reduced hospitalization and infection risks.
• Economic analyses reveal per-patient savings of $5,253–$6,991 over 18 months, offsetting upfront costs through fewer emergency visits and inpatient stays.
• Challenges include high DFU recurrence (50% within 1 year) and the need for prompt adjunctive therapies to prevent 1 in 6 cases from leading to amputation.

Read full article

Keywords:
diabetic foot ulcers,
cellular tissue products,
Apligraf,
Dermagraft,
cost-effective wound care

Optimizing Wound Bed Preparation: Advances in Debridement Techniques

Summary: This article reviews the latest advancements in debridement techniques aimed at optimizing wound bed preparation for chronic wounds. It discusses methods such as enzymatic, mechanical, and biological debridement, highlighting their efficacy in removing necrotic tissue and promoting healing, while addressing challenges like infection control and patient comfort during treatment.

Key Highlights:

• Enzymatic debridement effectively targets dead tissue with minimal damage to healthy tissue.
• Mechanical debridement offers rapid removal but requires careful application to avoid trauma.
• Biological debridement using larvae shows promise in infection management and biofilm disruption.
• Further research is needed to standardize protocols and enhance patient tolerability.

Read full article

Keywords:
wound bed preparation,
debridement techniques,
chronic wounds,
infection control,
wound healing innovation

Enhancing Diabetic Foot Prevention: Global Guidelines and Questionnaire Tools

Summary: This systematic review examines international guidelines and validated questionnaire tools for diabetic foot screening (DFS), highlighting their role in preventing diabetic foot ulcers amid rising diabetes prevalence. It synthesizes core screening elements like neuropathy, vascular, and visual assessments, along with risk stratification models and screening frequencies, while identifying variations across guidelines and the potential of tools like Q-DFD and MNSI for accessible, self-managed prevention.

Key Highlights:

• Core DFS components include monofilament testing for neuropathy, pedal pulse palpation for vascular status, and visual inspection for early ulcer signs.
• Risk stratification categorizes patients as low-, moderate-, or high-risk, with screening intervals from annual to quarterly based on IWGDF and ADA guidelines.
• Questionnaire tools such as Q-DFD and DFSQ-UMA enhance self-assessment and accessibility in diverse settings, reducing amputation risks.
• Challenges involve guideline standardization and implementation in resource-limited areas; broader adoption by general practitioners could lower healthcare costs.

Read full article

Keywords:
diabetic foot screening,
diabetic foot ulcers,
risk stratification,
questionnaire tools,
wound healing prevention

Open Data for Wound Care Research: A Comprehensive Dataset on Chronic Wounds

Summary: This article presents a newly released open-access dataset focused on chronic wounds, offering detailed clinical and imaging data to support wound care research. It emphasizes the dataset’s potential to enhance understanding of wound progression and improve treatment strategies, while noting the need for standardized analysis methods to maximize its utility.

Key Highlights:

• The dataset includes clinical records and high-resolution images of chronic wounds.
• It aims to accelerate research into chronic wound management and healing processes.
• Access is freely available to researchers, fostering global collaboration.
• Challenges include ensuring data consistency and developing robust analytical tools.

Read full article

Keywords:
open data,
chronic wounds,
wound care research,
clinical dataset,
wound healing innovation

Use of Three-Dimensional Acellular Collagen Matrix in Deep or Tunnelling Diabetic Foot Ulcers: A Retrospective Case Series

Summary: This case series assessed the effectiveness of a three-dimensional acellular collagen matrix in promoting angiogenesis and tissue regeneration in deep or tunnelling diabetic foot ulcers. The matrix demonstrated improved closure rates and reduced infection risk.

Key Highlights:

• Enhanced tissue growth and angiogenesis within wound tunnels.
• Improved wound closure timelines versus standard care.
• Reduced infection and improved tissue quality outcomes.
• Demonstrated versatility for complex diabetic ulcers.

Read full article

Keywords:
collagen matrix,
diabetic foot ulcer,
tunnelling wound,
wound regeneration

Advancing Wound Healing: Gelatin-Based Hydrogel Films with Manuka Honey

Summary: This article explores the development of gelatin-based hydrogel films incorporated with Manuka honey as an innovative solution for wound healing. The study highlights the films’ enhanced antibacterial properties, biocompatibility, and ability to maintain a moist wound environment, making them promising for clinical applications. It also discusses challenges in optimizing mechanical strength and honey concentration for practical use.

Key Highlights:

• Gelatin-Manuka honey hydrogels exhibit strong antibacterial activity against common wound pathogens.
• The films provide a moist, flexible environment conducive to tissue repair and regeneration.
• In vitro tests confirm biocompatibility with human skin cells, supporting safe application.
• Further research is needed to improve mechanical durability and scalability for clinical settings.

Read full article

Keywords:
gelatin hydrogel,
Manuka honey,
antibacterial wound dressing,
biocompatible materials,
wound healing innovation

Sustainable Wound Healing Using Riboflavin-Enhanced Nanocomposite Hydrogels

Summary: This study presents a riboflavin-enhanced nanocomposite hydrogel designed to promote sustainable wound healing through multifunctional mechanisms. The hydrogel integrates oxygen delivery, antibacterial effects, and biocompatibility to improve the healing process. Laboratory and animal studies demonstrated that the material enhances wound closure by reducing infection, relieving hypoxia, and promoting cellular activity.

Key Highlights:

• Hydrogel incorporates riboflavin to generate oxygen-reactive species for antimicrobial action and tissue repair.
• Supports oxygen diffusion and reduces hypoxic stress in damaged tissue.
• In vitro and in vivo results show improved cell compatibility and faster healing.
• Combines infection control, oxygenation, and tissue regeneration in one wound care platform.

Read full article

Keywords: nanocomposite hydrogels, riboflavin, wound healing, oxygen delivery, antimicrobial therapy

Incidence of diabetic foot ulcer and its predictors among adult diabetes patients in Northern Ethiopia: a retrospective cohort study

Summary: This retrospective cohort study assessed the incidence and key predictors of diabetic foot ulcers among adult diabetes patients in Northern Ethiopia. Following 321 individuals over several years, the research identified clinical and demographic factors significantly associated with ulcer development, emphasizing the importance of early detection and targeted prevention for high-risk patients.

Key Highlights:

• The incidence rate of diabetic foot ulcers was 1.01 per 100 person-years, with 11.8% of patients developing ulcers during follow-up.
• Older age (≥70 years) increased the risk nearly fifteenfold compared with younger patients.
• Other predictors included rural residence, hypertension, neuropathy, obesity, and abnormal HDL cholesterol levels.
• Findings underscore the need for proactive risk-based management in diabetic populations.

Read full article

Keywords: diabetic foot ulcer, incidence, predictors, retrospective cohort, Ethiopia

Clinical Evidence for and Cost-Effectiveness of Advanced Cellular Tissue Products for the Treatment of Diabetic Foot Ulcers

Summary: This review evaluates the clinical and economic evidence supporting advanced cellular tissue products (CTPs) as adjunctive therapies for diabetic foot ulcers. The article highlights studies demonstrating improved wound healing rates and reduced time to closure with certain CTPs compared to standard care. It also discusses economic models suggesting that CTPs may lower long-term healthcare costs by reducing complications and the need for amputations.

Key Highlights:

• CTPs, including bioengineered skin substitutes, show superior healing outcomes versus standard treatment.
• Economic analyses suggest potential cost savings through reduced infections and amputations.
• Comparative data indicate variations in cost-effectiveness across different product types.
• Further large-scale studies are needed to optimize patient selection and maximize clinical and financial benefits.

Read full article

Keywords: advanced cellular tissue products, diabetic foot ulcer, cost effectiveness, wound healing, health economics

Dehydrated Human Amnion/Chorion Membrane to Treat Venous Leg Ulcers: A Cost-Effectiveness Analysis

Summary: This cost-effectiveness analysis compared dehydrated human amnion/chorion membrane (dHACM) with standard care for venous leg ulcers. The results showed faster closure rates, fewer recurrences, and lower overall treatment costs, confirming dHACM as a clinically and economically viable option.

Key Highlights:

• Improved healing speed and reduced recurrence with dHACM.
• Lowered total care costs and fewer clinical visits required.
• Validated long-term cost-effectiveness for chronic ulcers.
• Reinforces biologic use in venous leg ulcer management.

Read full article

Keywords:
dHACM,
venous leg ulcer,
biologic therapy,
cost analysis

How living fungi bandages are shaping the future of healing

Summary: This article explores the development of living fungi-based bandages, particularly those made from mycelium hydrogels, as a groundbreaking approach to wound healing. The discussion highlights the unique biological and structural properties of mycelium that make it suitable for wound repair, its potential to promote tissue regeneration, and the current challenges researchers face in bringing this innovation to clinical use.

Key Highlights:

• Mycelium hydrogels mimic soft tissue and provide an ideal moist healing environment.
• Living fungi materials exhibit self-repair, biocompatibility, and adaptive wound response.
• Researchers have demonstrated strong hydration retention and mechanical stability in lab settings.
• Further studies are needed to address immune compatibility and long-term viability in patients.

Read full article

Keywords:
living fungi bandages,
mycelium hydrogel,
tissue regeneration,
biomaterials,
wound healing innovation

Smart Grey Wolf neural network (MGWONET): transforming diabetic foot ulcer analysis

Summary: This article presents the MGWONET model, an advanced neural network based on the Grey Wolf Optimizer algorithm, designed to enhance diabetic foot ulcer analysis and predict healing outcomes. The research outlines the model’s architecture, data integration methods, and validation process, demonstrating how artificial intelligence can improve wound assessment accuracy and support clinical decision-making.

Key Highlights:

• MGWONET applies Grey Wolf optimization to refine wound data interpretation.
• Achieves high accuracy in predicting diabetic foot ulcer healing outcomes.
• Facilitates early identification of non-healing wounds for timely intervention.
• Represents a step toward AI-driven diagnostic tools in wound care practice.

Read full article

Keywords: MGWONET, Grey Wolf Optimizer, artificial intelligence, diabetic foot ulcer, wound analysis

Therapy with Vancomycin-Loaded Polymethylmethacrylate Cement Demonstrates Limited Advantage in the Treatment of Infected Diabetes-Related Foot Ulcers: Only Patients with Osteomyelitis Benefited

Summary: This study evaluates the clinical effectiveness of vancomycin-loaded polymethylmethacrylate (PMMA) cement in treating infected diabetes-related foot ulcers. Results revealed that the therapy offered limited overall advantage, with significant improvement observed only among patients with confirmed osteomyelitis. Findings suggest that PMMA antibiotic delivery may be most beneficial when bone infection is present.

Key Highlights:

• Vancomycin-loaded PMMA cement showed benefit exclusively in patients with osteomyelitis.
• No significant improvement observed in soft-tissue infection cases without bone involvement.
• Results highlight the importance of infection type in guiding antibiotic delivery approaches.
• Authors recommend further studies to refine local antibiotic strategies for diabetic foot infections.

Read full article

Keywords:
vancomycin,
polymethylmethacrylate cement,
diabetic foot ulcer,
osteomyelitis,
antibiotic therapy

Research Roundup, Vol. 4, Issue 1

Summary: This issue of Research Roundup compiles highlights from current wound care studies. Topics include antimicrobial technology, regenerative therapies, and clinical diagnostic tools, offering practical insights for modern wound management.

Key Highlights:

• Reviews emerging data on biofilm disruption and infection control.
• Explores new regenerative and cellular therapy options.
• Features updates in wound diagnostics and imaging.
• Summarizes clinically relevant global research trends.

Read full article

Keywords:
research roundup,
antimicrobial,
regenerative medicine,
wound healing

Enhancing patient outcomes through effective guideline implementation

Summary: This article examines the impact of implementing clinical guidelines for pressure ulcer prevention and management. It analyzes changes in incidence rates, patient quality of life, and associated healthcare costs after adopting guideline-based practices in inpatient settings.

Key Highlights:

• Guideline implementation correlated with decreased pressure ulcer incidence.
• Quality of life metrics improved post-implementation.
• Healthcare costs were reduced by lowering resource use and ulcer complications.
• Supports wider adoption of standardized protocols in wound care practice.

Read full article

Keywords:
guideline implementation,
pressure ulcer,
quality of life,
healthcare costs,
wound prevention

The Role of Conjunctive Hyperbaric Oxygen Therapy in Decreasing Amputations in those with Diabetic Foot Ulcers: A Clinical Review

Summary: This clinical review appraises published evidence on the adjunctive use of hyperbaric oxygen therapy (HBOT) in diabetic foot ulcers (DFUs) and its impact on reducing major amputations and enhancing healing. Incorporating six comparative studies, the review synthesizes outcomes on wound size, infection, amputation rates, and mortality.

Key Highlights:

• HBOT as an adjunct to standard wound care demonstrated superior healing and reduced amputation in chronic DFUs.
• Meta-analyses included show consistent trends favoring HBOT over conventional therapy alone.
• The review process included filters, MeSH terms, and strict inclusion criteria to narrow to six high-quality studies.
• Authors call for larger prospective trials to better quantify risks, benefits, and optimal protocols.

Read full article

Keywords:
hyperbaric oxygen therapy,
diabetic foot ulcer,
amputation risk,
wound healing,
adjunctive therapy

Functionally Enriched Human Polymorphisms Associate to Species in the Chronic Wound Microbiome

Summary: This open-access study conducted a microbiome genome-wide association (mbGWAS) across >500 patients with chronic wounds, linking human genetic variants to relative abundance of specific bacterial species. The results show that host genetics partially shape wound microbial communities, revealing 193 candidate loci across 25 genomic regions associated with 16 bacterial species. These findings suggest a genetic influence on wound colonization and healing trajectories.

Key Highlights:

• Identified 193 candidate variants across 25 genomic regions linked to 16 wound bacterial species.
• Per-species heritability estimates ranged up to 20%.
• Functional annotation showed enriched pathways in extracellular matrix organization, immune signaling, and transport.
• Species associated via genetics co-occurred with known pathogens such as *Staphylococcus aureus*.
• Genetic distance among patients correlated with overall microbiome dissimilarity.

Read full article

Keywords:
chronic wound microbiome,
genetic variants,
mbGWAS,
host-microbiome interactions,
bacterial community structure

Heel Diabetic Foot Osteomyelitis: A Current Challenge in the Clinical Practice

Summary: This retrospective observational study assessed outcomes of patients with diabetic foot osteomyelitis (DFO) managed in a specialized diabetic foot service between 2019 and 2022. Researchers compared patients with heel DFO to those with forefoot or midfoot DFO over a one-year follow-up, examining healing rates, healing time, amputation, and mortality.

Findings: Among 114 patients (mean age 67.9 years, 72.8% male, 91.2% type 2 diabetes), 30 had heel DFO and 84 had forefoot/midfoot DFO. Heel DFO patients exhibited more severe infection indicators, including larger ulcers (>5 cm), higher C-reactive protein levels, and greater prevalence of gangrene and peripheral arterial disease (PAD). Healing outcomes were significantly poorer for heel DFO cases, with longer healing times and higher rates of major amputation.

• Healing rate: 66.7% (heel) vs 97% (forefoot/midfoot)
• Healing time: 14 ± 6 weeks (heel) vs 6.8 ± 5 weeks (forefoot/midfoot)
• Major amputation: 10% (heel) vs 0% (forefoot/midfoot)
• Mortality: 6.6% (heel) vs 4.8% (forefoot/midfoot)

Multivariate analysis identified heel DFO and PAD as independent predictors of major amputation and non-healing. The study concludes that heel DFO represents a distinct clinical challenge associated with worse prognosis and slower recovery compared to other DFO sites.

Read full article

Keywords:
diabetic foot osteomyelitis,
heel ulcer,
diabetic foot ulcer,
amputation risk,
peripheral arterial disease

Use of Hypothermically Stored Amniotic Membrane on Diabetic Foot Ulcers: A Multicentre Retrospective Case Series

Summary: This retrospective multicentre study assessed the clinical outcomes of applying hypothermically stored amniotic membrane (HSAM) in chronic diabetic foot ulcers. Treatment led to faster epithelialization, improved granulation tissue, and reduced inflammation compared with standard care.

Key Highlights:

• Evaluated HSAM’s role in difficult-to-heal diabetic ulcers.
• Observed accelerated closure and reduced infection risk.
• Highlighted regenerative and anti-inflammatory effects.
• Supports HSAM as an adjunct in chronic wound management.

Read full article

Keywords:
amniotic membrane,
diabetic foot ulcer,
wound healing,
HSAM

Edge Trenching: A Case Study of a Novel Debridement Technique

Summary: Debridement is essential in wound bed preparation, but wounds with vertical edges often stall because tissue in the wound base does not merge with wound margins. This case study introduces “edge trenching,” where a small trench is excavated between the wound base and wall to facilitate merger and create a favorable angle for epithelial migration. A 73-year-old male with a chronic Charcot ulcer underwent this technique, achieving closure over 13 months and remaining closed at six years.

Key Highlights:

• Vertical walls or rolled edges can prevent wound base-to-edge merging, stalling closure.
• Edge trenching excavates a trench at the base-edge interface to connect the two surfaces.
• The technique uses small curettes and repeat debridement visits to create a favorable transitional angle.
• Case outcome: successful healing in a challenging Charcot ulcer case, with long-term stability.

Read full article

Keywords:
edge trenching,
debridement,
chronic ulcer,
wound bed preparation,
wound edges

Efficacy and safety of polyhexanide compared with other wound dressings in patients with various wound types: a systematic review and meta-analysis

Summary: This systematic review and meta-analysis evaluates polyhexanide-containing dressings against alternative options across multiple wound types, synthesizing data on healing, infection control, and adverse events to guide formulary and bedside choices.

Key Highlights:

• Compares clinical endpoints: time-to-closure, infection indicators, pain, odor, and quality of life.
• Assesses safety profile and tolerance across etiologies (e.g., VLUs, DFUs, pressure injuries).
• Discusses antimicrobial stewardship considerations for antiseptic dressings.
• Notes heterogeneity in study designs and recommends standardized outcome reporting.

Read the article in WPR

Keywords:
polyhexanide,
systematic review,
meta-analysis,
antiseptic dressings

Research terminology in chronic wound research: a scoping review protocol

Summary: This protocol outlines a scoping review to catalog and standardize terminology used in chronic wound research—aiming to improve comparability, reporting quality, and evidence synthesis across studies and registries.

Key Highlights:

• Plans to map definitions for wound etiology, severity, “standard of care,” and outcome measures.
• Identifies inconsistencies that hinder meta-analysis and guideline development.
• Will propose a harmonized lexicon aligned with consensus frameworks and registries.
• Intended to support regulators, payers, and investigators with clearer standards.

Read the protocol in WPR

Keywords:
scoping review,
terminology,
chronic wounds,
standardization

Wound care practices and training needs among community pharmacists in Saudi Arabia: a cross-sectional study

Summary: This cross-sectional study surveys community pharmacists in Saudi Arabia to map current wound care practices, confidence, and perceived training gaps—informing education and referral pathways at the pharmacy level.

Key Highlights:

• Assesses product counseling, dressing selection, triage, and referral behaviors.
• Identifies knowledge gaps in infection signs, compression/offloading, and chronic wound flags.
• Recommends targeted education modules and standardized guidance tools for pharmacists.
• Supports pharmacist integration into early identification and community-based prevention.

Read the article in WPR

Keywords:
community pharmacists,
training needs,
Saudi Arabia,
primary care wound management

Antimicrobial stewardship in wound care: measurement, implementation, and outcomes

Summary: This article examines antimicrobial stewardship (AMS) specifically within wound care, outlining frameworks to measure antibiotic use, implement stewardship interventions, and assess clinical outcomes while minimizing resistance and toxicity.

Key Highlights:

• Defines AMS metrics relevant to wounds: antibiotic days, spectrum intensity, guideline adherence, culture-guided therapy.
• Describes implementation strategies: care pathways, education, formulary controls, and microbiology collaboration.
• Recommends outcome tracking: healing rates, infection recurrence, adverse drug events, and resistance trends.
• Emphasizes biofilm-aware practice, debridement, and topical/antiseptic stewardship alongside systemic therapy.

Read the article in WPR

Keywords:
antimicrobial stewardship,
wound infection,
antibiotic resistance,
biofilm

Submit Your Abstract for WOCNext

Summary: WOCN is accepting abstracts for WOCNext. Clinicians, researchers, and industry partners are invited to submit research, quality improvement, and education abstracts across wound, ostomy, continence, and foot & nail care practice areas.

Key Highlights:

• Abstract categories typically include research, case series, QI, education, and practice innovations.
• Ideal for sharing outcomes, protocols, and implementation strategies that improve patient care.
• Accepted abstracts may be presented as posters or oral sessions at WOCNext.
• Check submission portal for deadlines, formatting, and author guidelines.

Submit via WOCN

Keywords:
WOCN,
WOCNext,
abstract submission,
wound ostomy continence

Advancing Clinical Trial Design in Chronic Wounds: WCCC Proposes Modernized FDA Guidance

Summary: WoundSource reports on the Wound Care Collaborative Community (WCCC) proposals to modernize FDA guidance for chronic wound trials. The piece highlights recommended changes to endpoints, control arms, patient selection, and real-world methodology to speed innovation while maintaining rigor.

Key Highlights:

• Calls for clinically meaningful endpoints beyond complete closure alone (e.g., durable closure, infection control, pain, function).
• Encourages pragmatic and adaptive designs, leveraging real-world evidence and standardized care pathways.
• Recommends clearer definitions for “standard of care,” stratification by wound etiology/severity, and consistent offloading/compression.
• Supports composite outcomes and longer follow-up to assess durability and recurrence.

Read the full post on WoundSource

Keywords:
WCCC,
FDA guidance,
clinical trial design,
chronic wounds

Comparative study in adults with pressure ulcer stage I (ISRCTN13554350)

Summary: Trial registration detailing a completed comparative study in adults with stage I pressure ulcers. The record provides a plain-language summary, eligibility, and outcomes framework.

Key Highlights:

• Status: Registered Sept 24, 2025; completed; not recruiting.
• Population: Adults with stage I pressure ulcers.
• Utility: Protocol and outcomes help benchmark preventive and early-intervention strategies.

View the trial on ISRCTN

Keywords:
pressure ulcer,
stage I,
clinical trial registration

Efficacy of a full-thickness decellularised placental membrane allograft compared to standard of care in diabetic foot ulcers: a prospective, randomised controlled trial

Summary: Multicentre RCT comparing FT-DPM adjunct to standard care versus standard care alone in persistent DFUs. FT-DPM showed higher 12-week closure and greater percentage area reduction, with fewer serious adverse events.

Key Highlights:

• Design: Eight-site RCT; all wounds offloaded and debrided.
• Outcomes: 12-week closure 48% vs 27% (per protocol); area reduction ~79% vs 56%.
• Safety: Fewer serious AEs in FT-DPM group; none treatment-related.

Read the full article in JWC

Keywords:
Reyzelman,
Vayser,
Hanft,
Cazzell,
placental membrane,
DFU,
randomised controlled trial

Sequence LifeScience, Inc. Announces First Patient Enrolled in Groundbreaking Clinical Trial for Diabetic Foot Ulcers

Summary: Sequence LifeScience reported first-patient-in for a prospective, multicenter trial assessing outcomes of placental membrane allografts in hard-to-heal diabetic foot ulcers.

Key Highlights:

• Study aim: Evaluate wound closure and healing trajectory in chronic DFU using company’s allografts.
• Design: Prospective, multicenter clinical investigation focused on hard-to-heal ulcers.
• Rationale: Address persistent limb-loss risk and need for effective adjunctive biologics.

Read the press release on PR Newswire

Keywords:
Sequence LifeScience,
diabetic foot ulcer,
placental allograft,
clinical trial

Healogics Appoints Arti Masturzo, MD, as President of Healogics Specialty Physicians

Summary: Healogics announced Arti Masturzo, MD, as President of its physician group, HSP. The role focuses on clinical excellence, physician engagement, and integrating technology to advance specialty wound care services.

Key Highlights:

• Leadership focus: Strengthening quality, outcomes, and operational performance across HSP.
• Innovation agenda: Accelerating technology-enabled care models and partnerships.
• Organizational impact: Aligning growth initiatives with evolving patient and provider needs.

Read the press release at Healogics

Keywords:
Healogics,
Arti Masturzo,
wound care leadership

Artificial Intelligence Is Changing Your World — Is It Dystopian?

Summary: Editorial overview of AI’s rapidly expanding role in skin and wound care—from image analysis and infection detection to workflow automation—alongside cautions about bias, data integrity, and responsible adoption.

Key Highlights:

• Clinical promise: Decision support, triage, and remote monitoring may improve accuracy and access.
• Risks & governance: Data quality, transparency, and validation remain essential to avoid harm.
• Action items: Start small, audit outcomes, and align use with standards and patient consent.

Read the editorial in ASWC

Keywords:
artificial intelligence,
wound care technology,
clinical decision support

Closure Rate of Chronic Wound With Sinus Tract Based on Morphological and Pathological Features of the Endoscopic Evaluated Sinus Tract

Summary: Original research examining how endoscopic morphology and pathology of sinus tracts relate to closure outcomes in chronic wounds. The cohort showed a high overall closure rate, with morphologically complex tracts less common but clinically meaningful.

Key Highlights:

• Cohort & design: Prospective endoscopic evaluation of sinus tracts in chronic wounds with standardized follow-up.
• Key finding: Morphologically complex tracts were relatively infrequent but impacted healing dynamics; overall closure rate reported at ~85%.
• Clinical utility: Endoscopic tract characterization can guide targeted debridement, irrigation, and closure strategies.

Read the full study in Wounds

Keywords:
sinus tract,
endoscopic evaluation,
chronic wounds,
closure rate

Use of, and Medicare Expenditure on, Sutureless Amniotic Membrane Grafts Soared — and Maybe Not for a Good Reason

Summary: A new analysis reveals a steep rise in the use and Medicare costs of sutureless amniotic membrane grafts (AMGs) between 2011 and 2020. These grafts, often used in ophthalmology for conditions like dry eye, were reimbursed based on wholesale acquisition cost (WAC), not the provider’s true purchase price. This created significant profit margins that may have fueled overutilization. Experts call for reimbursement reform to prevent misuse while ensuring patient access when clinically appropriate.

Key Highlights:

• Sharp increase in use: Procedures billed for sutureless AMGs jumped from 319 in 2011 to more than 8,000 in 2020.
• Cost escalation: Medicare payments grew from $3.6 million in 2011 to $95.6 million in 2020.
• Profit-driven incentives: Providers could profit up to $600 per graft due to the gap between WAC and actual acquisition cost.
• Concerns of misuse: Utilization patterns suggest many applications may not have been clinically justified, echoing past controversies around skin substitute billing.
• Policy suggestions: Researchers recommend aligning reimbursement with real costs and enforcing oversight to balance access with responsible use.

Read the full article on Managed Healthcare Executive

Keywords:
sutureless amniotic membrane grafts,
Medicare expenditure,
reimbursement incentives,
overutilization,
ophthalmology grafts,
Managed Healthcare Executive

Pro-Angiogenic and Wound-Healing Potential of Bioactive Polysaccharides Extracted from Moroccan Algae Osmundea pinnatifida

Summary: Researchers investigated a bioactive polysaccharide (PSOP) extracted from the red alga Osmundea pinnatifida. Laboratory assays, chick chorioallantoic membrane (CAM) models, and rat wound models confirmed its antioxidant, pro-angiogenic, and wound healing properties. PSOP enhanced vascular growth, collagen formation, and accelerated closure, making it a promising candidate for advanced wound care therapies.

Key Highlights:

• Extraction & analysis: Structural characterization revealed PSOP’s high carbohydrate content and porous morphology, favorable for biomedical use.
• Antioxidant activity: Demonstrated strong radical scavenging and reducing power in vitro, supporting its role in reducing oxidative stress in wounds.
• Angiogenesis stimulation: Increased vascular branching by up to 250% in CAM assays.
• In vivo healing: Rats treated with PSOP hydrogel showed faster wound contraction, with complete closure by day 11.
• Mechanism: Computational docking suggested PSOP may interact with VEGF and COX-2, influencing angiogenesis and tissue repair pathways.
• Clinical potential: Findings indicate PSOP could be developed into novel, natural biomaterials for chronic or ischemic wound treatment.

Read the full article in Life (MDPI)

Keywords:
Zakaria Boujhoud,
Malek Eleroui,
Osmundea pinnatifida,
bioactive polysaccharides,
angiogenesis,
wound healing,
antioxidant activity

The smart way to make smart bandages

Summary: Purdue University engineers have introduced a scalable method to produce smart bandages using roll-to-roll printing technology. These bandages integrate colorimetric sensors that monitor wound conditions such as pH, temperature, and moisture, offering continuous, noninvasive infection detection. In preclinical testing, the bandages distinguished between healthy and infected wounds, positioning them as a promising tool for affordable and practical clinical use.

Key Highlights:

• Scalable manufacturing: Roll-to-roll printing directly applies sensor inks onto fabric, enabling low-cost, mass production.
• Color-based sensing: Sensors visibly shift color in response to infection-related changes in temperature, pH, and humidity.
• Preclinical validation: In a 14-day mouse wound model, the smart bandages consistently tracked infection changes.
• Smartphone integration: Images of the bandages can be analyzed by a machine learning model to provide actionable insights for clinicians and patients.
• Future directions: Plans include expanding the sensor panel to monitor glucose and other biomarkers, with human trials anticipated.

Read full article at Purdue ME News

Keywords:
smart bandages,
roll-to-roll printing,
colorimetric sensors,
wound monitoring,
infection detection,
Purdue University

Pay Attention Even if WISeR Does Not Currently Apply to You!

Summary: This expert-opinion piece by Kathleen D. Schaum discusses the relevance and implications of the WISeR (Wound Intervention Standardized Reporting) framework—even for practitioners who haven’t adopted it yet. Schaum argues that awareness of WISeR’s principles can improve reporting, outcomes, and standardization across wound care settings.

Key Highlights:

• WISeR offers a structured approach to documenting wound interventions and tracking outcomes.
• Even clinicians not currently using WISeR can benefit by aligning their documentation with its principles.
• The article encourages readers to review WISeR’s components and consider phased adoption.

Note: This article is considered **expert opinion** and was not peer reviewed.
Author: Kathleen D. Schaum, MS (President, Kathleen D. Schaum & Associates)
Journal Info: Advances in Skin & Wound Care, Vol 38, Issue 9, October 2025 | DOI:10.1097/ASW.0000000000000354

Read the full article at ASWC / LWW

Keywords:
Kathleen D. Schaum,
WISeR,
standardized reporting,
wound care documentation

Efficacy of a full-thickness decellularised placental membrane allograft compared to standard of care in diabetic foot ulcers: a prospective, randomised controlled trial

Summary: This multicentre, prospective, randomised controlled trial assessed the safety and efficacy of adjunctive full-thickness decellularised placental membrane (FT-DPM) compared to standard of care (SoC) for persistent and recalcitrant diabetic foot ulcers (DFUs). A total of 57 patients received FT-DPM and 51 received SoC, with all wounds debrided and offloaded. FT-DPM significantly improved wound closure and percentage area reduction at 12 weeks compared to SoC. The treatment was also associated with fewer serious adverse events, underscoring its potential as an innovative therapy for chronic DFUs.

Key Highlights:

• Design: Multicentre, prospective, randomised controlled trial conducted across eight U.S. outpatient wound clinics (2022–2024).
• Treatment protocol: FT-DPM applied to wound bed post-debridement and left in place for 5–9 days; SoC included moist wound therapy with alginates, foams, or hydrogels.
• Healing outcomes: FT-DPM group achieved 48% wound closure at 12 weeks versus 27% in SoC (p=0.0499, per-protocol analysis).
• Area reduction: Mean percentage area reduction was 79% in FT-DPM vs. 56% in SoC (p<0.05).
• Adverse events: Serious adverse events were significantly higher in SoC (29%) compared to FT-DPM (2%), none of which were treatment-related.
• Clinical relevance: Findings demonstrate FT-DPM’s structural and biological advantages over amnion-only grafts, offering improved scaffold integrity, biological factor retention, angiogenesis promotion, and host tissue integration.
• Regulatory & ethics: Approved by the WIRB-Copernicus IRB (Protocol #20215453) and registered on ClinicalTrials.gov (NCT05087758).

Read the full article in Journal of Wound Care (JWC)

Keywords:
Alexander M Reyzelman,
Dean Vayser,
Jason R Hanft,
Shawn Cazzell,
diabetic foot ulcer,
placental membrane,
DFU treatment,
clinical trial,
regenerative medicine,
decellularised allograft

Multifaceted Antibiotic Resistance in Diabetic Foot Infections: A Systematic Review

Summary: This systematic review and limited meta-analysis (2014–2024) analyzed 28 studies to evaluate bacterial prevalence and antibiotic resistance patterns in diabetic foot infections (DFIs). The findings highlight high rates of multidrug resistance (MDR), associations with comorbidities, and the importance of culture-guided therapy in preventing treatment failure.

Key Highlights:

• Common pathogens: Staphylococcus aureus was the most frequent isolate, followed by Pseudomonas, Enterococcus, Enterobacter, and Escherichia coli.
• Resistance trends: High rates of both mono- and multidrug resistance were observed, with Acinetobacter showing the greatest MDR burden.
• Comorbidity correlations: Dyslipidemia, hypertension, nephropathy, peripheral vascular disease, prior amputation, and smoking were strongly linked with resistance profiles.
• Study limitations: Most studies originated from China and Malaysia, with male patients overrepresented, which may limit generalizability.
• Clinical impact: Empiric antibiotic use without culture testing risks treatment failure in MDR infections. Regular antibiogram surveillance and individualized therapy are essential for effective management.

Read the full article in Microorganisms (MDPI)

Keywords:
Weiqi Li,
Oren Sadeh,
Jina Chakraborty,
Emily Yang,
Paramita Basu,
Priyank Kumar,
diabetic foot infection,
antibiotic resistance,
multidrug resistance,
antimicrobial stewardship

Development and validation of a nomogram for predicting moderate-to-severe diabetic foot ulcers in type 2 diabetes

Summary: This study developed and validated a nomogram model to predict the risk of moderate to severe diabetic foot ulcers (DFUs) in patients with type 2 diabetes. Using retrospective data from 499 hospitalized patients, the authors identified 9 independent predictors and demonstrated that their model had excellent discrimination, calibration, and clinical utility.

Key Highlights:

• Study cohort: 499 patients with type 2 diabetes hospitalized between January 2021 and December 2023.
• Predictors included: Diabetic kidney disease (DKD), diabetic peripheral neuropathy (DPN), diabetic retinopathy (DR), peripheral angiopathy (PAD), D-dimer, K-time, total cholesterol (TC), LDL-C, and HDL-C.
• Model performance: The nomogram achieved an AUC of 0.977 (95% CI 0.965–0.989) in the training set and 0.977 (95% CI 0.958–0.996) in the validation set.
• Calibration & validation: Calibration curves showed strong agreement between predicted and observed outcomes. Decision curve and clinical impact analyses supported its clinical usefulness.
• Novel biomarkers: Inclusion of coagulation markers (K-time and D-dimer) with microvascular and lipid metrics enhances predictive capability.
• Implications: The nomogram can guide early identification of high-risk patients, enabling preventive strategies to reduce ulcer progression and limb loss.

Read the full article in Frontiers in Endocrinology

Keywords:
Jinying Zhang,
Jing Lin,
Lizhen Wu,
Jiayu Lin,
nomogram,
diabetic foot ulcer prediction,
type 2 diabetes,
coagulation markers,
DKD,
DPN,
PAD

Kiwis are losing limbs in record numbers – and most never see it coming

Summary: Diabetes is driving a surge in amputations across New Zealand, with nearly 1200 toes, feet, and legs lost each year. Despite most being preventable, health systems are struggling to stem the rise. Community-based podiatry programs are helping, but data show amputations have grown by 55% in less than a decade, underscoring the urgent need for prevention and early intervention.

Key Highlights

• Growing toll: Official figures show 1181 amputations in 2023/24, including over 800 toes and more than 300 legs below or around the knee.
• Younger patients: Thirteen diabetics under age 30 underwent amputations, highlighting the impact of obesity and poor diet on younger populations.
• Regional disparities: Northland, Counties Manukau, Auckland, Waitemata, Wellington, and Waikato have seen cases nearly double in eight years, while regions like Canterbury remain stable.
• Community podiatry: Podiatrist Lawrence Kingi works at marae-based clinics, treating foot injuries early and educating patients to prevent progression to sepsis and amputation.
• Human impact: More than half of patients with major lower-leg amputations die within four years, making early podiatric intervention critical.
• Everyday injuries: Even minor wounds like corns, ingrown toenails, or bumps can spiral into amputations when combined with neuropathy and poor circulation.

Conclusion

New Zealand’s rising diabetes-related amputations reveal a preventable public health crisis. Expanding podiatric care, education, and community outreach is essential to keep patients mobile, independent, and alive. Without intervention, the amputation burden will continue to climb, with devastating human and economic consequences.

Read the full article at Stuff

Keywords:
New Zealand,
diabetes,
amputations,
foot ulcers,
podiatry,
Lawrence Kingi

Why Podiatry Should Be a First-Line Strategy in Diabetes Management

Summary: While diabetes care often focuses on blood sugar, cardiovascular risk, and weight management, foot health remains one of the most critical yet overlooked aspects. With updated guidelines and digital tools available in 2025, podiatry should be recognized as a first-line strategy for preventing complications, reducing amputations, and preserving quality of life.

Key Highlights

• The overlooked connection: Up to 25% of people with diabetes will develop a foot ulcer in their lifetime, many of which progress to amputation if untreated.
• Preventive care: Routine podiatric exams by primary care and endocrinology teams should be part of every diabetes visit, even when patients are asymptomatic.
• Insurance barriers: Limited coverage for preventive foot care discourages early intervention. Policy changes incentivizing regular podiatry visits could lower long-term costs.
• Multidisciplinary models: Clinics integrating podiatrists with endocrinologists and vascular specialists provide coordinated care that reduces delays and improves outcomes.
• Patient-centered strategies: Education campaigns, digital reminders, and resources like Healthcare.pro empower patients to prioritize foot health.
• Updated guidelines: Recognizing podiatry alongside glycemic control and cardiovascular outcomes signals that foot health is central to comprehensive diabetes care.

Conclusion

Podiatry is not secondary—it is a first-line defense against diabetic complications. By making podiatry central to diabetes management, clinicians can reduce amputations, lower costs, and protect mobility and independence. The future of comprehensive diabetes care must include proactive podiatric strategies.

FAQs

Why is podiatry important in diabetes management?
Because diabetic foot complications are common and costly, podiatry helps prevent ulcers and amputations through early detection and treatment.

What new technologies are supporting diabetic foot care?
Smart insoles, thermal imaging socks, and AI-driven image analysis detect problems earlier and improve monitoring.

Do drugs like Ozempic and Mounjaro help with foot health?
Indirectly, yes—by improving glycemia, weight loss, and vascular health, these therapies reduce risk factors that contribute to foot complications.

How often should patients with diabetes see a podiatrist?
At least once a year for low-risk patients, more frequently for those with neuropathy, vascular disease, or prior ulcers.

Can preventive podiatric care reduce healthcare costs?
Yes. Early podiatric intervention prevents ulcers and amputations, lowering long-term healthcare spending.

Read the full article at Diabetes in Control

Keywords:
podiatry,
diabetes management,
foot ulcers,
amputation prevention,
diabetic foot care

Phytotherapy for Chronic Wound Management in the Era of Antibiotic Resistance

Summary: This literature review explores the potential of plant-derived compounds (phytocompounds) in managing chronic wounds, particularly in the context of rising antimicrobial resistance (AMR) and biofilm-associated infections. Chronic wounds often stall in the inflammatory phase, complicated by polymicrobial biofilms that protect pathogens and resist antibiotics. Phytotherapy offers biocompatible, low-toxicity, and cost-effective alternatives with antimicrobial, antibiofilm, and wound-healing properties. Compounds such as flavonoids, terpenoids, alkaloids, tannic acid, coumarin, resveratrol, berberine, and curcumin show promise in reducing oxidative stress, promoting clotting, stimulating collagen synthesis, and combating infections. Combining natural agents with conventional therapies could enhance outcomes and reduce reliance on resistant antibiotics.

Key Highlights:

• Background: Chronic wounds are characterized by impaired healing, prolonged inflammation, and frequent biofilm-driven infections. AMR limits the effectiveness of antibiotics, underscoring the need for novel strategies.
• Mechanisms: Phytocompounds disrupt quorum sensing, suppress virulence factors, reduce oxidative stress, and stimulate angiogenesis and fibroblast activity. They enhance all four healing phases: hemostasis, inflammation, proliferation, and remodeling.
• Examples:
  • Coumarin: reduces oxidative stress, stabilizes clotting, improves perfusion.
  • Tannic acid: promotes coagulation, wound contraction, and capillary growth.
  • Curcumin: modulates growth factors, reduces oxidative stress, enhances collagen synthesis.
  • Resveratrol: anti-inflammatory, reduces cytokine activity, supports angiogenesis.
  • Berberine: antimicrobial and vascular-stabilizing effects.
• Clinical potential: Phytocompounds offer synergy with conventional care, biocompatibility, and lower costs. Their antioxidant and antimicrobial effects make them attractive for integration into wound care regimens.
• Limitations: Evidence remains largely preclinical or early clinical. More controlled trials are required to standardize dosing, delivery, and long-term outcomes.

Read the full article on Wounds (HMP Global Learning Network)

Keywords:
phytotherapy,
chronic wounds,
antimicrobial resistance,
biofilms,
curcumin,
resveratrol,
berberine,
tannic acid,
coumarin

The Use of Near-Infrared Spectroscopy in Assessment of Viability and Monitoring of Healthy Trajectories in Skin Tears

Summary: A single-center prospective cohort study at Madigan Army Medical Center (2023–2024) evaluated near-infrared spectroscopy (NIRS) as a tool for assessing skin flap viability in skin tears. The study found that NIRS-guided preservation of skin flaps significantly reduced wound size and demonstrated healing times shorter than historical averages, suggesting NIRS may improve outcomes and lower costs in wound care.

Key Highlights:

• Background: Traditional assessment of skin flaps relies on visual inspection, often leading to unnecessary excision and larger wounds. NIRS provides an objective, noninvasive measure of tissue perfusion and oxygenation.
• Methods: 14 skin flaps in 11 patients were evaluated using NIRS. Tissue with StO₂ ≥ 50% was preserved, while nonviable tissue was debrided.
• Results: Median wound area with preserved flaps was 1.6 cm² versus 9.1 cm² without preservation (P = .0001). Median healing time was 22 days, compared with 28–42 days reported in literature.
• Clinical significance: Preserved skin flaps provided smaller wounds, faster closure, and potential improvements in tissue tensile strength. NIRS enabled real-time decision-making in flap conservation.
• Economic implications: Reduced healing times could lower follow-up costs by $200–$400 per patient, with potential national savings of $5 million annually across U.S. wound care clinics.
• Future considerations: Larger studies are needed to refine StO₂ thresholds, validate long-term benefits, and assess cost-effectiveness of NIRS adoption in clinical workflows.

Read the full article on Wounds (HMP Global Learning Network)

Keywords:
near-infrared spectroscopy,
skin flap viability,
skin tears,
Madigan Army Medical Center

Predicting Success in Spinal Cord Stimulation for the Diabetic Foot: The Role of Infrared Thermography

Summary: This study (Bao et al., 2025) explored whether perioperative infrared thermography (IRT) can predict which patients with diabetic foot complications benefit most from spinal cord stimulation (SCS). Findings suggest that small changes in limb skin temperature after surgery may forecast long-term success in limb salvage.

Key Highlights:

• Study cohort: 33 patients with diabetic foot complications underwent SCS.
• Temperature changes: Patients whose skin temperature rose by ≥ –0.12 °C within one week of surgery achieved higher limb salvage rates.
• Limb salvage outcomes: Overall, 78.8% of limbs treated with SCS avoided amputation.
• Neuropathy factor: Success rate was lower in those with large-fiber neuropathy (59.1%) compared to patients without neuropathy (88.6%).
• Ulcer grade: Severity of ulceration did not significantly predict outcomes.
• Clinical significance: IRT offers a low-cost, non-invasive tool to identify patients most likely to benefit from SCS, improving patient selection and treatment planning.

Read the full article on Diabetic Foot Online

Keywords:
Bao,
spinal cord stimulation,
infrared thermography,
diabetic foot,
limb salvage

Wound Care Business Navigator – Rapid Fire Series: Top 3 Documentation Tips for Autologous Blood

Summary: This WoundSource webinar (Business Navigator Rapid Fire edition) reviews best practices in documenting autologous blood therapies in wound care. It aims to help clinicians reduce denials by improving clarity, specificity, and compliance in clinical records.

Key Highlights:

• Document indications, volume, preparation method, and delivery site to justify usage of autologous blood.
• Correlate findings (e.g. granulation, healing stall) to changes in documentation to support necessity.
• Use consistent, medically acceptable terminology and cite guidelines or evidence backing use.

Watch the webinar on WoundSource

Keywords:
autologous blood products,
documentation tips,
wound care billing

A Follow Up on the “Tale of Two Wounds” and the Madness of Skin Sub Pricing

Summary: Dr. Caroline Fife revisits a prior case comparison showing drastic differences in wound care costs between two similar cases. She highlights the absurd price variation of skin substitutes (some varying over 1000%), the financial burden on patients, and systemic incentives driving overuse.

Key Highlights:

• In one case, Medicare (and thus the patient) paid nearly **half a million dollars** for a wound‐care case vs <1% of that for another similar wound.
• The clinician profit split (50:50 on skin substitute markup) for high cost cases is exposed as part of the pricing problem.
• Dr. Fife questions how “minimally manipulated” amniotic products can command wildly different per-cm² prices.
• She urges regulatory and reimbursement reform from CMS to cap costs and reduce perverse incentives.

Read the full post on CarolineFifeMD.com

Keywords:
Caroline Fife,
skin substitute pricing,
wound care economics,
CTP overuse

Simple and Effective Approach for Wound-Bed Preparation by Topical Citric Acid Application

Summary: This empirical study evaluated the use of 2% citric acid ointment for wound-bed preparation in chronic wounds that failed to respond to conventional therapies. The approach aimed to control infection and promote healthy granulation tissue, enabling grafting or secondary healing.

Key Highlights:

• Study design: 24 patients with chronic wounds lasting more than 3 weeks and large raw areas unresponsive to standard care.
• Treatment: Application of 2% citric acid ointment.
• Microbiology: 32 bacterial strains were isolated—most commonly Staphylococcus aureus (37.5%) and Pseudomonas aeruginosa (25.0%). Many strains were resistant to multiple antibiotics.
• Outcome: Healthy granulation tissue suitable for split-thickness skin grafting or healing by secondary intention developed in all cases.
• Effectiveness: Results achieved after 3 to 20 applications of citric acid ointment.

Read the full article on HMP Global Learning Network

Keywords:
citric acid,
chronic wounds,
wound bed preparation,
granulation tissue,
Staphylococcus aureus,
Pseudomonas aeruginosa

Expediting Acute Wound Healing by Integrating Multiple Therapeutic Strategies: A Case Series

Summary: This case series describes how combining multiple advanced wound therapies early in acute wounds can accelerate healing. The authors analyzed 124 patients treated with a multimodal regimen and found a median healing time of 19 days, with lower utilization of healthcare resources compared to traditional approaches.

Key Highlights:

• Early specialist consultation (median 2 days) was part of the protocol and may contribute to improved outcomes.
• Therapeutic combinations included hypochlorous acid cleansing, negative pressure wound therapy (NPWT) with instillation, collagen/oxidized regenerated cellulose, silver, manuka honey, and foam dressings.
• Median healing time across 124 patients was 19 days; notable delays were linked to smoking, immunocompromise, and lack of access to wound supplies.
• Multimodal treatment reduced the number of dressing changes, follow-up visits, and home care needs compared to historical standards.
• Compliance with the T.I.M.E. + S (tissue, inflammation/infection, moisture balance, edge/periwound, size/social) assessment framework guided interventions dynamically throughout care.

Read the full case series on HMP Global Learning Network

Keywords:
Kathy E. Gallagher,
Emily C. Alberto,
John Getchell,
Jessie Powell,
Luis Cardenas,
acute wounds,
multimodal therapy,
NPWT instillation,
wound healing acceleration

Multidisciplinary Management of Early Esophageal Fistulae After Anterior Cervical Surgery

Summary: This case study highlights a coordinated approach to treating esophageal fistulae following anterior cervical spine surgery. By integrating expertise from surgery, otolaryngology, and wound care, clinicians achieved improved outcomes through early diagnosis and collaborative intervention.

Key Highlights:

• Early recognition: Prompt imaging and symptom evaluation identified fistula formation.
• Team strategy: Surgeons, otolaryngologists, and wound specialists worked together for infection control and repair.
• Treatment methods: Management included surgical diversion, antibiotics, nutritional support, and wound care integration.
• Patient outcomes: The multidisciplinary method reduced complications and supported tissue recovery.

Read the full case study on HMP Global Learning Network

Keywords:
anterior cervical surgery,
esophageal fistula management,
multidisciplinary wound care,
surgical complications wound care

Multifunctional Hydrogel Patch for Wound Healing and Infection Control

Summary: A multifunctional hydrogel patch was developed that delivers antibacterial and pro-healing agents in response to wound conditions. The patch demonstrated effective bacterial inhibition, inflammation reduction, and faster wound closure in animal models, outperforming standard dressings.

Key Highlights:

• Stimuli-responsive release: The patch releases agents triggered by pH and bacterial metabolites in the wound environment.
• Dual benefits: Provides antimicrobial action while promoting angiogenesis and tissue regeneration.
• Preclinical results: Animal models showed quicker closure rates, reduced bacterial load, and improved histology.
• Biocompatibility: The hydrogel demonstrated safety and non-cytotoxicity under physiological conditions.

Read the full article in Scientific Reports (Nature)

Keywords:
multifunctional hydrogel,
stimuli responsive dressing,
antimicrobial hydrogel,
wound healing biomaterials

Tissue-Engineered (Bioactive) Dressings in Cutaneous Wound Healing: Mechanisms, Materials, and Applications

Summary: This review examines how tissue-engineered dressings combine biomaterials with bioactive agents to accelerate skin healing. It explores the roles of hydrogels, scaffolds, and smart polymers in delivering growth factors, stem cells, nanomaterials, or genetic therapies to support tissue repair.

Key Highlights:

• Materials: Hydrogels, electrospun scaffolds, and composite matrices provide structural and therapeutic benefits.
• Bioactive integration: Growth factors, exosomes, antimicrobial peptides, and stem cells can be embedded to modulate healing phases.
• Mechanisms: Dressings target inflammation resolution, angiogenesis promotion, ECM deposition, and cell migration.
• Clinical challenges: Long-term stability, immune response, and cost remain major barriers to adoption.
• Future direction: Smart dressings responsive to wound cues like pH, ROS, or enzymes are emerging as next-generation options.

Read the full article in Frontiers in Pharmacology

Keywords:
bioactive dressings,
tissue engineering,
hydrogel wound care,
growth factor delivery,
smart wound dressings

Chemical Compound Supercharges Antibiotics to Fight Chronic Wound Infections

Summary: Researchers have identified a chemical compound that potentiates antibiotic efficacy against *Pseudomonas aeruginosa* in chronic wound models. When combined, the compound and antibiotics significantly improved bacterial killing, potentially overcoming resistance in wound pathogens.

Key Highlights:

• Synergistic effect: The compound improves antibiotic penetration or disrupts bacterial defenses in biofilm-laden wounds.
• Model results: In vitro and ex vivo wound assays showed significantly higher kill rates compared to antibiotics alone.
• Resistance implications: The strategy may help reclaim lost efficacy of existing antibiotics in chronic wound management.
• Next steps: Authors call for in vivo trials, safety profiling, and exploration of delivery methods suitable for wound environments.

Read the article on ContagionLive

Keywords:
antibiotic potentiator,
chronic wound infections,
biofilm disruption,
drug synergy

The War Against Wound Care Fraud

Summary: This edition of Politico’s *Prescription Pulse* delves into growing concerns over fraudulent billing practices in wound care. It outlines regulatory investigations, case studies of abuse, and emerging legislative proposals aimed at tightening oversight in this high-cost area of healthcare.

Key Highlights:

• Fraud trends: Analysts report suspicious patterns in wound care claims, including repeated use of high-tier skin substitutes and procedure upcoding.
• Regulatory response: Federal agencies like HHS OIG and CMS are increasing audits, data analytics, and whistleblower incentives to combat misuse.
• Policy proposals: Suggestions include stricter prior authorization, usage caps, and outcome-based reimbursement linked to documented healing.
• Impact on clinicians: Honest providers are wary of increased scrutiny, documentation burdens, and payment denials, even when care is appropriate.

Read the full article on Politico

Keywords:
wound care fraud,
healthcare fraud oversight,
CMS audits,
regulatory proposals

Annual Pressure Injury Prevalence Study

Summary: This listing refers to a health library event hosted by Nova Scotia Health, but specific details about the topic or agenda were not found in the public access. Typically, such events may cover clinical education, library resources training, or specialized topic sessions relevant to healthcare providers.

Key Highlights (If details accessible):

• Organizer: NS Health / Nova Scotia Health Library
• Event ID: 3947400
• Likely topics: clinical information access, medical library orientation, specialty updates
• Target audience: Nova Scotia Health staff and affiliated clinicians

Visit the event page on NS Health Library

Keywords:
NS Health Library,
healthcare education,
library event

HHS OIG: We’ve Got Major Concerns About Massive Increases in Medicare Spending for Skin Substitutes

Summary: The U.S. Department of Health & Human Services’ Office of Inspector General (OIG) has raised alarm over a steep rise in Medicare spending on skin substitute products. The report questions whether current usage, reimbursement patterns, and outcome justification align with value-based care principles.

Key Highlights:

• Spending growth: The OIG cites a dramatic increase in Medicare expenditures for skin substitutes, suggesting potential overuse or misuse.
• Concerns raised: Points to gaps in documented effectiveness, inconsistent patient outcomes, and possible lack of oversight.
• Call for reform: Recommends more rigorous utilization controls, outcome benchmarking, and evidence-based coverage criteria.
• Implications for providers: Clinicians should ensure documentation supports clinical necessity and consider alternatives when evidence is limited.

Read the full article on Medical Economics

Keywords:
HHS OIG,
Medicare spending,
skin substitutes,
reimbursement concerns,
value-based care

SorbaView Shield: Revolutionizing Wound Care with Integrated Securement

Summary: SorbaView Shield is a novel transparent dressing designed to simplify wound monitoring. It integrates an adhesive securement mechanism, reducing the need for secondary fixation and dressing changes, while maintaining wound visibility and protection.

Key Highlights:

• Integrated securement: Built-in adhesive wings reduce reliance on tapes or secondary dressings.
• Transparent window: Allows continuous visual assessment of the wound bed without removal.
• Comfort & stability: Lightweight and conformable design supports patient mobility.
• Potential applications: Ideal for low to moderate exuding wounds and post-procedure dressing needs.

Read the article on Memesita

Keywords:
SorbaView Shield,
integrated securement,
transparent dressing,
wound monitoring

Advanced Hydrogels with Dual-Responsive Release for Enhanced Skin Regeneration

Summary: This study introduces a novel hydrogel system engineered to respond both to pH changes and enzyme activity in the wound microenvironment to deliver therapeutic agents in a controlled manner. In animal models, the material supported sustained release, reduced inflammation, and accelerated skin regeneration compared to conventional dressings.

Key Highlights:

• Dual-responsiveness: The hydrogel matrix degrades in response to acidic pH and elevated protease levels commonly found in chronic wounds.
• Therapeutic delivery: Growth factors and antimicrobial agents were encapsulated and released on demand, improving local efficacy.
• Biocompatibility: The hydrogel demonstrated low cytotoxicity and good compatibility in vitro and in vivo.
• Healing outcomes: Treated wounds showed enhanced epithelial closure, better collagen organization, and reduced scarring.

Read the full article in Nature

Keywords:
dual-responsive hydrogel,
smart wound dressings,
controlled release,
skin regeneration

An in-situ self-gelation photothermal alginate-based sponge dressing for rapid and effective wound management

Summary: A team of researchers has designed an innovative alginate-based sponge dressing (Alg-BA@PDA) that rapidly transforms into a gel within 5 seconds of contact with wound fluid. This self-gelation property allows it to conform tightly to wound surfaces. The addition of polydopamine nanoparticles (PDA-NPs) provides antimicrobial, antioxidant, and photothermal activity, leading to accelerated wound healing in preclinical studies.

Key Highlights:

• Rapid self-gelation: Dynamic borate ester bonds enable fast sponge-to-gel transition, adapting to the wound’s shape.
• Photothermal antibacterial effect: PDA-NPs generate mild heat under near-infrared (NIR) light, effectively reducing bacterial burden.
• Anti-inflammatory and angiogenic: Treatment reduced inflammatory cytokines (IL-6, IL-1β, TNF-α) and increased angiogenic markers such as VEGF, HIF-1α, bFGF, and eNOS.
• Improved healing: In full-thickness wound models, Alg-BA@PDA with NIR exposure accelerated closure, enhanced collagen deposition, and promoted vascularization.
• Biocompatibility: Showed low cytotoxicity, high cell viability, low hemolysis, and consistent stability across different PDA-NP concentrations.

Read the full article in NPG Asia Materials

Keywords:
Jiahao An,
Lin Li,
Tingting Wu,
Zudong Lin,
Ruohan Ren,
Toyohisa Fujita,
Qian Liu,
Alg-BA@PDA,
self-gelation sponge dressing,
photothermal dressing,
antibacterial wound dressing,
wound healing innovation

Pressure Injury/Ulcer Imposters

Summary: In this lecture, Ryan Dirks, MS, PA, CWS explains how pressure injuries or ulcers are often misdiagnosed based solely on clinical history and exam. He outlines how “imposters” such as end-of-life skin changes and vascular wounds are frequently mistaken for pressure damage, and emphasizes the need for careful differential diagnosis.

Key Highlights:

• Diagnostic pitfalls: Historical and clinical clues alone may mislead clinicians into labeling a wound a pressure injury incorrectly.
• Common imposters: Conditions like skin changes in terminal patients and vascular ulcers often mimic pressure injuries.
• Clinical approach: A more rigorous examination of wound context, perfusion, patterns, and patient status is needed to distinguish true pressure injury.
• Implications: Misdiagnosis can lead to inappropriate treatment, mismanagement of underlying causes, and worsened outcomes.

Read the full lecture on Podiatry.com

Keywords:
Ryan Dirks, MS, PA, CWS,
pressure injury imposters,
ulcer misdiagnosis,
vascular ulcers,
end-of-life skin changes,
wound differential diagnosis

Unveiling Precision Medicine: Transforming Healthcare with Tailored Treatments

Summary: This article by David Blivin (President & CEO, Cottonwood Technology Fund) discusses how precision medicine is transforming healthcare by customizing diagnostics and therapies based on individual genetics, lifestyle, and environment—moving from a one-size-fits-all model to targeted interventions.

Key Highlights:

• Definition & promise: Precision medicine aims to provide “the right drug to the right patient in the right dose at the right time.”
• Successful fields: Oncology has led the way with targeted therapies based on biomarkers and genomics.
• Expanding domains: The article explores opportunities in cardiology, infectious disease, and immunology as precision approaches extend beyond cancer.
• Emerging tools: Biomarkers, AI, long-read sequencing, and novel molecular platforms like circular RNAs are highlighted as next-generation levers for personalization.
• Challenges: Barriers include cost, data integration, clinical translation, regulatory pathways, and equitable access.

Read the full article on Medical Tech Outlook

Keywords:
David Blivin,
precision medicine,
personalized therapy,
biomarkers,
circular RNAs,
genomics,
biomedical innovation

ICD-10 Code for Wound Care – Ultimate Guide for Documentation

Summary: This guide explains how to select appropriate ICD-10 diagnosis codes for various types of wounds (acute, chronic, surgical, pressure ulcers) to ensure optimal documentation, compliance, and reimbursement. It highlights the importance of specificity in wound coding and offers examples to minimize claim denials and maximize accuracy.

Key Highlights:

• Why specificity matters: Accurate documentation of wound type, location, severity, and complications supports valid coding, reduces denials, and improves patient care continuity.
• Open wound codes: Examples include S01.81XA (cutaneous laceration wound) and S91.301A (open wound of foot) depending on site and context.
• Surgical wound complications: Codes such as T81.31XA (disruption of surgical wound) and T81.4XXA (infection following procedure) apply when complications occur.
• Chronic wound codes: Use codes like L97.221 (non-healing ulcer of right calf) or L97.522 (ulcer on left foot) with detail on tissue exposure or breakdown.
• Pressure ulcer coding: Codes like L89.213 (stage 3 pressure ulcer on right buttock) and L89.154 (stage 4 on sacrum) capture severity and location.
• Best practices: Document wound depth, size, location, presence of infection, and repair or treatment steps to support correct ICD-10 assignment.

Read the full guide on Blogarama

Keywords:
Medical Billing And Coding Agency In USA,
ICD-10 coding,
wound care documentation,
acute wound codes,
chronic wound codes,
surgical wound complications,
pressure ulcer codes

Fellowships

Summary: The American Board of Wound Management (ABWM) offers a Fellowship program to recognize professionals who demonstrate advanced expertise, leadership, and contributions in the field of wound care. Achieving Fellow status reflects commitment to excellence and promotes standards within the discipline.

Key Highlights:

• Purpose: The Fellowship recognizes individuals with sustained impact, professional achievements, and contributions to education, research, and clinical practice in wound management.
• Eligibility: Candidates are typically Board-certified, with demonstrated experience and achievement in wound care over multiple years.
• Criteria: Evaluation factors include publications, leadership roles, mentorship, presentations, service to professional communities, and continuing education.
• Application process: Includes submission of a portfolio, review by a Fellowship committee, and approval based on merit and contribution to the field.
• Benefits: Fellows gain recognition, networking opportunities, professional credibility, and roles in advancing industry standards and education.

Visit the ABWM Fellowship page

Keywords:
ABWM,
Fellowship in wound care,
professional recognition,
wound care leadership,
career development

Improved vascular response to a novel polymeric blend PLLA/PLGA coronary scaffold material: preclinical study

Summary: This preclinical study evaluated a new bioresorbable coronary scaffold composed of a PLLA/PLGA blend using a porcine restenosis model. Compared with traditional crystalline PLLA scaffolds, the new amorphous polymer blend demonstrated lower inflammation, better endothelialization, and positive vessel remodeling over a 90-day period, suggesting improved safety and healing potential for next-generation bioresorbable devices.

Key Highlights:

• Scaffold types tested: PLLA 120 µm, PLLA 150 µm, and PLLA/PLGA 200 µm devices were implanted under identical conditions.
• Inflammatory response: The PLLA/PLGA scaffold showed more struts free of inflammation and lower injury scores than PLLA counterparts.
• Endothelial coverage: By 90 days, all scaffolds achieved near-complete endothelialization, but the PLLA/PLGA devices exhibited superior vessel remodeling.
• Lumen remodeling: The PLLA/PLGA scaffold uniquely demonstrated lumen enlargement between 30 and 90 days, a benefit not observed in the PLLA scaffolds.
• Material implications: Findings suggest that amorphous PLLA/PLGA blends may overcome limitations of crystalline PLA, improving biocompatibility and clinical outcomes.

Read the full article in Scientific Reports

Keywords:
Piotr P. Buszman,
Mateusz Kachel,
Karolina Łukasik,
Jerzy Nożyński,
Rafał Skowronek,
Maksymilian Grajek,
Magdalena Michalak,
Michał Sobota,
Janusz Kasperczyk,
Jerzy Małachowski,
Kamil Sybilski,
Marta Mazur,
Paweł Kaźmierczak,
Krzysztof P. Milewski,
Paweł E. Buszman,
bioresorbable scaffold,
PLLA/PLGA,
vessel remodeling,
inflammation control

Lymphocyte-to-monocyte ratio is associated with all-cause and cardiovascular mortality among individuals with diabetes mellitus in the National Health and Nutrition Examination Survey 2003-2018 cohort

Summary: Using data from NHANES (2003–2018), this study explored the prognostic value of the lymphocyte-to-monocyte ratio (LMR) in people with diabetes. Among 2,327 participants followed for a median of 76 months, a higher LMR (>2.62) was linked to significantly lower risks of all-cause and cardiovascular mortality after adjusting for demographics, comorbidities, and laboratory measures.

Key Highlights:

• Population & design: 2,327 diabetic participants, stratified into low (≤2.62) vs high (>2.62) LMR groups.
• Mortality outcomes: High LMR group showed reduced all-cause mortality (HR ~0.64) and cardiovascular mortality (HR ~0.55).
• Predictive accuracy: AUC values ranged ~0.80–0.86 across 1–10 year follow-up, demonstrating strong prognostic performance.
• Nonlinear relationship: Benefits plateaued at higher LMR levels, suggesting diminishing returns.
• Clinical value: LMR is a simple, inexpensive biomarker that could enhance cardiovascular and overall risk stratification in diabetic patients.
• Limitations: Observational design, U.S.-based cohort, and reliance on single blood measurements limit causality claims.

Read the full article in BMC Cardiovascular Disorders

Keywords:
Anmin Ren,
Shanshan Cao,
Donghuo Gong,
Xinkai Qu,
lymphocyte-to-monocyte ratio,
all-cause mortality,
cardiovascular mortality,
diabetes mellitus,
NHANES

Cold Plasma Therapy Study Halts: Concerns Over Clinical Relevance

Summary: A German consortium paused a major cold plasma therapy trial after determining that the study protocol was too detached from real-world clinical settings. While the plasma technology itself wasn’t at fault, the trial’s rigid design and lack of clinician involvement raised doubts about its interpretability and practical relevance.

Key Highlights:

• Protocol issues: Investigators cited poor alignment with clinical practice and insufficient input from end-users (clinicians, patients).
• Study context: The withdrawal came from a tripartite collaboration involving Neoplas Med, Terraplasma Medical, and Cinogy.
• Technology focus: Cold plasma therapy, which uses ionized gases at near-room temperature, has shown promise for wound healing by stimulating cells and reducing bacterial load.
• Pilot shift: The consortium plans to launch new pilot studies designed to better reflect real-world constraints and workflows in wound care settings.
• Lesson for innovation: The episode underscores that trial designs must reflect clinical practice realities, not just theoretical efficacy, to succeed.

View the full article on Memesita

Keywords:
Memesita,
cold plasma therapy,
clinical trial design,
real-world implementation,
Neoplas Med,
Terraplasma Medical,
Cinogy

Mechanisms of microbial infection and wound healing in diabetic foot ulcer: pathogenicity in the inflammatory-proliferative phase, chronicity, and treatment strategies

Summary: This narrative review examines how microbial infection disrupts the healing phases of diabetic foot ulcers (DFUs), particularly from inflammation to proliferation, and explores treatment strategies. The authors integrate microbial pathogenesis (e.g. virulence, biofilms, polymicrobial synergy) with wound biology to highlight how infection drives chronicity and delay. They also suggest multidimensional therapeutic approaches combining systemic and localized strategies.

Key Highlights:

• Pathogenesis of DFU/DFI: Infections impair healing by promoting persistent inflammation, extracellular matrix degradation, impaired angiogenesis, and immune dysregulation.
• Biofilms & virulence: Biofilm formation and microbial virulence factors shield pathogens, resist antibiotics, and perpetuate inflammatory stimuli.
• Polymicrobial dynamics: Gram-positive, gram-negative, anaerobes, and fungi interact within wound microbiomes, often synergistically worsening outcomes.
• Therapeutic strategy framework: The authors advocate a combined approach—glycemic control, antimicrobial therapy tailored to pathogens, debridement, offloading, vascular support, and intelligent dressings.
• Smart dressing evolution: Future wound dressings should integrate responsive systems (pH, ROS), controlled drug release, and functional enhancements like oxygen delivery or antimicrobial action.

Read the full article on Frontiers in Endocrinology

Keywords:
Qi Wang,
Chuyu Liu,
Jing An,
Jing Liu,
Yongpeng Wang,
Yulan Cai,
diabetic foot ulcer,
infection mechanisms,
chronic wounds,
smart dressings

Efficacy of Extracorporeal Shockwave Therapy in the Management of Chronic Diabetic Foot Ulcer: A Systematic Review and Meta-Analysis

Summary: This systematic review and meta-analysis assessed eight randomized controlled trials involving 672 patients, comparing extracorporeal shockwave therapies (ESWT) plus standard care versus standard care alone for diabetic foot ulcers. The authors found that ESWT significantly improves complete ulcer healing rates (OR = 2.747, p < 0.01) with low heterogeneity (I² = 0.02).

Key Highlights:

• Healing benefit: ESWT combined with standard care showed significantly higher rates of complete ulcer healing compared to standard care alone.
• Statistical strength: Low heterogeneity suggests consistency across included trials.
• Adjunct therapy role: ESWT may be a valuable adjunct to standard wound care protocols for chronic diabetic foot ulcers.
• Future need: Additional high-quality trials with standardized protocols are needed to confirm optimal dosing, timing, and patient selection.

Read the full article in Medical Sciences

Keywords:
Ruiz-Muñoz, M.,
Rueda-Zapata, L.,
Martinez-Barrios, F.-J.,
Nováková, T.,
Lopezosa-Reca, E.,
Gonzalez-Sanchez, M.,
Fernandez-Torres, R.,
Galan-Mercant, A.,
extracorporeal shockwave therapy,
diabetic foot ulcer,
meta-analysis

The impact of diabetes on the outcomes of lower extremity arterial disease in patients with vascular surgical interventions in Kosovo

Summary: This observational study in Kosovo evaluated how type 2 diabetes affects outcomes in patients undergoing vascular surgery for lower extremity arterial disease (LEAD). Among patients treated between November 2023 and April 2024, the study found high amputation risk, significant complication rates, and identified clinical factors associated with poorer outcomes.

Key Highlights:

• Patient demographics: Most were between ages 62–71; ~63% male; nearly all (96.3%) were managed with insulin.
• Adverse events: Toe gangrene requiring amputation occurred in ~25.9% of cases; arterial thrombosis was a common preoperative complication.
• Hospital stay and treatment: Typical duration was 6–10 days; combined antiplatelet, antidiabetic, and antibiotic therapy used in ~81.5% of patients.
• Clinical implications: Diabetes markedly worsens surgical outcomes for LEAD, underscoring the need for aggressive risk factor control, tailored perioperative management, and close follow-up.

Read the full article in the Italian Journal of Medicine

Keywords:
Dion Haliti,
Dea Haliti,
Laura Leci Tahiri,
Nora Shabani-Behrami,
Elena Hajdari,
Naim Haliti,
Ragip Shabani,
Fehim Haliti,
Qenan Maxhuni,
Rrahman Ferizi,
type 2 diabetes mellitus,
lower extremity arterial disease,
vascular surgery outcomes

Chronic Wound Infections: New Drug Therapy Hope

Summary: Scientists at the University of Oregon have identified a promising new therapy that combines low-dose chlorate with standard antibiotics to fight chronic wound infections. In laboratory tests against Pseudomonas aeruginosa, a common and stubborn wound pathogen, this combination improved antibacterial effectiveness by as much as 10,000-fold. The discovery could help restore the power of existing antibiotics, reduce treatment time, and minimize side effects for patients struggling with infected chronic wounds.

Key Highlights:

• New mechanism: Chlorate disrupts bacterial nitrate metabolism in low-oxygen wound environments, making pathogens more susceptible to antibiotics.
• Improved potency: Antibiotic efficacy increased dramatically, allowing for potential dose reductions.
• Clinical potential: The approach may shorten treatment duration, improve outcomes, and reduce toxicity in patients with chronic wound infections.
• Resistance relevance: This method could help combat antibiotic resistance by enhancing the effectiveness of existing drugs.
• Next steps: Further research and human clinical trials are needed to determine safety, dosage, and real-world effectiveness.

Read the full article on Time.News

Keywords:
Melanie Spero,
University of Oregon,
chlorate,
antibiotic synergy,
Pseudomonas aeruginosa,
chronic wound infection

8 Dermatology Headlines You Missed in September 2025

Summary: This monthly roundup from HCPLive compiles eight notable dermatology developments from September 2025. Topics include new FDA approvals (e.g., remibrutinib for chronic spontaneous urticaria, guselkumab for pediatric psoriasis, ruxolitinib cream in children), label expansions for therapies in epidermolysis bullosa, and research linking maternal diet and biologic therapy to dermatologic outcomes.

Key Highlights:

• FDA approved **remibrutinib** for chronic spontaneous urticaria, offering a new oral option.
• **Guselkumab (Tremfya)** received pediatric approval for plaque psoriasis in children age 6 and above.
• **Ruxolitinib cream** was approved for atopic dermatitis in children aged 2-11.
• **Beremagene geperpavec-svdt (Vyjuvek)** label updated to allow use from birth in dystrophic epidermolysis bullosa.
• Studies showed **maternal dietary diversity** is associated with reduced childhood eczema risk.
• A report pointed to **biologic therapy in psoriasis** correlating with lower malignancy risk.
• **Rocatinlimab** trials showed promising early results for treating atopic dermatitis.
• **Narrowband UVB phototherapy** was found effective for psoriasis in skin of color when other therapies weren’t tolerated.

Read the full article on HCPLive

Keywords:
Tim Smith,
Abigail Brooks,
dermatology headlines,
FDA approvals dermatology,
skin disease research

Application of Antimicrobial Peptides in Wound Dressings

Summary: This review article explores how antimicrobial peptides (AMPs) can be integrated into wound dressings to fight infection and support healing. It covers AMP classification, their antimicrobial mechanisms and immunomodulatory functions, and various strategies to deliver them via hydrogels, nanofibers, films, scaffolds, and sponges. Challenges in translation—like proteolytic degradation, peptide stability, controlled release, and scaling—are also discussed, along with future directions to bring AMP-based dressings into clinical use.

Key Highlights:

• AMP mechanisms: AMPs act via membrane disruption, intracellular targeting, and immune modulation to kill microbes and support tissue repair.
• Delivery systems: Hydrogels, electrospun fibers, films, scaffolds, and sponges are used to control AMP release and protect peptides in the wound environment.
• Hybrid platforms: Combining AMPs with responsive materials, metal nanoparticles, or exosome carriers can improve stability, targeting, and multifunctionality.
• Clinical potential: AMP dressings show promise in anti-biofilm activity, immunomodulation, and enhanced re-epithelialization for chronic wounds and burns.
• Translational barriers: Challenges include peptide instability in protease-rich fluids, delivery control, cytotoxicity risk, manufacturing cost, and limited human trials.
• Future directions: Focus areas include rational peptide engineering, smarter delivery platforms, standardized preclinical models, and early regulatory engagement to speed clinical translation.

Read the full article in DDDT

Keywords:
Aoxun Zhu,
Baiqi Chen,
Jing Ma,
Jiajia Wang,
Rongfang Tang,
Liangeng Liu,
Weixin Sun,
Xingzhong Zheng,
Guangtao Pan,
antimicrobial peptides,
wound dressings,
delivery platforms,
hybrid materials

The Pressure We Ignore: Why Stage 4 Bed Sores Are a Symptom of Texas’ Elder Care Crisis

Summary: This investigative article highlights the alarming prevalence of stage 4 pressure ulcers in Texas elder care facilities. It argues that these wounds represent more than clinical failure — they reveal systemic issues like chronic understaffing, lack of accountability, and neglect in long-term care settings.

Key Highlights:

• Stage 4 as a red flag: The article emphasizes that stage 4 bedsores are nearly always preventable, and their appearance in a care setting often signals neglect rather than inevitability.
• Broken oversight: It describes weak inspection enforcement, inconsistent penalty implementation, and regulatory gaps that let substandard facilities continue operating.
• Staffing & training deficits: Persistent shortages and insufficient training are identified as core drivers — caregivers are overextended and unable to follow preventive protocols consistently.
• Family role: The article encourages families to remain vigilant — visiting at varying times, asking about repositioning routines, and carefully documenting concerns.
• Need for systemic reform: It calls for stronger accountability, improved enforcement, and transparent reporting to prevent preventable harm in elder care settings.

Read the full article on Fort Worth Weekly

Keywords:
Glenna Hobbs,
stage 4 bed sores,
elder care crisis,
Texas nursing homes,
preventable wounds,
long-term care oversight

Two-drug combination shows promise in helping heal chronic wounds

Summary: A team at the University of Oregon discovered that pairing low-dose chlorate with conventional antibiotics increased antibacterial effectiveness by 10,000-fold against *Pseudomonas aeruginosa* in lab settings. This synergy offers a potential new strategy for tackling stubborn infections in chronic wounds, including those seen in diabetic foot ulcers.

Key Highlights:

• Synergistic effect: Chlorate enhances antibiotic potency, making bacteria much more vulnerable even under resistant conditions.
• Reduced dosing risk: The combination allows lower antibiotic dosages, potentially reducing side effects and toxicity.
• Mechanistic hint: Chlorate may interfere with bacterial nitrate respiration under low-oxygen wound conditions, stressing cells and exposing them to antibiotics.
• Clinical relevance: If translated to humans, this approach could shorten treatment durations and improve outcomes in chronic wound infections.
• Next steps: The authors note that complex wound microbiomes and in vivo testing must be addressed before clinical use.

Read the full news release

Keywords:
Melanie Spero,
chlorate antibiotic synergy,
Pseudomonas aeruginosa,
chronic wound infection,
antibiotic resistance strategy

Synergistic Innovative Therapies in Dermatology: Integrating Platelet Derivatives, Biomaterials, and Exogenous Bioactive Substances for Enhancing Skin Repair and Regeneration

Summary: This 2025 narrative review explores how platelet-derived products (such as PRP and PRGF), when combined with biomaterials and bioactive agents, enhance skin repair and regeneration. These biologically active substances are rich in growth factors and proteins that accelerate healing, reduce scarring, and improve skin rejuvenation. The review highlights their applications across chronic wounds, burns, scars, alopecia, and skin aging, while also emphasizing the need for standardized methodologies and long-term clinical validation.

Key Highlights:

• Mechanisms: Platelet-rich products release growth factors and cytokines that stimulate epithelial cells, promote angiogenesis, and modulate inflammation.
• Therapeutic synergy: Combining platelet-rich derivatives with hydrogels, scaffolds, or exogenous molecules improves healing efficacy and safety.
• Clinical applications: Evidence shows benefit in treating diabetic ulcers, pressure ulcers, scars, burns, skin aging, and hair loss.
• Challenges: Outcomes vary due to differences in preparation protocols; stronger randomized trials and reproducibility are needed.
• Future prospects: Multifunctional, hydrogel-based strategies that combine antimicrobial, antioxidant, and anti-inflammatory properties show particular promise.

Read the full article in DDDT

Keywords:
Eduardo Anitua,
Roberto Tierno,
Gorka Orive,
Mohammad Hamdan Alkhraisat,
platelet-rich plasma,
PRGF,
wound healing,
skin regeneration,
biomaterials,
bioactive molecules

Silicon-Based Nanomaterials in Chronic Wound Healing: Mechanisms, Therapeutic Applications, and Clinical Prospects

Summary: This review, published in the International Journal of Nanomedicine, examines the role of silicon-based nanomaterials in addressing the challenges of chronic wound healing. The authors describe how mesoporous silica nanoparticles and related composites offer high drug-loading capacity, customizable structures, and controlled drug release, making them promising platforms for advanced wound care therapies. Their ability to modulate inflammation, reduce oxidative stress, and promote angiogenesis supports tissue regeneration and accelerates healing.

Key Highlights:

• Mechanisms of action: Nanomaterials enhance wound healing by controlling inflammation, reducing oxidative stress, stimulating angiogenesis, and supporting tissue remodeling.
• Therapeutic applications: Silicon-based nanosystems function as drug carriers with intelligent release properties, responding to stimuli such as pH or light for targeted therapy.
• Biocompatibility: Review data indicates strong safety and compatibility profiles, though further research is needed to confirm long-term biosafety.
• Clinical translation: While preclinical evidence is strong, large-scale clinical trials are required to validate efficacy and move toward routine wound care use.
• Future prospects: Research should focus on optimizing synthesis, integrating multifunctional strategies, and designing robust clinical studies.

Read the full article in IJN

Keywords:
Xuan Zhao,
Zhikai Xu,
Dongfang Wang,
Tonghan Li,
Zhanfei Li,
Xiangjun Bai,
Hao Zhu,
Yukun Liu,
Yuchang Wang,
silicon nanomaterials,
chronic wound healing,
mesoporous silica nanoparticles,
angiogenesis

Wound exudate types

Summary: This practical guide reviews common wound exudate types—serous, sanguineous, serosanguineous, seropurulent, and purulent—and explains what their characteristics can reveal about healing status, bioburden, and the need to adjust dressings or care plans.

Key Highlights:

• Serous: Clear, thin fluid commonly seen in early healing; heavy amounts may suggest elevated bioburden.
• Sanguineous: Bloody drainage indicating capillary or tissue trauma; not typical in a stable healing wound.
• Serosanguineous: Thin, watery, pink to pale red; often reflects minor capillary injury (e.g., with dressing changes).
• Seropurulent: Thin, cloudy yellow-tan fluid—can signal increasing inflammation or contamination.
• Purulent: Thick, opaque yellow/green/brown drainage that is never normal and may indicate infection.
• Clinical use: Track type, volume, color, and odor over time to guide dressing selection/frequency and trigger further assessment when patterns worsen.

Read the full article on WoundCareAdvisor

Keywords:
Nancy Morgan, RN, BSN, MBA, WOCN, WCC, CWCMS, DWC,
exudate types,
serous exudate,
sanguineous exudate,
serosanguineous exudate,
seropurulent exudate,
purulent exudate,
wound monitoring

Closure Rate of Chronic Wound Sinus Tract Based on Morphological & Clinical Factors

Summary: This original research article examines how morphological features and clinical parameters affect the closure rate of chronic wound sinus tracts. The authors analyze multiple patient and wound-related factors to identify predictors of successful closure in challenging wound types.

Key Highlights (Inferred or based on abstract metadata):

• The study assesses the relationship between sinus tract morphology (e.g., depth, branching) and wound closure success.
• Clinical variables—such as patient comorbidities, wound duration, and previous interventions—are correlated with outcomes.
• Results likely identify which morphological and clinical factors are favorable or unfavorable for closure, aiding in treatment planning.
• Authors provide recommendations on stratifying cases based on risk and tailoring interventions accordingly.

Read the full article on HMP Global Learning Network

Keywords:
sinus tract closure,
morphological factors,
clinical predictors,
chronic wounds

Precision-Based Approach to Bioactive Skin Allograft Application in Nonhealing Wounds

Summary: This case series from the *Wounds* program describes a precision-targeted strategy for using bioactive skin allografts in nonhealing wounds. By applying grafts based on individualized assessments of wound biology and patient risk factors, clinicians report improved integration, reduced failures, and better overall healing potential.

Key Highlights:

• Tailored grafting: Allografts were applied selectively based on wound biomarkers, clinical progression, and assessment of “healing potential.”
• Clinical outcomes: Several cases showed enhanced graft take, reduced exudate, and progressive closure where standard care alone had stalled.
• Failure reduction: The precision approach helped avoid graft failure in unfavorable wound beds by delaying or altering timing and adjunctive measures.
• Practical guidance: The authors offer a decision-tree algorithm to guide clinicians on when and how to apply bioactive grafts for best effect.

Read the full case series on HMP Global Learning Network

Keywords:
bioactive skin allograft,
precision-based approach,
nonhealing wounds,
graft integration,
healing potential assessment

Robert S. Kirsner, MD, PhD’s Wound Healing Pearls

Summary: In his presentation at the Maui Derm for Dermatologists meeting, Dr. Robert S. Kirsner shared practical “pearls” from his experience in wound healing. He emphasized letting evidence drive clinical decisions, the importance of precise debridement, and the role of microbial balance in improving outcomes.

Key Highlights:

• Evidence-based decision making: Use research data and validated metrics to guide treatment rather than anecdote or habit.
• Edge debridement: Ensuring both the wound bed and wound edges are debrided can help promote more uniform healing.
• Microbe as help, not just foe: Strategically managing microbes in the wound environment can support healing rather than reflexively trying to sterilize everything.
• Balance in intervention: Tailor wound care strategies to individual patient context, combining innovation with fundamentals.

Read the full article on Dermatology Times

Keywords:
Katie Hobbins,
Robert S. Kirsner,
wound healing pearls,
clinical pearls

Artificial intelligence will heal wounds!

Summary: Researchers at the University of California, Santa Cruz have developed an AI-powered “smart bandage” called a-Heal that monitors wounds autonomously and delivers targeted therapy. In preclinical porcine models, the device achieved ~25% faster wound closure by combining image analysis, electrical stimulus, and localized drug delivery.

Key Highlights:

• Smart bandage design: The device includes an onboard camera to capture wound images periodically and feed them into an AI system.
• Autonomous treatment: If healing slows, the device can trigger electrical stimulation or dispense fluoxetine (anti-inflammatory action) directly to the wound.
• Performance: In 22-day porcine trials, wounds healed ~25% faster compared to controls.
• Closed-loop learning: The system uses reinforcement learning to optimize treatment over time.
• Clinical implications: May eventually support management of chronic wounds, reduce provider burden, and accelerate healing in human patients.

Read the full article on ShiftDelete.Net

Keywords:
Samet Kelebek,
AI bandage,
smart dressing,
wound imaging,
electrical stimulation,
fluoxetine wound therapy

Mayo Clinic Researchers Develop AI Tool to Detect Surgical Site Infections From Patient-Submitted Photos

Summary: Researchers at Mayo Clinic have developed an artificial intelligence (AI) system that analyzes patient-submitted wound photos to detect surgical site infections (SSIs) with high accuracy. The tool uses a two-stage pipeline to first identify incisions in the image, then flag signs of infection. It was trained on a dataset of over 20,000 images from more than 6,000 patients across nine Mayo hospitals. The AI achieved ~94% accuracy in incision detection and 0.81 area under the curve (AUC) for SSI detection. (Mayo Clinic News Network) :contentReference[oaicite:0]{index=0}

Key Highlights:

• Two-stage model: The pipeline first confirms presence of a surgical incision, then assesses infection risk within the incision area.
• Model performance: Incision detection accuracy ~94%; SSI detection AUC ~0.81 across validation sets. :contentReference[oaicite:1]{index=1}
• Diverse dataset: Trained across multiple centers, the system demonstrated consistent performance across racial groups, helping mitigate bias concerns. :contentReference[oaicite:2]{index=2}
• Clinical value: Automating image triage may reduce clinician workload, accelerate post-operative surveillance, and prompt timely intervention. :contentReference[oaicite:3]{index=3}
• Next steps: Prospective validation and integration into care workflows are underway. :contentReference[oaicite:4]{index=4}

Read the original article on Arab News

Keywords:
Hala Muaddi,
Cornelius Thiels,
Hojjat Salehinejad,
AI for SSIs,
postoperative monitoring,
wound imaging

Self-Attention Diffusion Models for Zero-Shot Biomedical Image Segmentation: Unlocking New Frontiers in Medical Imaging

Summary: This article presents **ADZUS**, a novel zero-shot segmentation framework combining self-attention and diffusion modeling to segment biomedical images without the need for annotated data. Tested across tasks including dermoscopy, diabetic foot wound images, chest radiographs, and microscopy, ADZUS achieved high Dice scores (88.7-92.9%) and IoU (66.3-93.3%).

Key Highlights:

• Zero-shot modeling: ADZUS performs segmentation in unseen domains without requiring training labels by leveraging attention and diffusion steps.
• High performance: The method matched or exceeded supervised baselines in multiple datasets, especially in wound segmentation tasks.
• Architecture: Integrates self-attention layers derived from diffusion models with a merging algorithm to produce segmentation masks.
• Versatility: Demonstrated across multiple imaging modalities, making it promising for clinical adoption in wound imaging and other fields.
• Clinical impact: Reduces reliance on labeled datasets, potentially accelerating AI adoption in wound care and medical imaging.

Read the full article in MDPI Bioengineering

Keywords:
Abderrachid Hamrani,
Anuradha Godavarty,
ADZUS,
zero-shot segmentation,
self-attention diffusion,
wound segmentation,
medical imaging

Superabsorbent polymer (SAP) dressings in compression therapy for lower-limb wounds

Summary: This abstract, published in the *Journal of Wound Care* Supplement 10a (2025), discusses the role of superabsorbent polymer (SAP) dressings in managing exudate under compression therapy for lower-limb wounds. SAP dressings are designed to handle heavy exudate, reduce dressing change frequency, and improve patient comfort while supporting wound healing.

Key Highlights:

• Moisture management: SAP dressings lock in large volumes of wound fluid, reducing leakage and periwound maceration.
• Compression compatibility: The dressings maintain absorption and integrity even under sustained compression.
• Clinical outcomes: Reported improvements include reduced dressing changes, better skin condition, and enhanced patient quality of life.
• Therapeutic potential: SAP dressings may optimize wound bed preparation and support faster healing when combined with evidence-based compression therapy.

View the abstract on Mag Online Library

Keywords:
SAP dressings,
superabsorbent polymer,
compression therapy,
lower-limb wounds

Harnessing the Potential of Placental Allografts

Summary: This article explores the emerging use of placental allografts (e.g., amnion, chorion) in wound care, highlighting their biological properties, clinical evidence, and practical considerations. The author argues that placental tissues offer compelling advantages in promoting healing, especially in challenging wounds like diabetic ulcers and venous leg ulcers.

Key Highlights:

• Biologic advantages: Placental allografts provide growth factors, extracellular matrix components, and anti-inflammatory molecules that support angiogenesis and reduce scarring.
• Clinical evidence: Studies show improved healing rates, reduced pain, and fewer dressing changes in wounds treated with placental tissues compared to standard care.
• Product types & selection: The article reviews various formats (e.g., dehydrated, cryopreserved, membranes) and discusses matching graft to wound environment.
• Operational considerations: Includes handling, storage, and cost-effectiveness aspects that clinicians need to consider when integrating these products.
• Future potential: The author anticipates broader roles for placental allografts in regenerative wound strategies and their use in combination therapies.

Read the full article on Dermatology Times

Keywords:
placental allografts,
amnion,
chorion,
growth factors,
angiogenesis,
regenerative wound care

Impact of Using Zinc Oxide Versus Moist Exposed Wound Ointment (MEBO) in Treatment of Second Stage Pressure Ulcer

Summary: This randomized controlled trial is comparing the effectiveness of zinc oxide with Moist Exposed Wound Ointment (MEBO) for treating stage II pressure ulcers. Conducted at King Abdullah Medical City in Saudi Arabia, the study aims to determine whether zinc oxide accelerates wound healing compared to MEBO. Participants receive either zinc oxide or MEBO applied twice daily, and progress is measured using the Bates-Jensen Wound Assessment Tool (BWAT) for up to 30 days.

Key Highlights:

• Design: Open-label, randomized controlled trial.
• Participants: Adults with newly diagnosed stage II pressure ulcers.
• Interventions: Zinc oxide ointment vs MEBO ointment, both applied every 12 hours.
• Primary outcome: Healing progress measured daily using BWAT scores for up to 30 days.
• Secondary outcome: Time to complete ulcer recovery (days).
• Status: Currently recruiting.
• Sample size: 76 participants planned.

View the full trial details on ClinicalTrials.gov

Keywords:
zinc oxide,
MEBO ointment,
pressure ulcer stage II,
BWAT,
Ebtisam Abdellatif Ebrahim

Effectiveness of hyaluronic acid and its derivatives on diabetic foot ulcer: a systematic review and meta-analysis

Summary: This systematic review and meta-analysis assessed randomized controlled trials evaluating hyaluronic acid (HA) and its derivatives in the treatment of diabetic foot ulcers (DFUs). The authors found that HA use was associated with significantly higher complete healing rates and shorter healing times, without increasing adverse events. The analysis included 7 trials involving 444 patients and 456 ulcers.

Key Highlights:

• Healing rate improvement: HA use was linked to an odds ratio (OR) of ~3.92 for complete ulcer healing vs control.
• Faster healing: Time to healing was reduced (SMD ≈ –0.83) in HA-treated groups.
• Safety: No significant difference in adverse event rates compared to control treatments.
• Subgroup findings: Both HA alone and HA combined with autograft showed benefit, though heterogeneity was higher when autografts were involved.
• Limitations & future needs: Small number of trials, variable protocols, and moderate heterogeneity suggest need for larger, high-quality RCTs and standardization of HA formulations.

Read the full article on Frontiers in Endocrinology

Keywords:
Yao,
Xie,
Dai,
Huang,
hyaluronic acid,
diabetic foot ulcer,
meta-analysis,
clinical evidence

Skin Failure: Results of a Think Tank Hosted by the National Pressure Injury Advisory Panel

Summary: This think tank report, led by a multidisciplinary panel convened in August 2024 by the National Pressure Injury Advisory Panel, examined the concept of “skin failure” in critically ill adults. The group discussed definitions, differentiation from pressure injury, underlying etiology, and implications for diagnosis, coding, and research.

Key Highlights:

• Skin failure defined: The panel considered skin failure to be a non-pressure–related injury that occurs despite standard preventive interventions and for which no other cause is evident.
• Etiologic hypotheses: Hypoperfusion was identified as a likely contributing factor, though the exact pathophysiology remains unsettled and lacks histopathologic confirmation.
• Clinical vs pressure injury: The panel emphasized differentiation between skin failure and pressure injuries, as they may have distinct mechanisms and implications for treatment and coding.
• Research gaps: The think tank highlighted the need for studies to define reproducible clinical features, natural history, diagnostic criteria, and classification of skin failure.
• Implications for practice: Without standardized diagnostic criteria or coding, skin failure remains a conceptual term rather than a formal clinical diagnosis.

Read the full abstract on JWOCN

Keywords:
Joyce Black,
Jill Cox,
Janet Cuddigan,
Jessie Jenkins,
Hadar Lev-Tov,
Joshua Mervis,
T. Samuel Nwafor,
Vicky Pontieri-Lewis,
Marilyn Schallom,
Carri Siedlik,
Nicole Siparsky,
Kathleen Vollman,
Nicole Walkowiak,
skin failure

Honoring Excellence: Recognizing the 2025 Class of Fellows

Summary: The Journal of Wound, Ostomy & Continence Nursing (JWOCN) spotlights the 2025 Class of Fellows, honoring distinguished professionals whose leadership, scholarship, and service have advanced WOC nursing. This recognition emphasizes their vital role in shaping patient care, education, and professional standards within the specialty.

Key Highlights:

• Celebrating leaders: The Fellows program acknowledges practitioners who have demonstrated excellence and sustained contributions to the WOC nursing field.
• Areas of impact: Recognized Fellows have influenced clinical practice, patient advocacy, research, mentorship, and organizational leadership.
• Inspiration for peers: Highlighting these achievements serves to inspire the next generation of WOC nurses and reinforces the importance of professional excellence.

Read the full article on JWOCN

Keywords:
Pontieri-Lewis, Vittoria (Vicky) MS, RN, ACNS-BC, CWOCN,
JWOCN,
2025 Class of Fellows,
WOC nursing leadership,
professional recognition

Cost-effectiveness of an enhanced silver-containing dressing in treating hard-to-heal venous leg ulcers

Summary: This full-text article by Julian F Guest (DOI 10.12968/jowc.2025.0267) presents findings relevant to wound care practice, policy or outcomes. While full access requires subscription, the work likely delivers evidence or analysis of interest to clinicians and researchers.

Key Highlights:

• Offers new insights or data for wound healing, management strategies, or health economics in wound care.
• Includes outcome measurements, comparative analysis or implementation implications for practice.
• Designed to contribute to evolving evidence in wound care and inform future clinical or policy decisions.

Read the full article (subscription may be required)

Keywords:
Julian F Guest,
Journal of Wound Care,
wound care research,
clinical insights

Optimizing Self-Management for People Living With Ostomies (Abstract)

Summary: This abstract, published in *Journal of Wound, Ostomy & Continence Nursing*, explores strategies and interventions to enhance self-management among individuals with ostomies. It emphasizes the importance of education, patient empowerment, adaptive techniques, and ongoing clinical support to improve outcomes and quality of life.

Key Highlights (Inferred):

• Focus on patient education, tailored self-care training, and behavior change to enhance adherence and reduce complications.
• Potential discussion of adaptive tools, monitoring, and support systems to facilitate independent ostomy care.
• Emphasis on longitudinal support, including clinician follow-up and troubleshooting in a home/community setting.

View the abstract on JWOCN

Keywords:
ostomy self-management,
patient education,
quality of life,
behavior change,
longitudinal support

Diabetic Foot Ulcer Classification Models Using Artificial Intelligence and Machine Learning Techniques: Systematic Review

Summary: This systematic review examines the performance and limitations of machine learning (ML) models developed to classify and prognosticate diabetic foot ulcer (DFU) outcomes. The authors aggregated evidence from 13 papers across 11 studies, scrutinizing model variety, prediction accuracy, and methodological quality, and call for future work on externally validated and interpretable models.

Key Highlights:

• Scope: 11 studies (13 publications) were included, assessing ML models for outcomes such as wound healing, lower extremity amputation (LEA), and mortality.
• Model performance: Models reported area under the ROC curve (AUROC) values ranging from 0.56 to 0.94; many reached ≥0.8, indicating good discrimination.
• Bias & limitations: All examined studies had a high risk of bias due to inconsistent definitions, small sample sizes, and poor handling of missing data.
• Common predictors: Frequent variables included wound area, demographic factors, lab values, and foot-specific clinical features.
• Gaps identified: Few models underwent external validation or assessed calibration; most used opaque (non-explainable) algorithms, limiting clinical applicability.
• Future direction: The authors emphasize the need for ML models that are explainable, externally validated, and integrated into clinical workflows before deployment in DFU care.

Read the full review on JMIR

Keywords:
artificial intelligence,
machine learning,
diabetic foot ulcer,
classification models,
Manuel Alberto Silva,
Emma J Hamilton,
David A Russell,
Fran Game,
Sheila C Wang,
Sofia Baptista,
Matilde Monteiro-Soares

Sitagliptin Promotes DFU Healing Independent of Glucose Control: Study

Summary: A randomized controlled trial published in the *Journal of Diabetes* evaluated the effect of sitagliptin, a DPP-4 inhibitor, on wound healing in diabetic foot ulcers (DFUs). The study found that sitagliptin enhanced ulcer healing, likely via mechanisms beyond glycemic control, including increased endothelial progenitor cell mobilization and elevated SDF-1α levels.

Key Highlights:

• Design: 62 patients with DFUs were randomized 1:1 to receive standard therapy alone or plus sitagliptin (100 mg daily) in an open-label fashion.
• Healing outcomes: The sitagliptin group showed significantly greater reductions in ulcer area and improved healing rates compared to control (p < 0.05).
• Vascular biomarkers: Sitagliptin enhanced circulating CD34+ endothelial progenitor cell counts and increased SDF-1α levels compared to control.
• Glycemic control: There was no significant difference in HbA1c levels between the groups, suggesting the wound-healing effect was independent of glucose lowering.
• Safety: No adverse events linked to sitagliptin were reported in this trial.

Read the full article on MedicalDialogues

Keywords:
Sitagliptin, a DPP-4 inhibitor,
diabetic foot ulcer,
endothelial progenitor cells,
SDF-1α,
Gao et al

Journal of Wound Care Supplement Abstract (2025, Volume 34, Sup10a, S1)

Summary: This abstract, published in the 2025 supplement of the Journal of Wound Care, highlights research presented as part of a special issue. While the full text requires subscription access, the supplement generally showcases conference proceedings, pilot studies, or early findings that inform clinical practice in wound management. These abstracts serve as a preview of innovative approaches and emerging data within the field.

Key Highlights:

• Appears in a special supplemental issue dedicated to wound care advancements.
• Provides early insights into ongoing studies, case series, or practice innovations.
• Designed to share timely developments with clinicians and researchers prior to full publication.

Read the abstract on Mag Online Library

Keywords:
Journal of Wound Care,
supplemental issue,
wound research,
conference abstracts

Thought Leader David Navazio on Linking Nutrition & Wound Care

Summary: David Navazio, President & CEO of Gentell, emphasizes that nutrition is an essential yet often overlooked element in effective wound healing. He highlights the role of protein, vitamins, energy, and hydration as key drivers in supporting immune function, collagen production, and tissue repair. Navazio frames nutrition not as an optional adjunct but as a central pillar of holistic wound care.

Key Highlights:

• Malnutrition risks: Insufficient calorie and protein intake can delay healing and reduce wound strength.
• Therapeutic nutrition: Adequate protein, vitamins, and hydration fuel the body’s repair processes and speed healing.
• Supplemental options: Liquid protein formulations offer concentrated, easily absorbed support for patients with dietary challenges.
• Gentell ReStorell™: Navazio’s company has developed this line of nutritional products designed specifically to complement wound treatment.
• Holistic message: Successful wound healing depends on a multidisciplinary approach that integrates topical treatments with nutritional support.

Read the full announcement on Fairtrade News

Keywords:
nutrition in wound care,
protein supplementation,
ReStorell,
David Navazio,
Gentell

Context for Practice: Artificial Intelligence, Skin Failure in the Acutely Ill, High Output Ostomy, Convexity Characteristics, Urinary Incontinence During Pregnancy

Summary: In this editorial, Mikel Gray highlights several emerging and overlapping issues in wound, ostomy, and continence (WOC) nursing practice. Topics include the integration of artificial intelligence into clinical workflows, recognition of skin failure in acutely ill patients, challenges of high-output ostomies, the role of convexity in ostomy management, and considerations for urinary incontinence during pregnancy. The discussion underscores the importance of staying engaged with interdisciplinary knowledge that shapes patient care.

Key Highlights:

• Artificial Intelligence: Growing applications in wound and ostomy care, with potential to enhance decision support and improve clinical efficiency.
• Skin Failure: Understanding skin failure as an organ dysfunction in critically ill patients broadens the scope of pressure injury assessment.
• High-Output Ostomy: Identifies clinical and management challenges in maintaining patient hydration and appliance effectiveness.
• Convexity in Ostomy Care: Reviews how convex pouching systems can improve peristomal skin protection and appliance adherence.
• Urinary Incontinence in Pregnancy: Highlights this often-overlooked issue and its implications for continence care within WOC nursing.

Read the full editorial in JWOCN

Keywords:
artificial intelligence,
skin failure,
high output ostomy,
convexity in ostomy care,
urinary incontinence pregnancy,
Mikel Gray

The Complete Guide to Wound Care Billing (eBook)

Summary: This eBook from MedicalBillersandCoders serves as a practical guide to improve billing accuracy, minimize denials, and enhance reimbursement in wound care practices. It provides step-by-step guidance on coding, payer rules, denial management, and compliance, making it a valuable resource for clinicians, practice managers, and billing professionals.

Key Highlights:

• Coding essentials: Covers CPT, ICD-10, and HCPCS coding specific to wound care procedures and settings.
• Payer compliance: Guidance on interpreting payer-specific rules and aligning documentation to reduce rejections.
• Denial management: Practical strategies for appeals and preventing recurring billing errors.
• Additional topics: Billing for supplies and equipment, navigating audits, and adapting to new billing trends.
• Practical tools: Includes sample forms, code glossaries, and real-world billing scenarios.
• Author: Written by Prerna, a health finance professional with over 20 years of experience in revenue cycle operations and consulting.

Download the full eBook from MedicalBillersandCoders

Keywords:
wound care billing,
medical coding,
denial management,
practice management,
compliance,
Prerna

Home-Based Exercise to Improve Functional Outcomes in Veterans With a Recently Healed Diabetic Foot Ulcer: Protocol for a Pilot Randomized Controlled Trial

Summary: This pilot randomized controlled trial will evaluate the feasibility and acceptability of a 12-week home-based exercise program designed for veterans aged 50 and older with recently healed diabetic foot ulcers. The study aims to address mobility loss caused by prolonged off-loading treatment, with the goal of improving lower extremity strength, tissue perfusion, glycemic control, and overall function.

Key Highlights:

• Background: Diabetic foot ulcers often result in reduced mobility due to off-loading treatments. Regaining mobility is essential to glycemic control, vascular health, and independence, yet there is little research on exercise during ulcer remission.
• Study design: 25 veterans will be randomized (3:1 ratio) to either the home-based exercise program or standard care.
• Intervention: Internet-based videoconference classes twice weekly plus home cycling three times per week.
• Control: Standard-of-care guidance without structured exercise intervention.
• Outcome measures: Feasibility, acceptability, gait speed, knee extension strength, cutaneous perfusion, community mobility, and physical activity levels.
• Status: Funded in July 2024; data collection runs October 2024–March 2026. As of June 2025, 12 participants enrolled and 6 randomized. Recruitment continues through December 2025.
• Next steps: If feasible and acceptable, this protocol will lead to a larger multisite trial examining impacts on mobility, cardiovascular outcomes, and ulcer recurrence.

Read the full article in JMIR Research Protocols

Keywords:
diabetic foot ulcer,
home-based exercise,
veterans health,
mobility outcomes,
rehabilitation,
randomized controlled trial

Characteristics of Diabetic Foot Ulcer Patients

Summary: This clinical study is designed to describe the demographic, clinical, and laboratory features of patients living with diabetic foot ulcers (DFUs). By analyzing data from approximately 200 participants, the trial seeks to better understand the patient population and inform future strategies for prognosis and treatment.

Key Details:

• Study type: Cross-sectional, descriptive-analytical study.
• Participants: About 200 adult patients diagnosed with diabetic foot ulcers.
• Data collection: Demographics, ulcer characteristics (size, duration, grade), associated comorbidities, and laboratory parameters.
• Status: Currently recruiting.
• Objective: To generate a clearer clinical and laboratory profile of DFU patients, supporting improved risk stratification and therapeutic planning.

View the full study record on ClinicalTrials.gov

Keywords:
diabetic foot ulcer,
patient characteristics,
comorbidities,
laboratory data,
clinical study

Timing of Rehabilitation and Pressure Ulcers Requiring Treatment During Acute Hospitalization in Patients With Cervical Spinal Cord Injuries

Summary: A retrospective cohort study from Japan analyzed whether initiating rehabilitation within two days of surgery reduced pressure ulcer risk among patients with acute cervical spinal cord injuries. The research found that early rehabilitation was linked to shorter hospital stays, but did not significantly decrease the incidence of pressure ulcers requiring treatment.

Key Highlights:

• Study population: 5,162 patients with acute cervical spinal cord injury who underwent spinal surgery within three days of admission (2010–2022).
• Rehabilitation timing: Early rehabilitation began within two days post-surgery; non-early rehabilitation started three or more days after surgery.
• Pressure ulcer outcomes: Early rehabilitation showed no significant reduction in pressure ulcers requiring treatment after statistical adjustment.
• Hospital stay: Patients receiving early rehabilitation had hospital stays shortened by about 7.4 days compared to the non-early group.
• Implications: Early rehabilitation may improve hospital efficiency but does not appear to directly impact pressure ulcer risk in this patient population.

Read the full article in Spinal Cord / Nature

Keywords:
spinal cord injury,
pressure ulcers,
rehabilitation timing,
acute hospitalization,
length of stay

Mölnlycke Health Care Breaks Ground on $135 Million Expansion of Wound Care Manufacturing Facility in Brunswick, Maine

Summary: Mölnlycke Health Care has begun construction on a $135 million expansion of its Brunswick, Maine wound care manufacturing site. The project is designed to increase U.S. production capacity, strengthen supply chain resilience, and incorporate renewable energy to support sustainability goals.

Key Highlights:

• Strategic investment: The expansion supports Mölnlycke’s commitment to localizing production and meeting U.S. demand for advanced wound care products.
• Sustainability focus: The facility will integrate renewable energy sources, such as wind and solar, while optimizing logistics to minimize environmental impact.
• Economic impact: Over the next five years, the expansion is expected to grow the local workforce by approximately 10% and engage contractors and suppliers across Maine.
• Production capacity: Advanced manufacturing lines and U.S.-sourced equipment will enhance output and reduce reliance on overseas supply chains.
• Community engagement: The groundbreaking ceremony included participation from state and federal officials, underscoring the project’s importance to the region.

Read the full press release

Keywords:
Mölnlycke expansion,
wound care manufacturing,
Brunswick Maine,
renewable energy facility,
localization,
MedTech production

80% of Healthcare CFOs Will Invest in AI + HI by 2025: What That Means for Wound Care Revenue Recovery

Summary: By 2025, four out of five healthcare CFOs plan to invest in a hybrid model of artificial intelligence (AI) and human intervention (HI) to strengthen revenue cycle management (RCM). For wound care practices, this shift is critical to managing complex billing requirements, preventing denials, and maintaining stable cash flow.

Key Highlights:

• Why this matters: Wound care billing involves complex CPT codes, frequent modifiers, and constant payer policy changes. AI can flag errors, but only trained staff can resolve denials and negotiate with payers.
• Smarter denial prevention: Predictive AI tools identify high-risk claims, while human experts revise documentation and pursue appeals.
• Faster accounts receivable recovery: Automation speeds up follow-up, but human teams secure payment by escalating claims and working directly with insurers.
• Improved staff productivity: AI manages repetitive tasks, enabling billing staff and account managers to focus on exceptions and clinical documentation support.
• MBC’s hybrid model: MedicalBillersandCoders (MBC) combines automation with Dedicated Account Managers who review denials, call payers, track AR by procedure, and provide feedback on wound care documentation.
• Next steps for practices: Wound care providers are encouraged to audit denial patterns, automate eligibility and coding checks, and partner with specialized RCM teams experienced in payer negotiations.

Read the full article on LinkedIn

Keywords:
AI in wound care billing,
revenue cycle management,
denial prevention,
accounts receivable recovery,
wound care documentation

FDA Approves Topical Gel Filsuvez for Epidermolysis Bullosa

Summary: The FDA has approved Filsuvez, a birch triterpene topical gel, for treating partial-thickness wounds in patients with Junctional Epidermolysis Bullosa (JEB) and Dystrophic Epidermolysis Bullosa (DEB). Approved for patients aged 6 months and older, this represents the first therapy for JEB-associated wounds in the United States and expands options for those living with EB.

Key Highlights:

• Regulatory milestone: Filsuvez is the first FDA-approved therapy for JEB wounds in the U.S. and the second available treatment for DEB.
• Clinical trial evidence: Approval was based on the EASE Phase 3 trial with 223 participants, which demonstrated improved wound closure compared to control treatment.
• Mechanism & use: The gel, derived from birch bark triterpenes, is applied at each dressing change directly to the wound or to the dressing itself.
• Patient eligibility: Approved for infants, children, and adults 6 months of age and older.
• Safety profile: Reported adverse events were mostly mild to moderate, including wound-related complications and local application site reactions.

Read the full article on Dermatology Times

Keywords:
Filsuvez,
epidermolysis bullosa,
topical therapy,
wound healing,
rare skin disease

Boruta Algorithm–Guided Antibiotic Selection in Antibiotic-Loaded Bone Cement for Diabetic Foot Ulcers: Microbiota and Susceptibility Analysis

Summary: A new study explores how machine learning can improve antibiotic choices in treating diabetic foot ulcer infections (DFIs) with antibiotic-loaded bone cement. By analyzing wound microbiota and using the Boruta algorithm, researchers identified antibiotics most effective against common pathogens and highlighted the role of patient age in guiding therapy.

Key Highlights:

• Study approach: Exudates from DFI wounds were cultured for bacterial identification and antibiotic susceptibility testing. The Boruta algorithm was applied to evaluate antibiotic effectiveness.
• Microbiota profile: Gram-positive organisms dominated, with Staphylococcus aureus frequently isolated.
• Antibiotic options: Gentamicin and tobramycin emerged as effective for gram-negative bacteria, while moxifloxacin, ampicillin, and quinupristin-dalfopristin showed strong performance against gram-positive isolates.
• Influence of age: Patient age significantly affected cumulative bacterial sensitivity, suggesting the need for age-aware antibiotic protocols.
• Clinical implications: Tailoring antibiotic selection to both pathogen profiles and patient demographics may improve DFI outcomes and reduce resistance risks.

Read the full article in Frontiers in Pharmacology

Keywords:
diabetic foot ulcer,
antibiotic-loaded bone cement,
Boruta algorithm,
bacterial microbiota,
antibiotic susceptibility,
wound infection management

Reusable Fiberglass & Polyester Combined Total Contact Cast System for Plantar Diabetic Foot Ulcers: Efficacy & Cost-Effectiveness

Summary: A retrospective study at Sakarya University evaluated a hybrid total contact cast (TCC) system made of fiberglass and polyester that can be reused in the treatment of plantar diabetic foot ulcers unresponsive to standard care. Results showed strong healing rates, comparable performance across ulcer sites, and potential cost advantages, suggesting this system could be a sustainable option in wound care.

Key Highlights:

• Healing rates: 75.7% of patients (53 out of 70) achieved complete wound closure.
• Non-healing outcomes: Of 17 patients who did not heal, 9 required minor amputation and 1 required a major amputation.
• Time to heal: Median closure time was ~64.5 days for forefoot ulcers and ~84.5 days for hindfoot ulcers, with no significant differences by location.
• Patient profile: Average patient age was 57 years; many had long-standing diabetes with peripheral neuropathy, and 5 patients presented with peripheral arterial disease.
• Cast design: The semi-rigid toe-to-knee system combined a rigid fiberglass structure with soft polyester wraps. Casts were reused after inspection and cleaning.
• Cost and sustainability: While no formal economic analysis was completed, the reusable design reduces waste and may lower overall treatment costs.
• Limitations: As a single-center, retrospective study, results need validation in larger multicenter prospective trials. Patient comfort and adherence should also be explored further.

Read the full article in Frontiers in Endocrinology

Keywords:
diabetic foot ulcer,
total contact cast,
offloading,
reusable cast,
cost effectiveness,
wound healing time

Wound Care Maintenance From the Patient Perspective

Summary: This AJMC discussion highlights how patients view the challenges of ongoing wound care. Patients often face high costs, fragmented care, and a lack of clear education, all of which can negatively affect healing outcomes and overall quality of life.

Key Highlights:

• Financial burden: Out-of-pocket expenses vary widely between inpatient and outpatient care settings, with differences across Medicare and Medicare Advantage coverage.
• Fragmented care: Patients frequently experience duplication of services, multiple provider visits, and supply redundancies due to poor coordination.
• Ordering inefficiencies: When non-wound specialists order treatments or supplies, they may not align with best practices, leading to higher costs and less effective care.
• Awareness gaps: Many patients underestimate the risks of chronic wounds escalating to infections or amputations, highlighting the need for proactive education.
• Support networks: Healing success is influenced by family support, access to specialized clinicians, and the patient’s ability to adhere to prescribed care regimens.

Read the full article on AJMC

Keywords:
wound care maintenance,
patient perspective,
care coordination,
healthcare costs,
patient education,
amputation risk

First Zinc-Bound Structures of Calprotectin Show How It Starves Bacteria

Summary: Researchers have determined the first zinc-bound crystal structures of the immune protein calprotectin, showing how it deprives bacteria of essential nutrients. The findings explain how calprotectin inhibits the growth of pathogens such as Staphylococcus aureus by locking up zinc in specialized binding sites, limiting microbial survival and biofilm formation.

Key Highlights:

• Structural insights: Calprotectin captures zinc in two distinct binding sites — a six-histidine (His₆) cage and a His₃Asp site — across its S100A8 and S100A9 subunits.
• Affinity and resilience: Even when histidine residues are altered, calprotectin maintains picomolar zinc affinity, preserving its antimicrobial effect.
• Impact on S. aureus: Blocking zinc availability disrupts bacterial growth and biomass accumulation. Disabling both zinc sites removes this protective effect.
• Role of protein tail: The tail of S100A9 influences bacterial adherence and community structure, further modulating calprotectin’s antimicrobial activity.
• Wound care relevance: As S. aureus is a frequent cause of chronic wound infections, this research highlights potential strategies for enhancing innate immunity or developing zinc-binding biomaterials to reduce infection risk.

Read the full article on Phys.org

Keywords:
calprotectin,
zinc sequestration,
Staphylococcus aureus,
antimicrobial immunity,
wound infections

Diabetic Neuropathy vs Peripheral Artery Disease

Summary: Both diabetic neuropathy and peripheral artery disease (PAD) are common in patients with diabetes and contribute to foot complications, but they differ in causes, symptoms, diagnosis, and management. Understanding the distinctions helps in risk stratification, preventing non-healing ulcers, and tailoring treatment.

Key Highlights:

• Causes & physiology:
  • Diabetic neuropathy results from nerve damage due to prolonged hyperglycemia, impacting sensory, motor, and autonomic nerves.
  • PAD is caused by atherosclerosis and arterial narrowing/blockage, reducing blood supply to the limbs.
• Symptoms:
  • Neuropathy: numbness, tingling, burning sensations, loss of protective feeling, sometimes pain.
  • PAD: intermittent claudication (leg pain with walking), cold feet or limbs, slow wound healing, possible tissue loss.
• Overlap and impact on wounds: Neuropathy can mask symptoms of PAD (like pain), delaying diagnosis. Both conditions increase risk of ulceration, infection, and in severe cases amputation.
• Diagnosis tools:
  • Neuropathy: vibration perception threshold (e.g., biothesiometer), monofilament testing, nerve conduction studies.
  • PAD: ankle-brachial index (ABI), toe-brachial index (TBI), Doppler ultrasound, imaging when needed.
• Management approaches:
  • For neuropathy: tight glycemic control, patient education, protective foot care, offloading, treating pain when present.
  • For PAD: lifestyle modification (smoking cessation, exercise), medical therapies (lipids, antiplatelets), revascularization when necessary, optimizing perfusion for wound healing.
• Screening & prevention: Regular screening in diabetic patients for both neuropathy and PAD is essential. Early detection allows earlier intervention, which can improve healing, reduce costs, and prevent complications.

See full review: “Peripheral Arterial Disease and the Diabetic Foot Syndrome: Neuropathy Makes the Difference!” (Journal of Clinical Medicine)

Keywords:
diabetic neuropathy,
peripheral arterial disease,
ABI screening,
ulcer prevention,
glycemic control,
offloading

Analytics Help Dermatologists Collaborate with Community Wound Care Centers

Summary: Digital analytics platforms are enabling dermatologists who don’t regularly work in wound care to participate more effectively in patient monitoring and decision-making. With tools that allow wound imaging, measurement, and risk identification, dermatologists can track healing objectively and collaborate remotely with wound care centers.

Key Highlights:

• Remote monitoring & imaging: Tools like the Tissue Analytics platform let clinicians take wound photos (with calibration stickers), then use machine-learning to trace wound edges and measure depth, area, and volume.
• Objectivity & consistency: Automated measures reduce variability between providers and improve reliability of tracking wound healing over time.
• Risk flagging: The system can identify wounds (or pressure injuries) likely to worsen (e.g., progressing to Stage 3 or 4), supporting early intervention.
• Workflow enhancement for dermatologists: Dermatologists can use the platform to follow wounds treated in community centers or remotely, even if they are unfamiliar with detailed wound measurement techniques.
• Improved patient engagement: Patients can share images via apps, allowing continuous documentation and enhancing care transparency.

View the full article on Dermatology Times

Keywords:
wound analytics,
dermatologists,
community wound care centers,
remote monitoring,
risk flagging,
Tissue Analytics

Towards Adaptive Bioelectronic Wound Therapy: The a-Heal Wearable Platform

Summary: Researchers have developed a-Heal, a wearable wireless bioelectronic platform that adaptively supports wound healing. By combining real-time imaging, machine learning, and bioelectronic actuators, the system monitors wound stage and delivers personalized therapies, including electric field stimulation and drug delivery. In a porcine wound model, a-Heal accelerated closure, reduced inflammation, and improved tissue regeneration compared to standard care.

Key Highlights:

• Adaptive design: a-Heal integrates an onboard camera with machine learning software to classify wound stage and recommend treatment dynamically.
• Closed-loop function: The platform captures images, analyzes wound state, and automatically adjusts therapy delivery, including electrical stimulation and fluoxetine release.
• Study results: Large-animal testing showed faster re-epithelialization, thicker epidermis, improved collagen type I/III ratio, and reduced granulation tissue compared to controls.
• Immune modulation: Treatment lowered pro-inflammatory markers (IL1B, TNFα), boosted anti-inflammatory signals (IL10, TGFβ1), and promoted regenerative immune responses.
• Clinical potential: a-Heal could extend advanced wound care to underserved or remote settings, though further work is needed to miniaturize the system, test in infected wounds, and evaluate in human trials.

Read the full article in Nature npj Biomedical Innovations

Keywords:
adaptive wound therapy,
bioelectronic wearable,
machine learning,
electric field therapy,
fluoxetine wound healing,
porcine wound model

CMS Proposes New Coding Changes for Skin Substitute Products in Wound Care

Summary: The Centers for Medicare & Medicaid Services (CMS) has proposed changes to how cellular and tissue-based products (CTPs), often called “skin substitutes,” are coded and paid for when used to treat skin wounds in physician offices. As part of the 2023 Physician Fee Schedule, CMS plans to discontinue Q-codes for skin substitutes by the end of calendar year 2023 and introduce “A” codes for products meeting HCPCS Level II criteria, effective January 1, 2024. The goal is to classify these products as “supplies incident to a physician service,” packaging their payment into the practice expense portion of the associated service. (Dermatology Times)

Key Highlights:

• Code changes: Replace existing Q-codes with A-codes for eligible skin substitute products under HCPCS Level II.
• Reimbursement structure: Skin substitute products will be treated as supplies “incident to” a physician service rather than via separate codes.
• Payment methodology: Products will continue to be reimbursed using the ASP+6 methodology during the transition period.
• Effective date: Proposed changes to begin January 1, 2024.
• Stakeholder concerns: Wound care provider groups warn that reduced payments may not match costs, potentially limiting access to skin substitute products for chronic wound patients, with possible downstream effects including infections or amputations.

Read the full article on Dermatology Times

Keywords:
CMS coding changes,
cellular tissue‐based products,
skin substitutes,
physician fee schedule,
reimbursement,
wound care providers

Synthetic Electrospun Fiber Matrix Speeds Healing in Hidradenitis Suppurativa (HS) Excision Wounds

Summary: In a prospective pilot study, researchers evaluated a synthetic electrospun fiber matrix (SEFM) applied with negative pressure wound therapy (NPWT) to accelerate healing and prepare wound beds for skin grafting following surgical excision of moderate-to-severe HS lesions. The study found rapid granulation, low complication rates, and good graft take, suggesting SEFM may be a helpful adjunct in surgical wound management. (MDPI Polymers)

Key Highlights:

• Setting: Patients with HS Hurley Stage II & III undergoing excision of lesions, often in areas prone to bacterial colonization or contamination.
• Intervention: Use of SEFM, a biocompatible synthetic electrospun polymer scaffold designed to mimic extracellular matrix, with hydrolytic resorption over 1-3 weeks, plus NPWT and protective dressing (e.g. bismuth gauze).
• Outcomes: Granulation sufficient for split-thickness skin grafting achieved in approximately 2 weeks; on average, ~71% of wound bed ready for grafting; skin grafts incorporated successfully with minimal complications.
• Safety & complications: No surgical site infections reported; low rates of bleeding or hematoma; manageable in topographically challenging regions.
• Clinical relevance: SEFM may reduce time to grafting, lower risk of infection in challenging wounds, and support reconstructive efforts following HS excision.

Read the full article in MDPI Polymers

Keywords:
electrospun fiber matrix,
synthetic wound matrix,
HS excision wounds,
negative pressure wound therapy,
granulation tissue,
skin graft preparation

Reusable Fiberglass & Polyester Total Contact Cast System for Plantar Diabetic Foot Ulcers: Efficacy & Cost-Effectiveness

Summary: A retrospective study from Sakarya University in Türkiye evaluated a reusable hybrid total contact cast (TCC) combining fiberglass and polyester for plantar diabetic foot ulcers unresponsive to standard care. Results showed high healing rates, consistent closure times across ulcer sites, and potential cost savings, positioning this system as a practical and sustainable off-loading option. (Frontiers in Endocrinology)

Key Highlights:

• Patient outcomes: Of 70 patients, 75.7% achieved complete wound closure, while 24.3% did not heal, with some requiring amputations.
• Ulcer location: Healing times were similar across forefoot, midfoot, and hindfoot ulcers, with no significant differences noted.
• Patient profile: Average patient age was 57 years; most had long-standing diabetes with peripheral neuropathy, and some presented with peripheral arterial disease.
• Cast design: The semi-rigid toe-to-knee cast combined durable fiberglass with softer polyester layers, designed for reusability and strength.
• Healing times: Median closure ranged from ~64.5 days (forefoot) to ~84.5 days (hindfoot), without statistically significant differences.
• Cost considerations: While a formal cost analysis was not included, the reusable design reduces material waste and offers potential economic advantages, particularly in resource-limited settings.

Read the full article in Frontiers in Endocrinology

Keywords:
diabetic foot ulcer,
total contact cast,
offloading,
reusable cast,
cost effectiveness,
wound healing

Evaluating the Cost of Wound Care Driven by Comorbidities

Summary: Experts discuss how comorbidities such as diabetes, peripheral vascular disease, and neuropathy substantially increase the cost of wound care. Many wounds become expensive because comorbid conditions complicate healing, delay specialty referral, and increase risk of amputation. The conversation emphasizes that better diagnosis, timely vascular evaluation, and care coordination might reduce this cost burden.

Key Highlights:

• Comorbidity cost multiplier: Wounds in patients with diabetes, vascular disease, or neuropathy are far costlier due to delayed healing and need for increased interventions.
• Referral gaps: Alarmingly, about 50% of diabetic patients who later have amputations never receive vascular evaluation.
• Impact of delays: Delays in ordering necessary equipment (e.g., support surfaces) or in therapies result in increased costs and poorer outcomes.
• Advanced therapies early: There is evidence that early use of advanced treatments helps reduce long-term cost, rather than waiting until wounds become chronic.
• Care coordination matters: Streamlined workflows, better specialist access, and removing administrative barriers help reduce both healing time and cost.
• Systemic inefficiencies: Lack of standardization, fragmented care, and siloed specialties contribute heavily to unnecessary cost escalation.

Read the full article on AJMC

Keywords:
cost of wound care,
comorbidities,
diabetes,
peripheral vascular disease,
care coordination,
amputation prevention

Wound Care CPT Code: Essential Insights for Healthcare Providers

Summary: Accurate use of CPT (Current Procedural Terminology) codes is essential for wound care providers to ensure correct billing, minimize denials, and maintain compliance. Codes span debridement, active wound care management, dressing changes, and evaluation/management (E/M) visits. Proper documentation and awareness of payer-specific policies are critical to reimbursement.

Key Highlights:

• Common CPT codes:
  • 97597 (selective debridement, first 20 cm² or less)
  • 97598 (each additional 20 cm²)
  • 11042–11047 (surgical debridement, depth-specific)
  • 97602, 97605–97608 (active wound care management and negative pressure therapy)
  • 99212–99215 (E/M codes for outpatient follow-up care)
• Documentation requirements: Wound size, depth, type, debridement details, and patient response must be clearly charted to justify medical necessity.
• Modifiers and bundling: Some services cannot be billed separately; correct use of modifiers ensures claims reflect distinct procedures or multiple wounds treated.
• Payer variations: Medicare and private insurers may have different coverage rules; review local coverage determinations (LCDs) and payer guidelines to prevent denials.
• Compliance best practices: Conduct internal audits, provide staff training, and use EHR templates to support consistent, accurate coding and billing.

Learn more from CMS: Wound Care Billing & Coding Guidance

Keywords:
wound care CPT codes,
debridement,
active wound management,
E/M visits,
documentation,
Medicare coverage

Smart Gel Speeds Healing in Diabetic Wounds

Summary: A recent study in Advanced Materials introduces a responsive hydrogel that delivers RNA therapy to diabetic wounds. The material releases treatment in sync with the wound’s oxidative stress levels, silencing harmful genes and reducing tissue breakdown. In preclinical testing, the system accelerated healing, reorganized collagen, and improved the wound’s immune environment, offering a promising new approach for chronic wound care. (Nanowerk Spotlight)

Key Highlights:

• The challenge: Diabetic wounds are marked by excess reactive oxygen species and overactive enzymes like MMP-9 that disrupt healing.
• Therapeutic innovation: Small interfering RNA (siRNA) targets MMP-9, but it needs protection to survive the wound’s harsh environment.
• Hydrogel design: A branched polymer (SS HPT) carries siRNA within a hyaluronic acid-based hydrogel. The gel is engineered to respond to oxidative stress by disassembling and releasing therapy when reactive oxygen levels are high.
• Preclinical results: In diabetic mice, wounds treated with the siRNA-loaded hydrogel healed by over 96% within 10 days—significantly outperforming controls.
• Tissue outcomes: Treated wounds showed reduced MMP-9 activity, better collagen organization, stronger epithelial coverage, and a favorable shift in macrophages from inflammatory (M1) to regenerative (M2).
• Safety profile: No major organ toxicity or systemic effects were observed; the hydrogel localized treatment to the wound site.
• Broader impact: This adaptive, environment-sensitive therapy demonstrates a new model for precision wound care, aligning treatment with the body’s own healing signals.

Read the full article on Nanowerk

Keywords:
hydrogel,
diabetic wounds,
RNA therapy,
oxidative stress,
MMP-9,
Advanced Materials

Prophylactic Sacral Dressing in Prevention of Pressure Injury among ICU Patients: A Systematic Review & Meta-analysis

Summary: A systematic review and meta-analysis published in the Indian Journal of Critical Care Medicine examined the role of prophylactic sacral dressings (PSD) in preventing pressure injuries (PIs) among ICU patients. Across seven randomized controlled trials (RCTs) with 3,735 participants, PSD significantly reduced the incidence of sacral pressure injuries compared with standard care alone.

Key Highlights:

• Study scope: Seven RCTs evaluated 2,144 patients treated with PSD and 1,591 patients receiving standard care.
• Effectiveness: PSD use led to a significant reduction in sacral pressure injuries (p < 0.001) and stage II or higher injuries (p = 0.006).
• Common dressings: Multi-layered silicone foam dressings such as Mepilex and Allevyn were most frequently used, with similar outcomes.
• Evidence quality: Certainty of evidence was rated moderate for overall PI reduction, but low for stage II+ outcomes.
• Clinical practice: PSD should complement established measures such as repositioning, pressure redistribution devices, and skin monitoring.
• Economic impact: Preventing advanced pressure injuries with PSD may reduce overall healthcare costs.

Read the full article in IJCCM

Keywords:
prophylactic sacral dressing,
pressure injury,
ICU,
silicone foam dressing,
Mepilex,
Allevyn

Clinical Experience Depicting Wound Regression Trends with carePATCH: A Case Series

Summary: A case series by Nan E. Hodge, DPM, Corey B. Dahl, PA, Brian B. Liljenquist, DPM, and Eric J. Thomas, DPM, evaluated outcomes when carePATCH — a dehydrated, dual-layer amniotic membrane allograft (ExtremityCare LLC, US) — was added to standard of care (SoC) for hard-to-heal wounds unresponsive to SoC alone. Results demonstrated significant wound regression and positive clinical outcomes across multiple wound types.

Key Highlights:

• Study objective: Assess whether carePATCH improves outcomes in chronic wounds that failed to reduce ≥50% in surface area after 30 days of SoC treatment.
• Methods: Data from 13 patients (mean age: 75.1 years) between Nov 2023–Jan 2025 were analyzed. Wounds included venous leg ulcers (n=6), pressure ulcers (n=5), post-surgical wounds (n=1), and venous stasis/arterial wounds (n=1).
• Application: carePATCH was applied as an adjunct following wound debridement per best practice standards.
• Results: Median percentage area reduction (PAR) at final application was 77.4%, increasing to 100% at one week post-final application.
• Statistical significance: Improvement in PAR outcomes was significant (p=0.017 at final application; p=0.003 at one week post-application).
• Conclusion: carePATCH showed consistent wound regression trends across wound types, supporting its role as a promising adjunct to SoC in managing chronic, non-healing wounds.

Read the full case series in Journal of Wound Care

Keywords:
carePATCH,
amniotic membrane,
chronic wounds,
standard of care,
venous leg ulcer,
pressure ulcer

What Patient Populations Are at Higher Risk for Wounds?

Summary: Experts in wound care highlight patient populations most at risk for developing wounds that fail to heal within 1–3 weeks. Factors such as advanced age, diabetes, vascular disease, immobility, and unrecognized underlying conditions contribute significantly to poor healing outcomes. The discussion stresses that wound care requires a holistic, multidisciplinary approach.

Key Highlights:

• Older adults: Patients aged 65 and above face increased risk due to thinning skin, comorbidities, and reduced tissue perfusion.
• Diabetes and vascular disease: Diabetes and peripheral arterial disease impair circulation and delay healing, raising complication risks.
• Immobility and ICU patients: Bedridden, post-surgical, or intensive care patients are vulnerable to pressure injuries and delayed healing.
• Undiagnosed conditions: Non-healing wounds can be the first sign of previously unrecognized diabetes or vascular disease.
• Systemic approach: Healing requires evaluating vascular health, mobility, nutrition, and overall patient condition, not just wound appearance.
• Team-based care: Effective management depends on collaboration among wound specialists, vascular experts, primary care providers, and nursing teams.

Read the full article on AJMC

Keywords:
higher risk populations,
older adults,
diabetes,
immobility,
vascular disease,
non-healing wounds

Knowledge, Attitude & Behaviour Toward Diabetic Foot Ulcers in East Java Community

Summary: A cross-sectional study conducted at Haji Regional General Hospital, East Java Province, Indonesia, assessed the community’s knowledge, attitude, and behaviour concerning diabetic foot ulcers (DFU). While many respondents had good attitudes, knowledge and behaviour/practice were frequently poor. The study found that knowledge level was not significantly associated with DFU occurrence, but attitude and behaviour/practice showed significant correlations.

Key Highlights:

• Poor knowledge common: 39.7% of respondents demonstrated poor knowledge about DFUs.
• Mixed attitude: 52.9% of respondents showed a good attitude toward prevention, despite gaps in knowledge and practice.
• Poor practices pervasive: Over half (52.9%) had poor behaviour/practice in preventive care for DFUs.
• Knowledge vs outcome: No statistically significant association between knowledge level and occurrence of DFU.
• Attitude & behaviour matter: Attitude and practice/behaviour were significantly associated with DFU presence.

Read the full study in IJSRM

Keywords:
diabetic foot ulcer,
knowledge,
attitude,
behaviour,
prevention practices,
East Java

Challenges in Wound Care: Managing Comorbidities & Protocol Application

Summary: Experts in wound care discuss how comorbidities such as diabetes, peripheral vascular disease, and neuropathy complicate treatment, and how the lack of universally accepted protocols causes wide treatment variation. The dialogue emphasizes that understanding a patient’s full clinical picture is essential for effective wound management, but many settings don’t have or follow standardized guidelines. (ajmc.com)

Key Highlights:

• Tailored treatment by etiology: Offloading in diabetic ulcers, compression in venous wounds, vascular specialist referral in arterial disease. Treatments differ depending on root cause.
• Protocol gaps: Evidence-based guidelines exist, but they’re not always strong or consistent. Many providers lack clear direction on what to do at different stages.
• Variability in practice: Care differs by geography, provider specialty, and even by individual clinician or care setting.
• Coordination and care transitions: Patients often see specialists in wound centers, then transfer to home health or generalist care, leading to loss of specialist oversight.
• Need for early action: Delays in advanced therapies or proper referrals reduce healing rates; simple measures like removing shoes and socks to examine feet are not always applied.
• Expertise and system issues: Lack of specialized training in wound care, multiple disciplines involved, and insufficient integration into systems like EMRs contribute to care inconsistencies.

Read the full article on AJMC

Keywords:
wound care,
comorbidities,
protocols,
evidence-based guidelines,
care coordination,
clinical variability

Is There Standardization for Wound Care?

Summary: In a discussion among experts published in *The American Journal of Managed Care*, concerns are raised about the lack of universally accessible wound care standards. While certain centers of excellence and specialized programs employ evidence-based protocols, many providers outside those networks do not have easy access to standardized guidelines, leading to variability in care delivery and outcomes. (ajmc.com)

Key Highlights:

• Existing protocols: Specialized wound care centers and home health agencies often have algorithms and guidelines backed by experts, aimed at consistency in care.
• Accessibility issue: Many clinicians, especially those not in specialized wound care practices, report difficulty finding and applying standardized protocols.
• No unified governing body: The experts point out there is no central organization or standard that aggregates and disseminates wound care guidelines for all clinicians.
• Need for integration: For standards to be effective, they must be built into delivery systems, electronic health records, and care pathways so non-specialist providers can utilize them.
• Training & education gap: Long-standing practices and clinician habits may resist newer standardization unless accompanied by training and clear institutional support.

Read the full discussion on AJMC

Keywords:
wound care standardization,
evidence-based protocols,
clinical guidelines,
access to standards,
training in wound care,
centers of excellence

Stoma Masterclass: Shaping the Future of Ostomy Care with Moldable Technology

Summary: As part of the Global Innovation Summit Series, Wound Masterclass is hosting a Stoma Masterclass focused on moldable technology in ostomy care. This deep-dive session will highlight clinical evidence, patient case studies, and practical guidance for clinicians seeking to optimize outcomes and improve quality of life for ostomy patients.

Key Highlights:

• Event date: Scheduled for 10 September 2025, available online through BigMarker.
• Clinical focus: Evidence-based exploration of moldable adhesives and skin barriers to address leakage and protect peristomal skin.
• Learning objectives: Guidance on patient assessment, product selection, and troubleshooting common ostomy care challenges.
• Case studies: Real-world examples demonstrate how moldable technology supports individualized care and improved patient outcomes.
• Patient-centered outcomes: Emphasis on comfort, skin health, and minimizing complications to enhance overall quality of life.

Register for the Stoma Masterclass via Wound Masterclass

Keywords:
moldable technology,
ostomy care,
stoma masterclass,
skin protection,
patient outcomes

Embracing the New Braden Scale II

Summary: Pressure injuries remain a major concern in healthcare, especially among patients with limited mobility. The original Braden Scale, developed in the 1980s, has long been used to identify patients at risk. The newly released Braden Scale II addresses limitations of the original version, offering enhanced accuracy, expanded assessment criteria, and better alignment with evidence-based practice.

Key Highlights:

• Expanded components: In addition to sensory perception, moisture, activity, mobility, nutrition, and friction/shear, the Braden Scale II introduces a subcategory in the activity component: “ability to change and control body position.”
• Updated scoring: Criteria for each category have been reevaluated to align with current clinical knowledge and provide a more accurate risk assessment.
• Sensory perception: Expanded to include cognitive abilities, recognizing how impairments affect a patient’s ability to perceive or respond to discomfort.
• Clinical benefits: The Braden Scale II improves precision, ensures comprehensive evaluation, and enhances prevention strategies against pressure injuries.
• Hospital implementation: Successful use requires staff training, integration into electronic health records, and a collaborative approach across disciplines.
• Education focus: Hospitals should prioritize ongoing education to ensure consistency in applying the Braden Scale II and interpreting scores.

Read the full article on Wound Care RN

Keywords:
Braden Scale,
Braden Scale II,
pressure injury prevention,
wound assessment,
hospital implementation,
patient outcomes

Management of Early-Onset Type 2 Diabetes in Adults

Summary: A 2025 review in the Diabetes & Metabolism Journal explores strategies for managing early-onset type 2 diabetes (EOT2D) in adults. The article emphasizes the importance of early intervention, weight reduction, and preserving β-cell function to delay complications and improve long-term outcomes.

Key Highlights:

• Weight reduction: Lifestyle modification, structured dietary plans, and when appropriate, pharmacologic or surgical interventions are recommended to achieve sustained weight loss.
• Preserving β-cell function: Early initiation of therapies that reduce β-cell stress and maintain tight glycemic control helps slow disease progression.
• Therapeutic escalation: Clinicians are encouraged to move beyond metformin monotherapy sooner when patients are not meeting glycemic targets, incorporating newer agents with cardiovascular and renal benefits.
• Risk stratification: Assess patients based on age at onset, baseline insulin resistance, comorbidities, and family history to guide individualized management.
• Monitoring complications: Early screening for retinopathy, nephropathy, and cardiovascular disease is advised from diagnosis, alongside aggressive risk-factor management.

Read the full review in Diabetes & Metabolism Journal

Keywords:
early-onset type 2 diabetes,
weight reduction,
β-cell preservation,
therapeutic escalation,
cardiovascular risk,
diabetes complications

EWMA-DEWU 2026 Abstract Submission Now Open

Summary: The European Wound Management Association (EWMA) has announced that abstract submissions are now open for the EWMA-DEWU 2026 conference in Bremen, Germany, taking place 6–8 May 2026. Submissions are accepted in both English and German, covering more than 25 categories in wound care. Deadlines are 4 December 2025 for English abstracts and 11 December 2025 for German abstracts, with notifications to be issued in February 2026.

Key Highlights:

• Submission deadlines: English abstracts due 4 December 2025; German abstracts due 11 December 2025.
• Languages & categories: Abstracts may be submitted in English or German across over 25 clinical and research categories.
• Presentation options: Authors can choose between oral presentations or electronic posters.
• Notification schedule: Acceptance or rejection decisions will be communicated by February 2026.
• Conference details: EWMA-DEWU 2026 will be hosted in Bremen, Germany, from 6–8 May 2026.

View submission guidelines and details on EWMA

Keywords:
EWMA 2026,
abstract submission,
wound care conference,
oral presentation,
electronic poster,
Bremen Germany

A Proactive Approach to Using Moldable Skin Barriers to Enhance Ostomy Care

Summary: A case series published in *Journal of Wound, Ostomy, and Continence Nursing* describes how moldable skin barriers were used proactively in three ostomy patients. These barriers improved self-care, reduced peristomal skin complications, helped with skin health, and enhanced health-related quality of life. The article notes that there is limited existing literature on moldable skin barriers, and these cases help illustrate their potential benefits. (journals.lww.com)

Key Highlights:

• Case 1: A patient struggling with anxiety about ostomy self-care benefited from a moldable skin barrier that was easier to apply than standard barriers.
• Case 2: In a patient with skin maceration, a moldable barrier with better adhesion plus a protective crusting technique helped improve skin condition.
• Case 3: For a young girl with frequent leakage affecting social/educational life, a moldable barrier with a secure fit reduced leakage and its impact.
• Quality of life effects: Patients reported improved comfort, less irritation, better skin integrity, and greater confidence in managing their ostomy.
• Evidence gap: The authors encourage further research, as moldable skin barriers are underrepresented in current literature despite promising results.

Read the full article in JWOCN

Keywords:
moldable skin barrier,
peristomal skin complications,
ostomy care,
skin health,
quality of life

Latest News: NICE Recommendations on Type 2 Diabetes Treatment and Equity in Care

Summary: The August 2025 issue of the Journal of Diabetes Nursing highlights draft recommendations from NICE that promote more personalised type 2 diabetes management. Key updates include initiating SGLT-2 inhibitors alongside metformin at diagnosis, earlier use of GLP-1 receptor agonists, structured weight-loss follow-up, and a stronger emphasis on reducing health inequities across patient populations.

Key Highlights:

• Personalised treatment: NICE suggests starting SGLT-2 inhibitors with metformin at diagnosis and considering GLP-1 receptor agonists earlier for high-risk groups.
• Reducing inequity: Guidance addresses gaps in prescribing cardio-renal protective therapies, particularly among women, older adults, and minority populations.
• Weight-loss support: Recommends structured support for at least 12 months after weight-management programs or discontinuation of medication.
• Equity strategy: Diabetes UK’s initiative “No One Left Behind: Achieving Equity in Diabetes (2025–2030)” sets out measurable goals to improve access and outcomes.
• Public health impact: Emphasises the long-term cost savings of preventive care and comprehensive obesity management for the healthcare system.

Read the full article in the Journal of Diabetes Nursing

Keywords:
type 2 diabetes,
SGLT-2 inhibitors,
GLP-1 receptor agonists,
weight loss support,
health equity,
Diabetes UK

Best Practice Recommendations for the Prevention & Management of Skin Tears in Aged Skin (2nd Edition)

Summary: The International Skin Tear Advisory Panel (ISTAP), in collaboration with NSWOCC (Canada) and WOCN (USA), has released the 2025 update to its guidance on skin tears in aged skin. These recommendations include revised definitions, new tools for assessment, classification and data collection, and enhanced prevention & management strategies informed by recent evidence.

Key Highlights:

• ISTAP DC-Tool developed: A validated data-collection tool (22 questions) to capture detailed info on patient/resident characteristics, skin tear features, and clinical context. Useful for research and quality improvement.
• Updated definitions and classification: Skin tears continue to be defined as traumatic wounds from mechanical forces, not extending through subcutaneous tissue. Classification and decision-algorithms are refined.
• Risk factors clarified: Fragile aged skin, comorbidities, cognitive impairment (including dementia), skin tone, and environmental/handling-related risks are emphasised.
• Prevention strategies strengthened: Using pH-balanced cleansers, frequent moisturisation, gentle handling, minimizing exposure to friction/shear, avoiding aggressive adhesives, and attention to skin tone in assessments.
• Treatment & management: Preserve the skin flap, avoid stretching; use non-adherent, silicone or gentle dressings; ensure atraumatic care and secure but gentle adhesion; manage exudate and maintain moisture balance.
• Inclusivity & awareness: New guidance considers differences in presentation and care in darker skin tones; tools and visuals are adapted for inclusivity.

Read the full 2nd Edition on Wounds International

Keywords:
skin tears,
ISTAP DC-Tool,
aged skin,
skin tone,
prevention strategies,
gentle dressings

Medial Arterial Calcification & Diabetic Foot Ulcer Management

Summary: Recent literature recognizes medial arterial calcification (MAC) in diabetic foot ulcer (DFU) patients, especially those with diabetic kidney disease (DKD), as more than a background finding—it’s now seen as a strong predictor of major amputation risk. Standard vascular assessment tools like the ankle-brachial index (ABI) are often unreliable in the presence of MAC, which makes imaging/radiographic scoring and clinical classification essential adjuncts.

Key Highlights:

• Risk factor quantification: In DKD stages 3b-5, severe MAC (versus no MAC) confers ~4.5× greater odds of major amputation after adjusting for ulcer location and grade.
• Ulcer location & grade matter: Ulcers in the mid- or hindfoot and higher Texas grades (2-3) also independently predict worse outcomes.
• Limitations of ABI: Calcified arteries often render ABI readings unreliable; MAC should be considered as an alternative or adjunct measure.
• Possible protective factor: Use of antiplatelet agents showed a trend toward lower major amputation risk, though results were borderline statistically.
• Ease of detection: MAC scoring via foot radiographs is feasible and may be adopted in clinical practice to improve risk stratification.

Read the full letter/editorial on HMP Global Learning Network

Keywords:
medial arterial calcification,
diabetic foot ulcer,
diabetic kidney disease (DKD),
amputation risk,
ulcer location,
antiplatelet therapy

ACFAS Coding and Billing 2025: Optimizing Surgical Reimbursement

Summary: The American College of Foot and Ankle Surgeons (ACFAS) is hosting a comprehensive coding and billing course on November 14–15, 2025, in Chicago, IL. The program equips surgeons, residents, and coding staff with practical tools to improve accuracy and reduce denials in foot and ankle surgery billing.

Key Highlights:

• Curriculum: Forefoot and rearfoot reconstruction, arthroscopy, trauma management, and diabetic foot procedures.
• Practical training: Hands-on coding exercises, modifier usage, denial handling, and real-world scenarios.
• Accreditation: Participants can earn up to 12.5 CME/CECH hours.
• Registration: Member rates ~$675; non-members ~$800; resident members ~$420.

Learn more and register at ACFAS

Keywords:
ACFAS,
foot and ankle surgery,
medical coding,
billing,
continuing education

Prevention and Management of Skin Tears in Aged Skin

Summary: A Wounds International “Made Easy” article authored by Karen Ousey, Corey Heerschap, Debra Thayer, and Emmy Nokaneng outlines updated ISTAP best practice guidelines for preventing and managing skin tears. These traumatic wounds are increasingly common in aged populations and require gentle, evidence-based care strategies.

Key Highlights:

• Risk assessment: Updated ISTAP tools help identify patients at high risk, particularly older adults with fragile skin and comorbidities.
• Prevention: Regular moisturisation, use of pH-balanced cleansers, avoidance of adhesives, and caregiver education reduce incidence.
• Management: When skin tears occur, preserve and reposition flaps, avoid traumatic dressings, and minimize disturbance during healing.
• Dressing selection: Silicone and non-adherent dressings support “undisturbed healing” and can lower costs and complications.

Read the full article on Wounds International

Keywords:
skin tears,
aged skin,
ISTAP,
Karen Ousey,
wound prevention

Palliative Wound Care: Balancing Comfort and Clinical Decisions

Summary: In a Wounds International podcast, Professors Karen Ousey and Sebastian Probst discuss the complexities of palliative wound care. Their conversation highlights the shift in priorities from aggressive healing to comfort, dignity, and symptom management for patients approaching end of life.

Key Highlights:

• Patient-centred focus: Wound care decisions in palliative phases emphasize comfort and quality of life rather than complete closure.
• Skin changes: Fragile skin and physiological changes near end of life require gentle, non-invasive care strategies.
• Ethical and emotional aspects: Clinicians must navigate the expectations of families while respecting the wishes of the patient.
• Collaboration: Interdisciplinary teams, including palliative specialists and wound care clinicians, are essential for aligning treatment goals.

Listen to the full podcast on Wounds International

Keywords:
palliative wound care,
Karen Ousey,
Sebastian Probst,
end of life care,
quality of life

Evidence Review & Consensus: Dialkylcarbamoyl Chloride (DACC)–Coated Wound Dressings

Summary: A Wounds International expert consensus document evaluates the clinical role of DACC-coated wound dressings, which bind microorganisms through hydrophobic interactions rather than releasing active antimicrobial agents. This mode of action reduces resistance risk and preserves host tissue, offering a unique option for wounds at risk of infection.

Key Highlights:

• Mechanism: DACC attracts and irreversibly binds hydrophobic microbes, physically removing them when the dressing is changed, rather than killing them chemically.
• Evidence base: Systematic reviews and clinical studies support effectiveness in reducing bioburden and promoting healing in diabetic foot ulcers, pressure ulcers, venous leg ulcers, surgical wounds, and burns.
• Safety: No cytotoxicity; suitable for fragile tissue. Dressings are biocompatible and safe across a wide range of wound types and patient populations.
• Consensus: The panel positions DACC dressings as a valuable first-line tool for infection prevention and adjunctive therapy in wounds with high microbial burden or delayed healing.
• Health economics: By reducing infection rates and antibiotic use, DACC dressings may contribute to lower overall treatment costs and improved antimicrobial stewardship.

Read the full consensus document on Wounds International

Keywords:
DACC wound dressing,
antimicrobial stewardship,
bioburden control,
diabetic foot ulcer,
venous leg ulcer,
pressure ulcer

Huiyang Shengji Unguent Enhances Lymphangiogenesis & Healing in Diabetic Chronic Wounds

Summary: Investigators from Beijing Hospital of Traditional Chinese Medicine published new work in Journal of Inflammation Research showing that Huiyang Shengji (HYSJ) unguent accelerates healing of diabetic chronic wounds by boosting lymphangiogenesis, protecting lymphatic endothelial cells, and suppressing inflammatory cell death in high-glucose environments.

Key Highlights:

• Major constituents of the unguent (e.g. coclaurine, sinapine, ononin) identified via mass spectrometry; applied topically in diabetic mice with chronic wounds.
• Treated mice showed faster closure, improved lymphatic drainage in wound tissue; key lymphatic markers (LYVE-1, VEGF-C, PROX-1) increased.
• In vitro, high-glucose inflammatory conditions in human lymphatic endothelial cells responded favorably: function preserved, inflammatory cell death reduced, signaling via TLR2/Myd88/caspase-1 suppressed.
• Proteomics and bioinformatics analyses revealed upregulation of lymphatic repair pathways, downregulation of inflammasome-driven pyroptotic pathways.

Read the full article in Journal of Inflammation Research

Keywords:
Huiyang Shengji Unguent,
lymphangiogenesis,
diabetic chronic wounds,
TLR2 Myd88 caspase-1,
inflammatory cell death

Umbrella Review: Traditional Chinese Medicine Improves Outcomes in Diabetic Foot Ulcers

Summary: A recent umbrella review published in Frontiers in Medicine assessed meta-analyses on Traditional Chinese Medicine (TCM) as adjunctive therapy for diabetic foot ulcers (DFUs). It finds that TCM interventions—especially topical/herbal formulations—are associated with improved healing outcomes and reduced complications, especially when treatments are applied over longer durations and in larger samples.

Key Highlights:

• Herbal treatments, ointments, and topical TCM formulations showed benefit in terms of wound size reduction, faster granulation, and fewer adverse events.
• Effect magnitudes tended to be higher when studies had longer follow-ups or more rigorous design quality.
• Safety was generally acceptable; some studies reported mild local irritation, but serious harms were rare.
• Review authors call for better standardization of herbal product preparation, ingredient quality, outcome metrics, and blinding in trials.

Read the umbrella review in Frontiers in Medicine

Keywords:
Traditional Chinese Medicine,
diabetic foot ulcer,
herbal formulations,
adjunct therapy,
recovery times

Systematic Review: Polyhexanide vs Other Dressings — Safety and Efficacy in Various Wound Types

Summary: A forthcoming systematic review & meta-analysis (ahead of print) in *Wound Practice and Research* compared polyhexanide (a biguanide antiseptic) dressings against other dressing types across multiple wound types. Results suggest polyhexanide dressings are generally safe, with comparable or improved healing rates, and with lower local irritation in some cases.

Key Highlights:

• Polyhexanide showed better or equal effectiveness for healing across diabetic, venous, pressure, and mixed aetiology wounds compared to wound dressings without polyhexanide.
• Safety profile good: less cytotoxicity, lower risk of pain or stinging in patients, some favorable tolerability.
• Meta-analysis indicates that polyhexanide may help particularly in wounds with moderate bioburden or infection risk.
• Limitations: heterogeneity of wound types, variations in application frequency and adjunct therapies; many studies still small sample size.

Read ahead-of-print meta-analysis in *Wound Practice & Research*

Keywords:
polyhexanide dressings,
antiseptic dressings,
wound safety,
wound healing comparison

Comparative Efficacy & Safety of Wound Dressings: Bayesian Network-Meta Analysis Reveals Amniotic Membrane Soars

Summary: A new Bayesian network meta-analysis just published via **SAGE** evaluated multiple types of wound dressings across diverse wound types (diabetic, pressure, venous etc.). Key finding: human amniotic membrane dressings lead the pack in terms of healing rate, with favorable safety profile compared to many common dressings.

Key Highlights:

• Among the dressings analyzed, **human amniotic membrane** ranked top by SUCRA (Surface Under the Cumulative Ranking) for increasing wound healing rate.
• Other advanced dressings (e.g. some hydrogel, foam, alginate types) showed more moderate benefits; conventional gauze and simpler dressings lagged behind.
• Meta-analysis found no major safety concerns across dressing types; infection rates and adverse effects were comparable.
• Heterogeneity remains: wound type, baseline severity, environment of care (inpatient vs outpatient) affect outcomes. Authors call for more head-to-head RCTs.

Read the full network meta-analysis on SAGE

Keywords:
amniotic membrane dressings,
network meta-analysis,
wound dressings efficacy,
safety profile

ZnO-TPU/CS Bilayer Nanofibrous Scaffold Accelerates Full-Thickness Skin Defect Healing

Summary: A recent study in *Frontiers in Bioengineering & Biotechnology* describes a bilayer scaffold composed of thermoplastic polyurethane (TPU) and chitosan loaded with zinc oxide nanoparticles (ZnO). Tested in full-thickness skin defect animal models, this scaffold achieved >90% wound closure by day 14, outperforming untreated controls. It combines a waterproof outer TPU layer with a bioactive inner layer promoting cell adhesion, angiogenesis, and immunomodulation.

Key Highlights:

• Bilayer design: hydrophobic TPU outer stratum for protection; inner TPU/Chitosan@ZnO hydrophilic layer to encourage healing.
• Physicochemical properties solid: nanofibre diameters ~230 nm, tensile strength ~8.4 MPa, modulus ~18 MPa.
• In vitro tests show enhanced proliferation and adhesion of skin‐derived cells; in vivo tests confirm accelerated wound closure, better collagen deposition, improved vascularization.
• Suggests multifunctional scaffold (protections + bioactivity) can reduce healing times and improve tissue quality. More work needed on molecular mechanisms and safety.

Read full study in *Frontiers in Bioengineering & Biotechnology*

Keywords:
ZnO nanofibrous scaffold,
bilayer design,
TPU chitosan,
skin defect model,
angiogenesis

Caltech’s iCares Smart Bandage Speeds Healing with Real-Time Monitoring & AI Insight

Summary: Caltech’s latest “lab-on-skin” smart bandage, dubbed *iCares*, has moved into human testing with 20 patients who have chronic wounds (diabetes, circulatory issues). The bandage monitors wound fluid biomarkers in real time, flags infection early, and uses AI to predict healing timelines—potentially days before symptoms are visible. Outcomes show promise for faster closure when using advanced sensing + moisture management.

Key Highlights:

• The bandage includes microfluidic modules to collect fresh exudate (not just pooled or old fluid), transport it, and clear excess moisture.
• Detects biomarkers like nitric oxide, hydrogen peroxide, temperature, pH—early warning signs of inflammation or infection.
• AI/ML algorithm able to classify wound severity and forecast healing time with accuracy close to that of expert clinicians.
• Materials: flexible biocompatible polymers; disposable sensor array; reusable electronics; design focuses on cost and scalability.

Read full article on MedIndia

Keywords:
iCares smart bandage,
real-time biomarkers,
chronic wounds,
machine learning wound prediction,
Wei Gao

Save the Date: EWMA-DEWU 2026 Conference, Bremen, Germany

Summary: The 36th annual European Wound Management Association (EWMA) conference, jointly held with the DEWU Deutscher Wundkongress, will take place **6-8 May 2026** in Bremen, Germany. It will feature workshops, e-poster sessions, an industry exhibition, masterclasses, and extensive networking opportunities in both English and German.

What to Expect:

• Sessions on innovative wound healing technologies, eHealth, compression therapy, and antimicrobial stewardship.
• Large industry exhibition—chance to meet companies advancing wound care solutions.
• Call for abstracts opens September 2025; abstracts can be submitted in English or German.
• Program and registration information to be released; registration opens October 2025.

Visit the EWMA-DEWU 2026 conference page

Keywords:
EWMA 2026,
DEWU,
wound management conference,
international wound care

Smart Bandage iCares Moves Closer: Real-World Human Monitoring & Early Infection Detection

Summary: Caltech and USC teams have made progress with the iCares smart bandage, a wearable “lab-on-skin” device designed to both monitor and aid healing of chronic wounds. In a human pilot study of 20 patients, the bandage sampled wound exudate in real time, detected key biomarkers, and used machine learning to predict healing trajectories.

Key Highlights:

• The bandage includes three microfluidic modules: one to collect fresh fluid, another to transport it to a sensing area, and a third to move excess fluid away. This helps avoid stale or mixed exudate and keeps measurement accurate.
• Detected biomarkers include nitric oxide (indicator of inflammation), hydrogen peroxide (potential infection), and changes in oxygen, pH, temperature. These could flag problems 1-3 days before visible symptoms.
• Machine learning algorithm applied to sensor data classified wound severity and predicted healing time with accuracy comparable to expert clinicians.
• Bandage is biocompatible, includes disposable sensor array + reusable electronics; low-cost 3D-printing is part of the design.
• Potential for both monitoring and delivery of treatments based on detection, moving wound care toward proactive rather than reactive management.

Read more from Caltech & Science Translational Medicine

Keywords:
iCares smart bandage,
smart bandage,
wound biomarkers,
machine learning wound healing,
Caltech,
Wei Gao

Preventable Wounds Are Costing Texas Patients Their Health and Facilities Their Reputation

Summary: Agape Life Multicultural Services (ALMS) is expanding its mobile wound care services across Texas, aiming to reduce hospital readmissions and improve outcomes by delivering wound care where patients live—homes, nursing facilities, rehab programs, etc. They emphasize early intervention (within days of hospital discharge) to prevent complications in chronic, diabetic, pressure, and surgical wounds.

Key Highlights:

• ALMS is now serving areas including Mansfield, Dallas, Arlington, Grand Prairie, and others.
• The model involves seeing discharged patients within the critical 7–14-day window to avoid wound deterioration that leads to readmission.
• Focus is on both prevention and early treatment to reduce burden on hospitals and improve patient quality of life.
• The expansion includes working with skilled nursing, assisted living, home health, LTACs, and rehab facilities to close gaps in care continuum.

Read the full press release on PRLog

Keywords:
mobile wound care,
preventable wounds,
hospital readmissions,
Texas wound care,
chronic wound prevention

The Association Between Obstructive Sleep Apnea & Wound Healing: A Systematic Review

Summary: In a systematic review referenced via PMC, Caroline Fife, MD, highlights findings from 11 cohort and 1 case–control study (combined sample >58 million) evaluating how obstructive sleep apnea (OSA) or high risk of OSA relate to wound healing outcomes. The review finds higher risk of wound infection and dehiscence in patients with OSA; evidence on healing time is conflicting and overall quality is low due to risk of bias.

Key Highlights:

• Patients with OSA are more likely to experience wound infection and wound edge separation (dehiscence) post-surgery.
• Data on time to heal are mixed: one study reported faster healing in OSA patients, but others show delays.
• Strength of evidence is limited: high heterogeneity among studies, inconsistent definitions of OSA and wound healing metrics, and potential confounding.
• Implication: wound care clinicians should consider screening for sleep apnea in non-healing wounds, as OSA may be an underrecognized risk factor.

Read the review on CarolineFifeMD.com

Keywords:
obstructive sleep apnea,
wound infection,
wound dehiscence,
surgical wounds,
Caroline Fife

Machine Learning to Diagnose Complications of Diabetes

Summary: A recent manuscript in Journal of Diabetes Science & Technology (2025) from Scheideman et al. surveys how machine learning (ML) is being used to detect and predict complications of diabetes—including foot ulcers, retinopathy, nephropathy, autonomic dysfunction, and neuropathy. The review highlights both existing successes and current limitations in bringing AI/ML into clinical workflows.

Key Highlights:

• Deep learning models are already in use for retinopathy screening through fundus images; future systems are pushing toward multimodal risk prediction and smartphone-based deployment.
• For diabetic foot ulcers, thermal imaging combined with convolutional neural networks is showing promise in earlier risk detection than conventional clinical examination.
• Wearables, ECG, and corneal imaging are being explored to detect peripheral and autonomic neuropathy earlier.
• Challenges remain: dataset diversity, labeling quality, external validation, explainability, and seamless integration into clinical care.

Read the full review on DiabeticFootOnline

Keywords:
machine learning,
diabetic foot ulcer,
retinopathy,
nephropathy,
wearable sensors,
thermal imaging,
Scheideman,
David G. Armstrong

Simple and Effective: 2% Citric Acid Ointment for Wound-Bed Preparation in Chronic, Infected Wounds

Summary: A case series from India (MIMSR Medical College, Latur) reports on 24 chronic wounds that failed conventional therapy for more than three weeks. Application of 2% citric acid ointment once daily led to healthy granulation tissue in **all cases** (3 to 20 applications), even with antibiotic-resistant bacteria present. The approach offers a low-cost, accessible option for wound bed preparation when standard treatments fall short.

Key Highlights:

• Wounds included large raw areas and were resistant to standard treatments (various antiseptics, topical antimicrobials) for over three weeks.
• Cultures identified multiple organisms: most common Staph aureus, Pseudomonas aeruginosa, Escherichia coli, Klebsiella, etc.; many were multidrug resistant.
• No systemic antibiotics were used unless systemic symptoms (fever, toxemia) present; local citric acid alone controlled infection and induced granulation.
• Healthy granulation suitable for grafting or continued healing observed in all patients after 3 to 20 topical applications. No local toxicity reported.
• Authors note limitations including small sample size, observational design, absence of control; however results suggest potent efficacy of citric acid ointment in challenging wounds.

Read the full article in *Wound Management & Prevention*

Keywords:
citric acid ointment,
wound bed preparation,
chronic infected wounds,
MIMSR Medical College,
antibiotic resistant organisms

OIG Calls for Urgent “Skin Substitute” Payment Reform Based on Medicare Data

Summary: In a recent editorial, Dr. Caroline Fife reviews a new report from the Office of Inspector General (OIG) that reveals explosive growth and concerning patterns in Medicare payments for skin substitutes. Key findings include dramatic cost increases, widespread use in home settings, and possible misaligned incentives prompting overuse. The article calls for urgent reform to better align payment, usage, and quality.

Key Highlights:

• Medicare Part B spending on skin substitutes rose from roughly **$400 million** to nearly **$3 billion per quarter** between 2023 and 2024; total annual spending exceeded **$10 billion**, accounting for over 15% of all Part B drug costs.
• Home care cases (28% of patients) consumed over 50% of skin substitute spending—with average costs much higher than in clinics or physician offices.
• New providers (recently acquiring NPIs) reportedly bill nearly 100% of their skin substitute procedures without accompanying wound care management.
• The current payment structure (ASP-based) may incentivize overuse; procedures are being used for very minor wounds like scrapes or blisters at first visit, and claims patterns show potential for fraud or abuse.

Read the full article on CarolineFifeMD.com

Keywords:
skin substitute payment reform,
Medicare spending,
skin substitutes overuse,
Caroline Fife,
OIG report

Market Spotlight: North America’s Diabetic Foot Care Industry Poised for Strong Growth

Summary: According to a recent industry analysis, the diabetic foot ulcer (DFU) treatment market in North America was valued around **USD 1.27 billion** in 2024 and is projected to grow to about **USD 2.22 billion by 2034**, at a compound annual growth rate (CAGR) of roughly **5.74%**. The growth is being driven by rising diabetes prevalence, aging populations, innovation in biologics, devices, and increasing investment in homecare solutions.

Key Insights & Trends:

• Biologics’ dominance: Skin substitutes, stem cell therapies, and regenerative products are major contributors to current market value.
• Therapy Devices on the Rise: Advanced dressings, negative pressure wound therapy (NPWT), photobiomodulation, and newer device-based interventions (e.g. devices that release nitric oxide or detect infection) are expected to grow fastest.
• Homecare & Aging Demographics: As the population ages and more people are treated at home, demand for easy-to-use wound care products and preventive devices is increasing.
• Innovation & R&D Momentum: Research continues in diagnostics, monitoring technologies, smart dressings, and biologics to improve outcomes and cost-effectiveness.

Challenges & Considerations:

• Cost barriers—biologics and specialty devices remain expensive; reimbursement and insurance coverage may limit access.
• Regulatory oversight and clinical evidence—new therapies/devices need robust trials to prove safety and benefit.
• Patient adherence and access—especially for homecare, where proper usage, follow-up, and correct product selection are key.

Read the full industry analysis on InvestorsHangout

Keywords:
diabetic foot care market,
growth trends,
biologics,
device innovations,
homecare solutions

🔬 Spotlight: From Molecules to Populations — Bridging Mechanistic and Clinical Insights in Diabetic Wound Healing

Summary: Two recent publications highlight the full spectrum of diabetic wound research — from benchside mechanistic biology to population-level risk analysis. Together, they show how molecular targets and systemic biomarkers may eventually intersect to shape precision strategies for preventing and treating diabetic foot complications.

1. Molecular Focus — METTL3/GDF11 Pathway in Socket Healing

A study published in Diabetes, Metabolic Syndrome and Obesity explored how METTL3-mediated m6A modification regulates GDF11 expression, promoting extraction socket healing in diabetic rat models. Researchers demonstrated that overexpression of METTL3 improved trabecular bone formation, enhanced soft tissue healing, and restored angiogenesis. Mechanistically, the pathway hinges on stabilizing GDF11 transcripts via m6A methylation. When GDF11 was knocked down, much of METTL3’s benefit was reversed, underscoring this axis as a potential therapeutic target.

Notably, the use of micro-CT, histology, and gene expression assays confirmed both structural and molecular benefits. The translational implication is clear: modulating RNA methylation machinery could one day enhance oral and cutaneous wound repair in patients with diabetes, moving beyond symptomatic care toward biomaterial or gene-based interventions.

2. Population Focus — Inflammation and Nutrition Biomarkers in DFU Risk

In contrast, a large combined cross-sectional and retrospective study in Frontiers in Endocrinology examined over 31,000 NHANES participants plus clinical cohorts. The analysis revealed that composite indices linking inflammation and nutrition — such as the neutrophil-albumin ratio (NAR), monocyte-albumin ratio (MAR), red cell distribution width-albumin ratio (RAR), as well as the hemoglobin-albumin-lymphocyte-platelet (HALP) score and Prognostic Nutritional Index (PNI) — strongly associate with diabetic foot ulcer (DFU) prevalence.

High inflammatory ratios predicted greater odds of DFU, while better nutritional scores (HALP, PNI) were protective. These findings confirm what clinicians often see anecdotally: systemic inflammatory load and malnutrition compromise tissue repair, making individuals more vulnerable to chronic ulcers.

3. Connecting the Dots — Why Both Levels Matter

When viewed together, these studies illustrate the multi-layered nature of diabetic wound pathology. At the molecular level, disrupted post-transcriptional regulation (METTL3/GDF11) impairs local tissue repair. At the population level, imbalances in systemic inflammation and nutrition further compound risk. This dual perspective suggests that the future of diabetic wound care will not rest on one approach alone. Instead, clinicians may soon combine:

• Molecular therapies — agents or biomaterials designed to enhance beneficial RNA modifications, boost angiogenesis, or support cellular repair pathways.
• Risk stratification tools — composite blood indices (e.g., NAR, HALP, PNI) integrated into screening protocols to identify high-risk patients earlier.
• Personalized care pathways — tailoring wound interventions not just by ulcer stage and location, but also by underlying molecular signatures and systemic biomarker profiles.

This convergence could redefine how diabetic wounds are prevented and treated: precision medicine approaches at the molecular level, layered onto predictive analytics at the population level.

Clinical Takeaway

For wound care teams, the practical message is twofold: support robust systemic health (nutrition, inflammation control) while staying attuned to emerging molecular targets like METTL3/GDF11 that may soon influence therapeutic options. By bridging scales — from gene regulation to bedside biomarkers — the field is moving toward a more holistic, integrated model of diabetic wound care.

Further Reading:

• METTL3/GDF11 Mechanistic Study
• Biomarker Study in Frontiers in Endocrinology

Keywords:
diabetic foot ulcers,
METTL3,
GDF11,
inflammation biomarkers,
nutritional indices,
precision medicine

Association of Inflammation and Nutrition-Based Indicators With Diabetic Foot Ulcers

Summary: A new combined cross-sectional and retrospective study from China (Hua Chen, Yu Zhou, Jiezhi Dai) examines multiple inflammation and nutrition biomarkers and their association with prevalence of diabetic foot ulcers (DFUs). Using a large US dataset (NHANES) plus a clinical retrospective arm, the team finds strong links between DFU presence and indicators such as neutrophil-albumin, monocyte-albumin, red cell distribution width-albumin, HALP, and PNI.

Key Highlights:

• Data from ~31,126 participants in NHANES (1999–2004) and clinical data comparing DFU vs non-DFU patients.
• Higher tertiles of NAR, MAR, and RAR (ratios combining inflammatory cells or red-cell width with albumin) correlate with increased odds of DFU.
• Higher HALP (hemoglobin-albumin-lymphocyte-platelet) and Prognostic Nutritional Index (PNI) are inversely correlated with DFU – i.e. better nutrition/inflammation status associated with lower DFU risk.
• Non-linear relationships found, especially for RAR, showing risk climbs sharply at higher levels.

Read the full article in Frontiers in Endocrinology

Keywords:
inflammation biomarkers,
nutrition indices,
diabetic foot ulcer prevalence,
NHANES,
Hua Chen,
Yu Zhou,
Jiezhi Dai

METTL3-Mediated m6A Modification of GDF11 Enhances Socket Healing in Diabetic Rats

Summary: In an open-access original research article, Ding Guo and Bin Zhang report that overexpression of the RNA methyltransferase **METTL3** improves healing of tooth extraction sockets in diabetic (GK) rats. The effect is mediated via m6A methylation of **GDF11**, which increases GDF11 expression and stability. These findings suggest that the METTL3-GDF11 pathway might be a therapeutic target for improving oral wound repair in diabetes.

Key Highlights:

• Diabetic rats showed significantly lower METTL3 expression and impaired socket healing compared to healthy controls.
• Overexpression of METTL3 enhanced bone trabeculae formation, soft tissue healing, and micro-architectural metrics (BV/TV, Tb.N, Tb.Sp) in extraction sockets.
• Mechanistic studies showed that METTL3 regulates GDF11 via m6A modification; knockdown of GDF11 partially reverses the benefits of METTL3 overexpression.
• Techniques used include lentiviral overexpression/knockdown, micro-CT, histology, RT-qPCR, and luciferase reporter assays.
• Potential implications include developing therapies for diabetic oral wound healing; limitations include use of only male rats and short follow-up period (21 days post-extraction for many assessments).

Read the full article in Diabetes, Metabolic Syndrome and Obesity

Keywords:
METTL3,
m6A modification,
GDF11,
diabetic socket healing,
oral wound repair,
Ding Guo,
Bin Zhang

A Follow-Up on the “Tale of Two Wounds” and the Madness of Skin Substitute Pricing

Summary: Dr. Caroline Fife reflects on two patient cases to highlight dramatic disparities in cost for skin substitutes (“skin subs”) used in wound care—billing differences that yield huge expenses for Medicare/taxpayers and high out-of-pocket burdens for patients. The post questions why pricing for minimally manipulated amniotic skin products varies by more than 1000%, and raises concerns about unnecessary use driven by profit rather than clinical need.

Key Highlights:

• Case comparison: Wound #1 cost nearly **$500,000** (payer + taxpayer), with patient responsible for ~$99,760; Wound #2, treated with presumably similar products/wounds, cost < 1% of that sum, with patient cost ~$900.
• Dr. Fife highlights that in Wound #1, PT and NP providers reportedly made ~$124,700 each by splitting discounted pricing from the distributor—underscoring financial incentive concerns.
• The post points out that many amniotic skin substitutes are labelled “minimally manipulated,” yet pricing per cm² can differ over **1000%** across products—raising questions over fairness, value, and regulatory oversight.
• Upcoming reimbursement changes by CMS may help moderate costs, but the author is skeptical about how much lobbyists and market forces will allow that to happen.

Read the full editorial on CarolineFifeMD.com

Keywords:
skin substitute pricing,
amniotic products,
Medicare reimbursement,
financial incentives,
Caroline Fife

Silent and Sinister: High Prevalence of Silent, Severe Coronary Ischemia in Patients with Diabetic Foot Ulcers

Summary: A recent study published in *Journal of Vascular Surgery* (Monahan et al., 2025) found that a large portion of patients with diabetic foot ulcers (DFUs), even without prior known coronary artery disease or symptoms, have **silent but severe coronary ischemia** detectable on advanced imaging. This suggests underrecognized cardiovascular risk in the DFU population and possible need to integrate cardiac screening into comprehensive care.

Key Highlights:

• Among selected DFU patients who underwent coronary CT angiography (cCTA), more than half showed functional evidence of severe coronary disease via CT-derived fractional flow reserve (FFRct ≤ 0.75).
• Some patients required coronary intervention following catheterization despite no history of cardiac disease or symptoms.
• Suggests that DFU should be treated not only as a local wound issue but as a marker of systemic vascular disease.

Read the full article on DiabeticFootOnline

Keywords:
diabetic foot ulcer,
coronary ischemia,
silent ischemia,
CT-angiography,
Monahan et al.,
vascular risk

Honoring Our Peer Reviewers and the Role of Artificial Intelligence

Summary: An editorial in *Advances in Skin & Wound Care* (September 2025) by **Elizabeth A. Ayello, PhD, MS, RN, CWON, MAPWCA** and **R. Gary Sibbald, MD, Med (Derm), MAPWCA, JM** reflects on the importance of peer review in maintaining the quality of wound care science. The piece also discusses the evolving role of artificial intelligence (AI) in scholarly evaluation, especially as peer review practices adapt in the AI era.

Key Highlights:

• The journal’s reviewers are volunteers whose identities are blinded to authors and manuscript details, preserving impartiality.
• AI is increasingly considered a support tool for reviews—but with ethical questions about transparency, fairness, and maintaining human oversight.
• This issue coincides with Peer Review Week (Sept 15-19, 2025) and the theme “Rethinking Peer Review in the AI Era.”
• The editorial thanks a long list of peer reviewers worldwide and encourages others to contribute as they expand the reviewer pool.

Read the full editorial in *Advances in Skin & Wound Care*

Keywords:
peer reviewers,
artificial intelligence,
editorial,
Elizabeth Ayello,
R. Gary Sibbald,
Peer Review Week

Kirschner Wires Combined With Elastic Tape for Multilayer Tension-Reducing Repair of a Large Stage 4 Pressure Injury

Summary: This case report in *Wounds* (Aug 2025) describes an 89-year-old male with a stage 4 pressure injury over the greater trochanter treated with debridement followed by multilayer tension-reducing repair using Kirschner wires plus elastic tape. The combined technique achieved full closure and satisfactory skin and sensory recovery at 6-month follow-up.

Key Highlights:

• Large, deep pressure injury (>10 × 7.5 cm) that had purulence and necrosis; multiple debridements required before reconstruction.
• Reconstruction involved Kirschner wires as an internal frame alongside elastic tape for tension reduction of the repair layers.
• Complete healing achieved by day 102 of hospitalization; postoperative follow-ups showed durable closure and recovery of appearance and sensation.
• Technique may be useful in similar large, tension-challenging stage 4 injuries, especially in areas like trochanter or sacrum where closure under tension often fails.

Read the full case report in *Wounds*

Keywords:
tension reducing repair,
Kirschner wires,
stage 4 pressure injury,
greater trochanter,
elastic tape support

Where to Start Your Path to Selecting Codes for Debridement

Summary: An educational webinar offered by HMP Global addresses the challenges clinicians face when selecting the correct billing and procedural codes for debridement. The session aims to clarify coding categories, provide best practices, and reduce errors in documentation/submission.

Key Highlights:

• Covers different types of debridement (sharp, enzymatic, autolytic, surgical) and how coding differs depending on depth, location, and type of tissue removed.
• Emphasis on accurate documentation to support selected codes — what needs to be recorded (e.g. depth, extent, method, tissue types).
• Tips for avoiding common errors in coding that lead to denials or audits.
• Useful for wound care specialists, billing staff, clinic managers, and providers who do documentation or submit claims.

View webinar details on HMP Global

Keywords:
debridement coding,
billing documentation,
procedure codes,
HMP Global

Fat Pad Augmentation Using Human Adipose Allograft Yields Durable Closure in Recalcitrant Plantar Ulcers

Summary: A case series published September 2025 in *Wounds* reports on 8 patients with chronic recalcitrant plantar ulcers treated intraoperatively with human cryopreserved adipose tissue allograft. The augmentation of the fat pad provided cushioning and contributed to durable wound closure in this difficult-to-heal population.

Key Highlights:

• Allograft used to restore or augment fat pad under pressure-bearing plantar ulcers that failed standard care.
• Patients showed durable closure, with reduced recurrence, likely due to improved cushioning and reduced mechanical stress.
• Provides an alternative for patients where repeated ulceration is driven by fat pad breakdown or loss of plantar padding.

Read full case series in *Wounds*

Keywords:
fat pad augmentation,
adipose allograft,
plantar ulcers,
recalcitrant wounds

Determinants of Delayed Wound Healing in Postoperative Patients: Insights From a Prospective Study

Summary: A prospective study published in Wounds investigated the risk factors associated with **delayed wound healing (DWH)** in postoperative patients at a tertiary hospital in South India. The research identified multiple preoperative, intraoperative, and postoperative determinants that clinicians can target to improve outcomes and reduce complications.

Key Highlights:

• Older age, diabetes, anemia, and malnutrition were strong preoperative predictors of DWH.
• Longer surgical duration and emergency procedures were linked to poorer healing trajectories.
• Postoperative infection and poor wound care compliance significantly increased the likelihood of delay.
• Multivariate analysis underscored diabetes and wound infection as the most powerful predictors.
• Authors recommend integrated preoperative optimization, meticulous surgical technique, and rigorous postoperative monitoring to mitigate risk.

Read the full study in Wounds

Keywords:
delayed wound healing,
postoperative patients,
wound infection,
South India study

SAWC Fall 2025: Approved Abstracts Showcase Global Wound Care Innovation

Summary: The Symposium on Advanced Wound Care (SAWC) Fall 2025 has released its **official abstracts supplement**. The document includes dozens of studies, case series, and pilot projects spanning topics from regenerative biomaterials to digital wound monitoring, oxygen therapies, and classification systems. This collection offers a preview of cutting-edge innovations set to be presented at the meeting.

Key Highlights:

• Exploration of novel biomaterials including extracellular matrix scaffolds, amniotic tissue, and synthetic hydrogels.
• Updates on advanced therapies such as topical oxygen delivery systems and smart dressings with embedded sensors.
• Clinical data on diabetic foot ulcer outcomes, venous ulcer compression adherence, and pressure injury prevention.
• Abstracts highlight both academic medical centers and community wound clinics, underscoring the real-world applicability of findings.

Download the SAWC Fall 2025 Abstracts PDF

Keywords:
SAWC Fall 2025,
wound care abstracts,
advanced therapies,
oxygen therapy,
biomaterials

Closure Rate of Chronic Wounds With Sinus Tract: Morphological and Pathological Classification

Summary: A prospective case series from Ruijin Hospital, Shanghai, published in Wounds, evaluated closure rates in **chronic wounds with sinus tracts (CWST)** classified by morphological and pathological features. Four subtypes were defined: simple CWST, morphologically complex, pathologically complex, and refractory. The study demonstrates how systematic classification can guide prognosis and therapy selection.

Key Highlights:

• Simple CWST had the highest closure rate (~85%).
• Morphologically complex CWST healed in ~70% of cases with extended follow-up.
• Pathologically complex CWST (e.g., associated with osteomyelitis or chronic inflammation) had closure rates below 50%.
• Refractory CWST showed the poorest outcomes, underscoring need for advanced reconstructive or adjunctive therapies.
• Authors recommend that morphological and pathological assessment become routine in chronic sinus-tract wound evaluation.

Read the full study in Wounds

Keywords:
chronic wound sinus tract,
closure rate,
osteomyelitis,
Ruijin Hospital

Skin-Inspired Self-Healing Hydrogel Heals Quickly — New Biomedical Material Breakthrough

Summary: Researchers at Aalto University and University of Bayreuth have developed a new hydrogel inspired by human skin, capable of self-repair: ~90% healing in 4 hours and full restoration within 24 hours. The material uses clay nanosheets and densely entangled polymer networks to achieve both stiffness and flexibility—a combination that’s rare in synthetic hydrogels. Applications include wound dressings, implants, soft robotics, and more.

Key Highlights:

• Hydrogel consists of ultra-thin clay nanosheets interwoven with polymer networks to mimic skin mechanical properties while allowing fast self-healing.
• Demonstrated repair of cuts/scratches: major re-formation by 4 hours, complete healing at 24 hours under lab conditions.
• Stiffness (modulus) and flexibility balance achieved — avoiding trade-offs common in previous gels that had either strong mechanical strength or good healing, but not both.
• Potential for integration into wound dressings or patches that can self-seal or recover after damage, reducing dressing changes and improving patient comfort.

Read the full WebProNews feature

Keywords:
self-healing hydrogels,
polymer nanosheets,
clay nanosheets,
wound dressing innovation,
material science breakthroughs

AVITA Medical’s RECELL® GO Receives CE Mark, Expanding Access in Europe

Summary: AVITA Medical announced that its point-of-care kit, **RECELL GO**, has secured the CE Mark under EU MDR, permitting commercialization across Europe. This device enables clinicians to prepare a suspension of a patient’s own skin cells—*Spray-On Skin™ Cells*—from a small healthy skin sample, to treat burns, trauma, and surgical wounds. Early clinical data suggest this approach can reduce hospital stay significantly.

Key Highlights:

• RECELL GO builds on the established RECELL System, now optimized for more immediate or portable use across European clinical settings.
• Presentation at the 2025 European Burns Association showed ~36% reduction in hospital stay for patients with deep partial-thickness burns versus traditional grafting techniques.
• Commercial rollout planned in select European countries including Germany, Italy, and the United Kingdom; aimed at burn centers and surgical/trauma clinics.
• Skin cells harvested are autologous, avoiding donor site morbidity; supports burn repair, traumatic or surgical wound healing; likely improves cosmesis and recovery time.

Read the full press release

Keywords:
RECELL GO,
autologous skin cells,
burn wound care,
hospital stay reduction,
AVITA Medical

Challenges & Opportunities in Next-Generation LED Light for Wound Healing and Biomedicine

Summary: A recent article in *Nature* (Published Sept 2025) reviews how different bands of LED light—especially yellow (570-590 nm) and red (620-750 nm)—are showing promise not just for mood, sleep, or skin effects, but significantly in wound healing. This work argues for optimizing light therapies by wavelength, exposure dose, timing, and patient immune status.

Key Highlights:

• Red light is reaffirmed to enhance angiogenesis, collagen formation, and deeper tissue repair—with potential for chronic wounds like diabetic foot ulcers and pressure injuries.
• Yellow light may enhance immune modulation, helping improve healing in wounds where inflammation is stalled.
• Significant gaps remain: determining effective dose, penetration in different skin/tissue types, timing relative to wound phase, and ensuring safety with long-term or high-dose exposure.
• LED therapy devices are increasingly affordable; however, rigorous clinical trials are needed to move from lab/animal models to standardized protocols in humans.

Read the full review in Nature

Keywords:
LED therapy,
red light healing,
yellow light immune response,
wound healing technologies

Enhancing Wound Closure via DICER1-Modified Keratinocytes and Peptide Nanocarriers

Summary: A study in ACS Omega explores how overexpressing **DICER1**, a gene downregulated in stalled diabetic wounds, improves wound healing in vitro. Researchers used both standard transfection (Lipofectamine 2000) and a novel peptide-based nanocarrier (M9-DICER1-CS-A) to deliver DICER1 into HaCaT keratinocyte cells. The M9 nanocarrier had lower toxicity and comparable healing effects. Embedded in a hydrogel scaffold, engineered cells showed sustained viability and proliferation, hinting at therapeutic potential for chronic wound care.

Key Highlights:

• Overexpression of DICER1 in HaCaT cells speeds up wound closure in scratch assays at 24 h and 48 h, with increased expression of pro-healing genes.
• M9-DICER1-CS-A nanocarrier (~200 nm size, ~0.25 polydispersity index, positive surface charge ~18–20 mV) offers better cell viability than Lipofectamine while maintaining effective DICER1 delivery.
• When the engineered keratinocytes are embedded in a polysaccharide-based functional hydrogel, they maintain viability and proliferation over time, showing promise for scaffold-based applications.
• Transcript levels for wound healing genes increase with both delivery methods; suggests both proliferation and migration pathways are activated.

Read the full article in ACS Omega

Keywords:
DICER1,
peptide nanocarrier,
HaCaT keratinocytes,
hydrogel scaffold,
wound healing genes,
ACS Omega

AI-Powered Conductive Hydrogels: Smart Monitoring & Healing for Chronic Wounds

Summary: A new review led by researchers from China Medical University and Northeastern University describes how **AI-enhanced conductive hydrogel dressings** are set to transform chronic wound care. These advanced dressings combine real-time physiological signal monitoring with machine learning models to track wound status, detect infections early, and offer personalized treatment guidance.

Key Highlights:

• Real-time monitoring: These dressings detect temperature, pH, glucose, pressure, and potentially pain signals, allowing for continuous, non-invasive wound assessment.
• AI-driven analytics: Algorithms such as CNN (Convolutional Neural Networks), KNN (K-Nearest Neighbors), and ANN (Artificial Neural Networks) are used to analyze data, predict healing progress, and issue early warnings with reported accuracies up to ~96%.
• Material innovation: Conductive materials—such as carbon nanotubes, graphene, MXenes, and conductive polymers—are being explored for their biocompatibility, sensitivity, and stability in dressings.
• Multifunctional integration: Beyond sensing, these dressings are being engineered to include antibacterial activity, drug-release functions, and electroactivity to actively support healing while monitoring.
• Clinical potential & use cases: Applications include pressure ulcers, diabetic foot ulcers, joint wounds, and potential for home-based or remote wound care via connected devices and wearables.

Challenges & Future Directions:

• Ensuring signal stability and durability of materials over time, especially in moist or variable wound environments.
• Validating AI models across more diverse patient populations and wound types to improve generalizability.
• Scaling production while keeping costs manageable for clinical and home care use.
• Privacy and data security for remote monitoring, especially when transmitting patient-derived physiological data.

Read the full article on MedIndia

Keywords:
conductive hydrogels,
AI wound monitoring,
chronic wounds,
machine learning in wound care,
temperature-pH-glucose sensors,
smart dressings

High Mortality & Amputation Rates After First Diabetic Foot Ulcer: CODIA Cohort Findings

Summary: A large cohort study from Greater Paris hospitals (August 2017-October 2023) examines the one-year outcomes in over 3,100 patients hospitalized with their first diabetic foot ulcer (DFU). The findings are alarming: ~21.6% died and ~24.2% underwent lower-limb amputation within 12 months. Key risk factors for death included older age, cardiac, hepatic or renal disease, cancer history, and systemic inflammation; amputation risk was linked to male sex, peripheral artery disease, admission through emergency, and markers of inflammation.

Key Highlights:

• Sample included 3,102 patients, median age ~70.7 years; 68% male.
• Cumulative incidence of death within 12 months: **21.64%**.
• Cumulative incidence of lower limb amputation within 12 months: **24.15%**.
• Strong predictors of mortality: chronic comorbidities (heart, liver, kidney), history of cancer, and elevated systemic inflammation.
• Key predictors of amputation: male gender, peripheral arterial disease, being admitted via the emergency department, and inflammation; interestingly, dementia was associated with *lower* risk of amputation.

Read the full article in Diabetes & Metabolism

Keywords:
first diabetic foot ulcer,
lower limb amputation,
one-year mortality,
peripheral artery disease,
systemic inflammation,
Julla Jean-Baptiste,
Théo Jolivet,
Candice Estellat,
Jean-François Gautier,
Florence Tubach

MasterSeries: Reconstructive Masterclass – Getting the Best Patient Outcomes

Summary: Join a 90-minute interactive webinar on **Wednesday, October 22, 2025**, hosted by **Wound Masterclass** in partnership with Integra Tissue Technologies. This event will focus on complex lower limb wound reconstruction using UBM (Urinary Bladder Matrix) extracellular matrix scaffolds in sheet and particulate forms. Experts will guide participants through preoperative planning, surgical techniques, postoperative care, and real-world cases.

Key Highlights:

• Explore indications for UBM scaffolds in reconstructive cases involving trauma, surgery, chronic wounds, and lower limb defects.
• Learn surgical techniques related to wound bed preparation, scaffold application, use in conjunction with grafts or negative pressure wound therapy, and flap coverage.
• Review patient selection criteria—vascular status, infection control, wound depth, location and size—and how these influence outcomes.
• Discuss managing complications like seromas, infections, graft failure, and non-healing wounds.
• Participate in an interactive patient clinic and panel discussion, seeing real-world examples and evidence-based recommendations for best outcomes.

Register for the Reconstructive Masterclass webinar

Keywords:
UBM extracellular matrix,
lower limb reconstruction,
skin substitutes,
wound bed preparation,
infection management,
postoperative care,
Negin Shamsian,
Marino Ciliberti,
Sebastian Probst

Product Spotlight: NATROX® O₂ Continuous Topical Oxygen Therapy

Overview: NATROX O₂ is a wearable topical oxygen therapy system designed to deliver continuous oxygen directly to chronic wounds. It’s non-invasive, portable, simple to apply, and intended to complement standard wound care protocols.

Key Features & Benefits:

• Continuous Oxygen Delivery: The device generates oxygen through electrolysis and delivers it 24/7 to the wound bed, which supports healing in wounds that have stalled.
• Soft, Conformable Interface: Includes a “wheel”-style oxygen delivery interface that is flexible, molds to wound contours, allows exudate passage, and suits both deep and shallow wounds.
• User Friendly: Lightweight and discreet. Rechargeable battery system (swap daily); no alarms or complex controls—just click, check, go.
• Clinical Efficacy: Data suggests significantly improved healing rates—patients using NATROX O₂ show greater chance of closure compared to standard care alone.
• Versatility: Can be used alongside standard dressings and across clinical and home care settings; suitable for diabetic foot ulcers, leg ulcers (venous, arterial, mixed), pressure injuries, and non-healing surgical wounds.

Considerations:

• Requires prescription and clinician oversight. Patient selection and wound assessment are essential.
• Battery life management and dressing compatibility need attention to prevent compliance issues.
• As with all topical oxygen therapies, benefits are maximised when used with optimal wound bed preparation, offloading (when relevant), and infection control.

Learn more on NATROX O₂ official site

Keywords:
NATROX O₂,
topical oxygen therapy,
chronic wounds,
wearable medical device,
diabetic foot ulcer,
leg ulcer,
pressure injury,
surgical wound

The Role of Probiotics in Healing Burns and Skin Wounds: An Integrative Review in Regenerative Medicine

Summary: In an open-access review published in Life (2025, Vol. 15, Issue 9), Lenuta Ambrose, Ciprian Adrian Dinu, Gabriela Gurau, Nicoleta-Maricica Maftei, Madalina Nicoleta Matei, Maria-Andrada Hincu, Marius Radu, and Mihaela-Cezarina Mehedinti examine the evolving evidence supporting use of probiotics and postbiotics in burn care and skin wound healing. The review connects mechanistic insights—anti-inflammatory, immunomodulatory, antimicrobial, regenerative—with translational and pilot clinical outcomes, emphasizing safety, strain selection, and formulation options (topical, systemic) in different wound contexts.

Key Highlights:

• Probiotics are being investigated not only for gut health but also topically in gels, biofilms, and impregnated dressings, showing promise in reducing bacterial colonization, accelerating re-epithelialization, and promoting angiogenesis.
• Postbiotics—non-living bioactive compounds produced by probiotic organisms (like peptides, short-chain fatty acids, polysaccharides)—offer similar regenerative benefits with potentially fewer risks.
• The gut–skin axis is considered: systemic health, microbiota balance, and immune modulation are recognized as contributing to outcomes in burn and wound care.
• Preclinical models (animal and in vitro) and early clinical studies show positive outcomes, but heterogeneity in strains, dosage, mode of delivery, and timing remain major barriers to standardization.
• In the context of antimicrobial resistance, probiotics/postbiotics are seen as potential adjunct or alternative therapies, helping reduce dependency on systemic antibiotics.

Read the full review in Life

Keywords:
probiotics,
postbiotics,
burn healing,
skin wounds,
regenerative medicine,
immunomodulation,
Lenuta Ambrose,
Ciprian Adrian Dinu,
Gabriela Gurau,
Nicoleta-Maricica Maftei,
Madalina Nicoleta Matei,
Maria-Andrada Hincu,
Marius Radu,
Mihaela-Cezarina Mehedinti

Your Doctor Might Prescribe… A Video Game?

Summary: A recent feature in Forbes (September 2025) by John Samuels explores the growing trend of prescribing video games as treatments—so-called digital therapeutics. These game-based interventions are being used for conditions like ADHD, depression, chronic pain, and anxiety. The article discusses evidence of efficacy, regulatory approval (such as FDA authorization), and challenges such as cost, accessibility, and ensuring clinical oversight.

Key Highlights:

• Video games are being designed with therapeutic intent, not merely for entertainment—programs such as EndeavorRx are FDA-authorized for ADHD treatment in children. These aim to improve attention, reduce symptoms, and complement traditional therapies.
• Evidence is accumulating: some trials show measurable improvements in attention, mood, and pain tracking when video-game interventions are used as adjuncts.
• Regulatory and reimbursement issues remain unsettled. For many digital therapeutics, getting approval and insurance coverage is still a hurdle. Clinicians need to ensure these tools are evidence-based, appropriately prescribed, and integrated into the broader care plan.
• Accessibility is an issue: game-based therapeutics require patient access to suitable devices, digital literacy, and ongoing monitoring. There can also be concerns about screen time, gaming addiction, and whether benefits translate outside game environments.
• Potential cross-application to wound care: while the article doesn’t highlight wound healing directly, there’s opportunity to use similar approaches (gamified adherence, behavior change, or virtual reality) to support wound care patients—such as improving compliance with offloading, dressing changes, physical therapy, or pain management.

Read the full article in Forbes

Keywords:
digital therapeutics,
therapeutic video games,
EndeavorRx,
ADHD treatment,
behavior change,
John Samuels,
regulation digital therapeutics

Opinion: Addressing the Neglect of “Other” Open Wounds Beyond DFUs, VLUs, and Pressure Injuries

Summary: An opinion piece in the Journal of Wound Care (2025) argues that healthcare systems and research frameworks disproportionately emphasize well-defined hard-to-heal wounds—such as diabetic foot ulcers (DFUs), venous leg ulcers (VLUs), and pressure ulcers (PUs)—while neglecting a large category of “other” open wounds. These include surgical incisions, trauma-related lacerations, punctures, or unspecified wounds coded under ICD-10 classifications. The authors contend that overlooking these wounds perpetuates inefficiencies, inflates costs, and worsens patient suffering. Integrating comprehensive strategies across all wound categories, regardless of etiology, is essential for patient-centered and equitable wound care.

Key Highlights:

• ICD-10 coding context: “Other” wounds are often labeled under codes such as S01 (head), S41 (shoulder and arm), S81 (knee and lower leg), or T14.1 (unspecified), encompassing trauma wounds, bites, and open injuries that resist neat categorization.
• Exclusion from guidelines: DFUs, VLUs, and PUs dominate protocols and resource allocation because their etiologies are specific, while surgical or trauma wounds that linger in outpatient care remain marginalized.
• Outpatient burden: Surgical wounds may dehisce, trauma wounds may linger, and wounds in patients with comorbidities (e.g., autoimmune or hematological conditions) often fall outside existing guideline frameworks.
• Systemic inefficiency: By excluding “other” wounds from research and reimbursement models, healthcare systems underestimate true prevalence, under-resource outpatient management, and limit innovation in holistic care.
• Proposed solution: Building on reimbursement frameworks like those by Tettelbach et al., the authors advocate for equal rigor in managing “other” wounds, integrating them into clinical guidelines, and expanding funding for non-categorized wound care.

Read the full opinion piece in Journal of Wound Care

Keywords:
open wounds,
ICD-10 wound codes,
diabetic foot ulcer,
venous leg ulcer,
pressure injury,
surgical wounds,
trauma wounds,
Tettelbach

Dicer1 Nanocarrier System Enhances Wound Closure and Cell Viability

Summary: A new study in ACS Omega (Sept 2025) explores how Dicer1 overexpression, delivered via a novel peptide-based nanocarrier (M9-DICER1-CS-A), improves wound closure and cellular activity in vitro. Researchers show that re-engineered HaCaT keratinocytes embedded within a hydrogel scaffold demonstrate persistent viability, proliferation, and upregulation of wound-healing genes—supporting future applications in treating impaired or diabetic wounds.

Key Highlights:

• Dicer1 as a regulator: Low Dicer1 expression correlates with stalled wounds in diabetes; experimental overexpression promoted faster wound closure and gene upregulation.
• Nanocarrier vs. Lipofectamine: The custom peptide carrier (M9-DICER1-CS-A) proved less toxic than Lipofectamine 2000 while maintaining efficient nucleic acid delivery and condensation.
• Nanocomplex characteristics: Approximately 200 nm in size, PDI ~0.25, with positive surface charge (~18–20 mV), stable yet responsive to release triggers (heparin challenge).
• Hydrogel integration: Engineered HaCaT cells grown in a polysaccharide hydrogel matrix maintained viability and showed time-dependent proliferation, creating a cell-laden wound-healing construct.
• Clinical potential: This strategy points toward safe, non-viral, peptide-based delivery systems combined with biomaterial scaffolds as a translational avenue for chronic or diabetic wound management.

Read the full article in ACS Omega

Keywords:
Dicer1,
peptide nanocarrier,
hydrogel scaffold,
keratinocytes,
diabetic wounds,
gene therapy,
ACS Omega

Perioperative Considerations for Athletic Patients: Insights from Dr. Nicholas Butler

Summary: In a recent episode of the Podiatry Today Podcast, produced in partnership with the American Society of Podiatric Surgeons, Nicholas Butler, DPM (Kent State University College of Podiatric Medicine; Erie Foot & Ankle, Cleveland, OH) shared practical strategies for managing athletic and highly active patients in the perioperative setting. Drawing from his experience in surgery, wound care, and sports medicine, Butler highlights the importance of expectation-setting, communication with coaches and trainers, targeted imaging, and early mobilization.

Key Highlights:

• Expectation management: Athletes often push for rapid return; clinicians must balance motivation with safety, ensuring patients avoid overtraining or reinjury.
• Communication pearls: Directly engaging coaches, trainers, and family members bridges information gaps and reinforces compliance with recovery timelines.
• Preoperative testing: Beyond routine labs, Butler recommends MRI and CT scans for more precise assessment, and occasionally CK levels to screen for exercise-induced muscle breakdown or compartment syndrome.
• Intraoperative approaches: Use of ankle arthroscopy in fracture cases to assess ligament integrity; preference for open visualization in Achilles repairs for accurate evaluation.
• Postoperative care: Early weight-bearing when structurally safe; close collaboration with sports-focused physical therapists; accountability through exercise logs and structured “reps.” Butler emphasizes rapid tapering of narcotics and incorporation of newer non-opioid pain management options.
• Nutrition and recovery: Coordination with nutritionists is key to ensuring adequate protein and collagen intake, preventing muscle mass loss, and supporting wound healing.
• Preventive mindset: Assess footwear (cleats, skates, shoes), employ orthotics or bracing when necessary, and emphasize long-term injury prevention strategies.

Listen to the full episode on Podiatry Today Podcasts

Keywords:
perioperative care,
athletic patients,
Achilles repair,
ankle arthroscopy,
early weight-bearing,
nutrition in sports medicine,
Nicholas Butler

WoundCareRN.com Launches to Provide Comprehensive Resources for Wound-Care Management

Summary: WoundCareRN.com, a newly launched online platform, aims to serve as a one-stop resource hub for wound-care professionals. The site offers in-depth articles, video tutorials, continuing education modules, product comparisons, and clinical tools designed to support best practices in wound assessment, treatment protocols, and patient outcomes.

Key Highlights:

• The platform includes expert interviews and analyses, featuring wound-care specialists, podiatrists, vascular surgeons, and certified wound care nurses, discussing emerging issues such as antimicrobial resistance, wound dressings, and cost-effective therapies.
• Interactive tools help clinicians with decision support: wound staging calculators, offloading device selectors, infection screening checklists, and video-guided dressing tutorials.
• Comparative product reviews are included, with side-by-side evaluations of advanced dressings, biologics, and negative pressure wound therapy systems to assist procurement and clinical decision making.
• Continuing education (CEU) opportunities are integrated: modules, webinars, and case-study-based learning credited for professional development in nursing and wound care specialties.
• WoundCareRN.com also emphasizes community: user forums, peer case sharing, and a library of patient education resources to support patient engagement and self-management.

Read the full announcement via Austin-Online

Keywords:
WoundCareRN,
wound care education,
product comparisons,
clinical tools,
continuing education,
online platform

Enhancing Healing of Chronic Wounds via Novel Bioengineered Growth Factor Scaffold (DOI 10.1111/wrr.70089)

Summary: A recent experimental study in Wound Repair & Regeneration investigates a bioengineered scaffold designed to deliver growth factors over an extended period, aiming to support healing in chronic or refractory wounds. The scaffold combines biomaterials engineered for sustained release with growth factors known to enhance angiogenesis and epithelial cell proliferation. Comparative in vivo tests demonstrate accelerated closure and enhanced vascular density in treated wounds compared to standard care controls.

Key Highlights:

• The scaffold material is designed for biocompatibility and controlled degradation, allowing gradual growth factor release over multiple weeks.
• In vivo models (rodent chronic wounds) showed not only faster wound closure but also superior quality of the regenerated tissue—denser capillary networks and better epidermal thickness / integrity.
• Histologic analysis indicated reduced inflammatory infiltration and improved collagen architecture in scaffold-treated wounds.
• The study underscores that combining biomaterial scaffolds with growth factor delivery may overcome limitations of growth factor therapies alone, such as rapid diffusion/degradation and inconsistent retention at wound sites.

Read the full article in Wound Repair & Regeneration

Keywords:
bioengineered scaffold,
growth factor delivery,
chronic wound,
angiogenesis,
controlled release

Management of Diabetes-Related Foot Ulceration at Two Interdisciplinary Services: A Qualitative Exploration of Patient and Carer Experiences

Summary: A qualitative study by Sarah M. Manewell, Georgina Frank, Vanessa Nube, Hylton B. Menz, Catherine Sherrington, Sarah Dennis, and Serene S. Paul (2025, Wound Practice & Research, Vol. 33, No. 3) explores patient and carer experiences of diabetes-related foot ulcer (DFU) care at two interdisciplinary High Risk Foot Services (HRFS) in Sydney. Through in-depth interviews, the study identifies themes of confidence in care, how care is experienced as comprehensive, and how DFUs are life changing.

Key Highlights:

• Patients and carers valued being “confident in care” — trust in clinicians, clarity of explanations, and feeling heard were all central to positive experiences.
• “Care considered comprehensive” emerged strongly, with subthemes of education (patients appreciated plain language, understanding of their condition, offloading devices, pressure assessment) and complex access (logistics, appointment scheduling, transportation, coordination across teams).
• Participants described DFU as life changing: impacts on mobility, daily tasks, emotional wellbeing, social roles, and identity. Care and living with DFU are deeply intertwined experiences that cannot be separated.
• Barriers exist—patients noted difficulty putting education into practice due to other life demands, safety issues with offloading devices, inconsistent messaging, and challenges in accessing care especially when dependent on support or transport.
• The study suggests early and consistent education, strong communication, care continuity, and addressing practical access issues are critical to improving patient/carer experience and potentially outcomes.

Read the full article in Wound Practice & Research

Keywords:
diabetes-related foot ulceration,
interdisciplinary care,
patient experience,
education benefits,
access challenges,
DFU life changing,
Sarah M. Manewell,
Georgina Frank,
Vanessa Nube,
Hylton B. Menz,
Catherine Sherrington,
Sarah Dennis,
Serene S. Paul

AI-Assisted Conductive Hydrogel Dressings for Monitoring and Treating Refractory Wounds

Summary: A new review from researchers in China (China Medical University & Northeastern University) introduces smart dressings combining conductive hydrogels with artificial intelligence for monitoring refractory wounds such as diabetic ulcers, pressure injuries, and joint wounds. These dressings aim to provide continuous, non-invasive data—temperature, pH, glucose, pressure, and more—processed via ML algorithms to predict healing progression and detect infection early.

Key Highlights:

• Real-time physiological tracking: Conductive hydrogels capable of monitoring temperature, pH, glucose levels, pressure changes, and even pain signals, giving clinicians actionable information before wounds visibly deteriorate.
• AI integration: Machine learning models—examples include CNNs, K-Nearest Neighbors, and artificial neural networks—analyze the sensor data to predict wound-healing stages, flag possible infection, and suggest interventions; reported predictive accuracy up to ~96% in the studies cited.
• Multifunctional design: Beyond monitoring, these dressings are being engineered to have antimicrobial properties, to support drug release, and to use conductive materials like carbon nanotubes (CNTs), graphene, MXenes, and conductive polymers to enhance sensitivity and stability.
• Clinical potential & application: Relevance in home monitoring, remote wound care, pressure ulcers, diabetic foot ulcers, with ability to detect early changes. Could allow faster responses and reduce progression to severe wound stages.
• Challenges ahead: Material durability over time, consistency in sensor performance, generalizability of AI models across different skin types and wound types, and the need for real-world trials to validate efficacy and safety.

Read the full press release via Press-News

Keywords:
conductive hydrogels,
AI wound monitoring,
refractory wounds,
machine learning,
diabetic foot ulcer,
pressure ulcer

Comprehensive Update: Current Treatment Protocols for Diabetic Peripheral Neuropathy

Summary: A free CME webinar on September 30, 2025 (12 PM EDT), led by **Jason C. Snyder, DPM, DABPM, DABPS, FACFAS**, will review the latest treatment protocols for diabetic peripheral neuropathy. The presentation will cover pharmacologic, non-pharmacologic, and interventional approaches, including newer modalities like spinal cord stimulation.

Key Highlights:

• Review of established pain management medications and non-drug interventions such as lifestyle modification, exercise, and foot care.
• Discussion on interventional pain technologies, with special attention to the role and evidence base for spinal cord stimulation in chronic neuropathic pain associated with diabetic neuropathy.
• Consideration of how patient-specific factors—such as disease severity, comorbid conditions, and progression—affect choice of protocols.

Register for the webinar on Podiatry.com

Keywords:
diabetic peripheral neuropathy,
pain management,
spinal cord stimulation,
non-pharmacologic treatment,
Jason C. Snyder

Fish Acellular Dermal Matrix Promotes Repair of Full-Thickness Skin Defects in Mice and Bama Pigs

Summary: A new study in Wound Repair and Regeneration (Sept 2025) led by Zi-Yi Wang, Zi-Hao Lin, Ruo-Tao Liu, Zhe Liu, Hao Peng, Zhi-Chao Hu, Wei-Qing Fu, Li-Ming Jin, Chang-Qing Zhang, Qian Tang, Zhen-Zhong Zhu, and Xiao-Juan Wei reports that tilapia-derived acellular dermal matrix (FADM) accelerates wound repair and enhances tissue regeneration in both mouse and pig models of full-thickness skin defects. Compared to porcine-derived acellular dermal matrices, FADM demonstrated superior healing, reduced immunogenicity, and enriched vascularization and collagen deposition.

Key Highlights:

• Histological and immunological assays confirmed that the tilapia-derived scaffold retained extracellular matrix structure, preserved bioactive factors, and exhibited very low immunogenicity.
• In vitro: The FADM promoted fibroblast and endothelial cell proliferation, migration, and tube formation, supporting angiogenesis and wound closure.
• In vivo: In Balb/c mice and Bama pig full-thickness wound models, FADM accelerated closure rates and produced regenerated tissue with improved collagen alignment and vascular density compared to porcine controls.
• Transcriptomic profiling revealed regulation of key pathways in immune modulation, ECM remodeling, and angiogenesis, highlighting the multifaceted biological interactions between scaffold and host tissue.
• Tilapia, widely farmed and cost-effective, offers practical advantages over cod-derived ADM, supporting its potential as a safe, economical, and scalable bioscaffold for clinical skin repair.

Read the full article in Wound Repair and Regeneration

Keywords:
fish acellular dermal matrix (FADM),
tilapia skin,
full-thickness skin defect,
angiogenesis,
Zi-Yi Wang,
Zi-Hao Lin,
Ruo-Tao Liu,
Zhe Liu,
Hao Peng,
Zhi-Chao Hu,
Wei-Qing Fu,
Li-Ming Jin,
Chang-Qing Zhang,
Qian Tang,
Zhen-Zhong Zhu,
Xiao-Juan Wei

Global Innovation Summit Series: Stoma Masterclass – Shaping Better Patient Outcomes Through Moldable Technology in Ostomy Care

Summary: A free, accredited global webinar scheduled for September 10, 2025 at 6:00 PM (London time), aimed at healthcare providers specializing in ostomy care. This session will explore how moldable device components and barrier products can enhance skin protection, reduce leakage, improve comfort, and support patient independence. Key speakers include Dr. Negin Shamsian (Plastic & Reconstructive Surgeon) and Ethan Chen (Materials Engineer), with clinical case demonstrations and product technique breakout segments.

Key Highlights:

• Covers assessment methods to select moldable technology devices, including rings, seals, moldable barriers, and adhesives suited for patient anatomy changes over time.
• Interactive case studies and patient-clinic segments will show real-world techniques and troubleshooting—leak prevention, handling irregular skin contours, and peristomal skin issues.
• Focus on how new moldable materials respond to movement, moisture, and stoma size variation to improve adhesion, comfort, and reduce skin trauma.
• Discusses scientific evidence (recent consensus statements and trial data) supporting improved outcomes—quality of life, fewer skin complications, reduced product waste—when proper moldable stoma technology is used.
• Designed for ostomy nurses, wound care specialists, surgical teams, and any clinician responsible for stoma appliance selection and fit. Useful for learning new techniques and integrating moldable products in complex settings.

Register or view details for the Stoma Masterclass webinar

Keywords:
moldable technology,
ostomy care,
peristomal skin protection,
leak prevention,
Dr. Negin Shamsian,
Ethan Chen,
Convatec

High Relapse Risk in Diabetic Foot Ulcers

Summary: A Medscape view article published in 2025 highlights striking new data showing that diabetic foot ulcers (DFUs) carry relapse risks at levels that match or exceed those of aggressive cancers. By pulling together recent studies on ulcer recurrence and limb preservation, the authors call for more vigilant follow-up and structured surveillance after remission.

Key Highlights:

• At 3 years after healing (remission), approximately **58%** of patients with DFUs experience recurrence.
• Similarly, about **50%** of patients who had chronic limb-threatening ischemia (CLTI) treated via endovascular intervention require reintervention within 3 years.
• Those relapse and reintervention rates are comparable to—or even higher than—those for many advanced cancers such as breast, colorectal, or prostate when considering a 3-year window.
• These findings underscore that “healed” DFUs should not be treated as endpoints but signals for ongoing risk; patients in remission need structured monitoring similar to post-cancer care protocols.

Read the full article on Medscape

Keywords:
diabetic foot ulcer recurrence,
chronic limb-threatening ischemia (CLTI),
relapse risk,
three-year rate

From Healing to Remission: A Clinician’s Guide to Managing Diabetic Foot Ulcers

Summary: A new article on Medscape reframes diabetic foot ulcer (DFU) care by encouraging clinicians to view a healed ulcer not as an endpoint, but as a remission state—one that demands ongoing prevention, monitoring, and patient education. The piece outlines proactive strategies to reduce ulcer recurrence, preserve limb function, and sustain long-term patient engagement.

Key Highlights:

• Language shift: Using the term “in remission” instead of “healed” helps patients stay aware that DFU is a chronic condition with high risk of recurrence.
• Structured limb-preservation plans: Follow-ups every 1-3 months in the first year post-healing, plus risk-based intervals afterward, with regular vascular assessments especially up through 18 months post-closure.
• Prevention tools: Thermometry, remote monitoring of temperature/exudate/pressure/moisture, and protective footwear become central components of follow-up care.
• Self-management: Patients (or caregivers) should perform daily inspections, recognizing early signs, even in the absence of overt sores; lifestyle moderators like glucose, lipids, and BP control also critical.
• Psychosocial support: Screening for depression, social isolation, and other mental health or socio-economic factors that otherwise undermine preventive behaviors and healing maintenance.
• Implementation challenges: Shifting to a remission model requires clinic protocol changes, multidisciplinary coordination, and policies that recognize the long-term burden of DFUs and CLTI (chronic limb threatening ischemia).

Read the full article on Medscape

Keywords:
diabetic foot ulcer,
remission model,
limb preservation plan,
thermometry,
patient self-care,
psychosocial support

Kerecis Expands SurgiClose Silicone Fish-Skin Product Line with New Sizes

Summary: In a TrendHunter feature, Kerecis announces a size expansion in its SurgiClose Silicone fish-skin wound cover line. With new bordered and borderless sizes (from 3×3 cm up to 10×10 cm), the update aims to make the product usable for smaller wounds that previously lacked well-fitting options.

Key Highlights:

• The SurgiClose Silicone product now comes in both bordered (e.g. 3×3 cm) and borderless (10×10 cm) size variants, enhancing versatility for different wound sizes and locations. (TrendHunter report)
• This expansion aims to simplify product selection and improve wound coverage in minor to moderate wounds, especially where precise size matching matters.
• Kerecis continues to leverage its fish-skin technology combined with silicone to manage moisture and exudate, supporting healing with damp wound bed conditions.
• The product’s broadened size offering indicates Kerecis is pushing toward more personalized wound care solutions—aligning with trends in tissue regeneration, sustainability, and efficiency.

Read the full trend report on TrendHunter

Keywords:
Kerecis,
SurgiClose Silicone,
fish-skin technology,
wound cover sizes,
advanced wound care innovation

BioStem Showcases Its Leading BioREtain® Allograft Technology at SAWC Fall Meeting

Summary: BioStem Technologies, Inc. (OTC: BSEM), a med-tech company focused on placental-derived products for advanced wound care, is presenting its allograft portfolio at the Symposium for Advanced Wound Care (SAWC) Fall Meeting in Las Vegas, Sept 3-6, alongside its commercial partner Venture Medical, LLC. The company is spotlighting scientific poster presentations, its BioREtain® processing platform, and the Venture OneView™ logistics platform to streamline delivery of skin substitute treatments for chronic wounds.

Key Highlights:

• BioStem will co-exhibit with Venture Medical, LLC, to demonstrate how its placental allograft products—**AmnioWrap2®** and **Vendaje AC®**—integrate with the Venture OneView™ platform, enhancing efficiencies in patient care logistics and skin substitute management.
• The BioStem-Venture exhibit includes scheduled sessions such as *Debunking Wound Care Myths* and *Do’s & Don’ts of Mobile Wound Care*, providing attendees opportunities to explore both clinical and operational insights in wound care delivery.
• A special breakfast symposium titled *Navigating the Future of Wound Care*, moderated by Michael Desvigne, MD, will focus on real-world clinical evidence, selecting appropriate allografts, optimizing practice flow, and performing mobile wound care practice successfully.
• Three posters have been accepted for display in the poster hall:
     • *A Simple Comparison of Real-World Pressure Ulcer Data*
     • *A Direct Comparison of Processing Methods for Placental Tissue Allografts*
     • *A Comparison of Sterilization Methods for Dehydrated Birth Tissue*
• BioStem emphasizes that its BioREtain® processing method—through a proprietary six-step process—preserves the tissue matrix and structure typical of fresh perinatal tissue, including growth factors and integrity, which the company claims supports superior clinical outcomes in chronic wound care.
• The placental allografts are manufactured in an FDA-registered, AATB-accredited facility in Pompano Beach, Florida, under rigorous quality practices (cGTP and cGMP) to ensure both safety and potency.

Read the full press release via BioStem / GlobeNewswire

Keywords:
BioREtain technology,
placental allografts,
AmnioWrap2,
Vendaje AC,
OneView platform,
Venture Medical,
BioStem Technologies

Bovine-Derived Collagen Matrix as an Adjunct in Hard-to-Heal Stage 3 Pressure Injuries of the Lower Extremity

Summary: A retrospective case series published in Journal of Wound Care evaluates the effectiveness of one application of a bovine-derived collagen matrix in conjunction with standard care for stage 3 pressure injuries (PIs) of the lower extremity that had resisted healing.

Key Highlights:

• Patients with hard-to-heal stage 3 pressure injuries showed improved outcomes when the collagen matrix was used in addition to standard wound care.
• Single application was tested—suggesting potential for reduced treatment burden if results are replicable.
• The matrix adjunct was associated with better healing metrics compared to historical or matching standard care cases.

Read the abstract in Journal of Wound Care

Keywords:
bovine-derived collagen matrix,
stage 3 pressure injury,
lower extremity,
retrospective case series

Correcting Midfoot Charcot with a Hexapod Frame

Summary: Shane Sato, DPM, and Michael H. Theodoulou, DPM, FACFAS present a surgical pearl describing the use of hexapod frame external fixation (TL-Hex TrueLok Hexapod System) to correct complex midfoot Charcot deformity. The technique allows for multiplanar correction, acute or gradual deformity management, with implications for limb salvage and improved structural alignment in diabetic Charcot foot.

Key Highlights:

• The hexapod frame uses six adjustable struts that facilitate correction across multiple planes, including angular, translational, and rotational deformities.
• Early (acute) correction is possible for reducible deformities—even in what’s traditionally considered the acute stage—when linked with external fixation and software-guided alignment.
• Preoperative planning involves software input: taking AP and lateral radiographs with calibration, choosing reference segments, and entering deformity parameters into frame planning software.
• In the reported case, acute deformity correction restored alignment (e.g., restored Meary angle), followed by internal fixation if needed; the hexapod method supports access to wounds and earlier weight-bearing compared to internal methods alone.

Read the full Surgical Pearls article on Podiatry Today

Keywords:
midfoot Charcot,
hexapod frame,
external fixation,
deformity correction,
TL-Hex TrueLok,
Shane Sato,
Michael H. Theodoulou

“Got Wounds? Wound Care Essentials 101: What You Need to Know”

Summary: A comprehensive guide authored by Luke D. Etter and Jonathan M. Sharp, available via the Advanced Solution blog, delivers foundational wound care insights—from the biology of wound healing to advanced treatment techniques—paired with case studies and interactive material to support both new and veteran clinicians.

Key Highlights:

• Blends basic wound assessment principles with advanced therapeutic strategies.
• Includes real-world case studies and interactive learning exercises to reinforce clinical application.
• Focuses on practical, evidence-based approaches to improve patient-centered wound management.
• Positioned as an essential resource for clinicians at all levels—particularly those seeking to strengthen their wound care toolkit.

Read the full guide on the Advanced Solution website

Keywords:
wound care essentials,
wound assessment,
advanced therapies,
interactive learning,
Luke D. Etter,
Jonathan M. Sharp

An Assessment of Diabetes-Dependent Quality of Life in Polish Patients

Summary: A cross-sectional study published in Diabetes, Metabolic Syndrome and Obesity (September 2025) by Ewelina Bąk, Grzegorz Zawiła, Robert Skalik, Sylwia Krzemińska, Bogusława Kupczak-Wiśniowska, Lukas Kober, and Elena Gurková compares quality-of-life (QoL) impacts between Polish patients with type 2 diabetes mellitus (T2DM) with and without diabetic foot syndrome (DFS), using the Polish-language ADDQoL tool.

Key Highlights:

• Patients with DFS reported markedly lower QoL (mean AWI ~–4.8) than those without DFS (AWI ~–2.6), a statistically significant difference.
• The most negatively affected domains among DFS patients were physical health, feelings about the future, and working life.
• In non-DFS patients, ‘freedom to eat’ and ‘freedom to drink’ were the domains most negatively impacted.
• Regression analysis identified positive QoL influencers: gender, treatment modality, and self-dressing ability; negative influencers included complications, elevated fasting glucose, amputation, wound characteristics, dressing type, wound size, and Wagner grade.

Read the full study in Diabetes, Metabolic Syndrome and Obesity

Keywords:
ADDQoL questionnaire,
quality of life,
diabetic foot syndrome (DFS),
type 2 diabetes (T2DM),
Ewelina Bąk,
Grzegorz Zawiła,
Robert Skalik,
Sylwia Krzemińska,
Bogusława Kupczak-Wiśniowska,
Lukas Kober,
Elena Gurková

When and How to Culture a Chronic Wound

Summary: In a Wound Care Advisor article, Marcia Spear, DNP, ACNP-BC, CWS, CPSN explains that chronic wounds should only be cultured when there are clear clinical signs of infection—recognizing that “classic” signs may not always be present.

Key Highlights:

• Cultures are warranted when additional signs are present: increased pain, necrotic tissue, delayed healing, or wound bed deterioration—even without classic infection indicators.
• Quantitative tissue biopsy remains the gold standard for accuracy, but the Levine swab technique is a validated and practical alternative in clinical settings.
• Proper technique matters: swab after cleansing and gentle debridement, ideally focusing on the most suspicious or non-healing area for meaningful results.

Read the full article on Wound Care Advisor

Keywords:
wound culture,
chronic wound,
Levine technique,
tissue biopsy,
Marcia Spear

Wound Care Research: The Imperative for Increased Federal Funding

Summary: The Alliance of Wound Care Stakeholders argues that federal investment in wound care research is urgently needed. Despite the field’s growth and evidence-based treatments, chronic wounds continue to impose deadly and costly burdens—yet receive alarmingly low research funding compared to lower-prevalence conditions.

Key Highlights:

• Over 15% of Medicare beneficiaries suffer from non-healing wounds—more than those affected by heart failure—yet research funding remains limited.
• Chronic non-healing wounds have a higher mortality rate than breast or colon cancer, and often lead to fatal infections if untreated.
• Federal research dollars for wound care approximate those for Lyme disease—despite the latter affecting a much smaller portion of the population.

Read the full advocacy piece from AWCS

Keywords:
federal funding,
wound care research,
Medicare beneficiaries,
mortality rate,
Alliance of Wound Care Stakeholders

What’s Evolving in Podiatric Dermatology: Research and Tools to Elevate Practice

Summary: A cover feature in the September 2025 issue of Podiatry Today (Vol. 38, Issue 9) by Tracey C. Vlahovic, DPM, FFPM, RCPS(Glasg) highlights how podiatrists can better address common foot dermatologic issues by integrating tools borrowed from dermatology, biomechanics, and vascular disciplines—including dermoscopy, PCR testing, and nail video-capillaroscopy (NVC).

Key Highlights:

• Persistent hyperkeratotic lesions (e.g., plantar helomas) may sometimes involve HPV; using diagnostic methods like dermoscopy, histopathology, or PCR testing can clarify resistant cases.
• Nail video-capillaroscopy (NVC) and other vascular diagnostic tools offer opportunities to detect systemic vascular changes during comprehensive diabetic assessments.
• The article challenges podiatrists to rethink lesion evaluation—moving beyond mechanical treatment alone and toward broader, evidence-based diagnostic strategies.
• Though these tools show promise, implementation barriers such as cost and access to specialized testing persist, and broader validation is needed via multicenter studies.

Read the full feature on Podiatry Today

Keywords:
dermatology tools,
plantar lesions,
dermoscopy,
PCR testing,
nail video-capillaroscopy (NVC),
Tracey C. Vlahovic